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Abstract 
Many types of immune cells rely on secretory lysosomes to execute their 
function. These specialised organelles perform the catabolic function of 
conventional lysosomes and possess the added capacity to undergo 
regulated exocytosis. In particular, the cytotoxic function of natural killer (NK) 
cells depends on the rapid, polarised secretion of secretory lysosomes, 
known as lytic granules, for the targeted destruction of malignant and virally 
infected cells. Dysregulation of the biogenesis and exocytosis of secretory 
lysosomes is the cause of several severe immunological diseases such as 
Chédiak-Higashi syndrome (CHS). In CHS, mutations in the LYST gene 
result in enlarged secretory lysosomes that cannot undergo exocytosis. 
However, the mechanisms underlying LYST function remain elusive. Here, 
characterisation of the giant lysosome phenotype of beige cells reveals 
altered phosphoinositide metabolism and increased autophagy, indicating a 
potential role for LYST in regulating these pathways. Furthermore, RNA 
interference of LYST recapitulated the giant lysosome phenotype, 
suggesting a strategy for analysis of the pathways in which LYST functions.  
Pharmacological inhibition of the phosphoinositide kinase PIKfyve induces a 
giant vesicle phenotype resembling that in beige cells. However, on further 
analysis PIKfyve inhibition was shown to induce giant endosomes as 
opposed to the giant lysosomes found in beige cells. Despite these 
differences, PIKfyve inhibition, like LYST mutations, reduced NK cell granule 
exocytosis at a late stage in the pathway. Thus, LYST and PIKfyve act upon 
different intracellular compartments but inhibit the formation and exocytosis 
of NK cell granules. These results extend our knowledge of the exocytosis of 
secretory lysosomes within the immune system and suggest future 
strategies to define the pathways by which lysosomal biogenesis and 
exocytosis is regulated. 
  
- iii - 
 
Table of Contents 
Acknowledgements ....................................................................................... i!
Abstract ......................................................................................................... ii!
Table of Contents ........................................................................................ iii!
List of Figures ............................................................................................. vii!
List of Tables ............................................................................................... ix!
Abbreviations ............................................................................................... x!
Chapter 1 Introduction ................................................................................. 1!
1.1! Conventional and Secretory Lysosomes ........................................ 1!
1.1.1! Targeting of Newly Synthesised Lysosomal Proteins 
to Lysosomes ...................................................................... 3!
1.1.2! Endosome Maturation ......................................................... 4!
1.1.3! Delivery of Cargo to Lysosomes ......................................... 7!
1.1.4! PtdIns(3,5)P2 in the Endolysosomal System ....................... 9!
1.1.5! Secretory Lysosomes ....................................................... 13!
1.2! The LYST Protein ......................................................................... 16!
1.2.1! Chédiak-Higashi Syndrome .............................................. 16!
1.2.2! Identification of the LYST/beige Gene and Protein 
Characteristics .................................................................. 17!
1.2.3! Cellular Defects of CHS and LYST Function .................... 20!
1.2.4! LYST-Interacting Proteins ................................................. 27!
1.3! Natural Killer Cells ........................................................................ 29!
1.3.1! Natural Killer Cell Function ............................................... 29!
1.3.2! Formation of the Immunological Synapse ......................... 30!
1.3.3! Mechanisms of Granule Exocytosis .................................. 31!
1.3.4! Lessons from Genetic Diseases ....................................... 36!
1.4! Aims ............................................................................................. 40!
Chapter 2 Materials and Methods ............................................................. 41!
2.1! Culture of Mammalian Cell Lines ................................................. 41!
2.1.1! Cell Line Maintenance ...................................................... 41!
2.1.2! Storage and Recovery ...................................................... 41!
2.2! Human NK Cells ........................................................................... 42!
2.2.1! Isolation of Peripheral Blood Mononuclear Cells .............. 42!
- iv - 
 
2.2.2! Isolation of NK Cells .......................................................... 43!
2.2.3! NK Cell Maintenance ........................................................ 43!
2.2.4! NK Cell Stimulation ........................................................... 43!
2.3! Murine Fibroblasts ........................................................................ 43!
2.3.1! Mice .................................................................................. 44!
2.3.2! Establishment of Fibroblast Cultures ................................ 44!
2.3.3! Fibroblast Purity and Maintenance ................................... 44!
2.4! SV40T Transfection ..................................................................... 44!
2.5! YM201636 Treatment .................................................................. 45!
2.6! Gene Silencing Using Small Inhibitory RNA (siRNA) ................... 45!
2.7! Quantification of Vesiculated Phenotype ..................................... 46!
2.8! Immunofluorescence .................................................................... 47!
2.8.1! Indirect Immunofluorescence ............................................ 47!
2.8.2! Immunofluorescence Analysis of NK-92-K562 
Conjugates ........................................................................ 48!
2.8.3! Plasma Membrane PtdIns(4,5)P2 ...................................... 48!
2.8.4! LysoTracker Staining ........................................................ 51!
2.9! Confocal Microscopy .................................................................... 52!
2.10!Live-Cell Time-Lapse Microscopy ................................................ 52!
2.11!LC3B Puncta Quantification ......................................................... 52!
2.12!Lipid-Overlay Assay ..................................................................... 53!
2.13!Degranulation Assay .................................................................... 54!
2.14!Enzyme-Linked Immunosorbent Assay (ELISA) .......................... 55!
2.15!Assessment of Cell Viability ......................................................... 56!
2.16!Gamma (γ)-Radiation to Induce Senescence .............................. 57!
2.17!Senescence-Associated β-Galactosidase Activity ....................... 57!
2.17.1!X-Gal Colourimetric Assay ................................................ 57!
2.17.2!C12FDG Flow Cytometric Assay ........................................ 57!
2.18!Cell Size Analysis ......................................................................... 58!
2.19!Quantification of Aberrant Nuclei ................................................. 59!
2.20!Quantification of Protein Expression by Western Blotting ............ 59!
2.20.1!Preparation of Cell Lysates ............................................... 59!
2.20.2!Sodium Dodecyl Sulphate-Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) ........................................... 60!
2.20.3!Western Blotting ................................................................ 61!
2.20.4!Probing .............................................................................. 61!
- v - 
 
2.20.5!Densitometry Analysis of Western Blots ........................... 63!
2.21!Quantitative Real-Time Polymerase Chain Reaction (qRT-
PCR) ............................................................................................ 63!
2.21.1!RNA Extraction ................................................................. 64!
2.21.2!RNA Treatment and Quantitation ...................................... 64!
2.21.3!Complementary DNA (cDNA) Synthesis ........................... 64!
2.21.4!qRT-PCR .......................................................................... 65!
2.22!Statistical Analysis ....................................................................... 66!
Chapter 3 Characterisation of the beige Phenotype ............................... 67!
3.1! Introduction .................................................................................. 67!
3.2! Establishment of beige Fibroblast Cultures .................................. 67!
3.3! The Enlarged Vesicles of beige Fibroblasts are Lysosomes ....... 71!
3.4! Enhanced Constitutive Autophagy in beige Fibroblasts ............... 74!
3.5! Altered Abundance of Lipid-Binding Proteins in beige ................. 77!
3.6! Discussion .................................................................................... 81!
Chapter 4 Modelling the beige Phenotype Using RNA Interference ..... 90!
4.1! Introduction .................................................................................. 90!
4.2! Reduction of Lyst Expression Causes Accumulation of 
Enlarged Cytoplasmic Vesicles .................................................... 90!
4.3! Lyst Silencing by siRNA Causes Lysosomal Enlargement 
and Enhancement of Autophagy .................................................. 96!
4.4! Lyst-Silencing Induces Senescent-Like Changes in 
Fibroblasts .................................................................................. 101!
4.5! siLyst 2 Transfection Results in a Failure to Initiate 
Cytokinesis, Aberrant Nuclei and Cell Enlargement .................. 105!
4.6! Off-Target Binding of siLyst 2 and Further siRNA Validation ..... 108!
4.7! Discussion .................................................................................. 113!
Chapter 5 The Inositol Lipid Kinase PIKfyve is Required for the 
Exocytosis of Natural Killer Cell Lytic Granules ........................... 120!
5.1! Introduction ................................................................................ 120!
5.2! PIKfyve Inhibition Induces Endosome Enlargement in 
Fibroblasts .................................................................................. 121!
5.3! PIKfyve Inhibition Impairs NK Cell Lytic Granule Exocytosis 
But Not Cytokine Secretion ........................................................ 123!
5.4! Discussion .................................................................................. 131!
Chapter 6 Conclusion and Future Work ................................................. 139!
6.1! Key Findings .............................................................................. 139!
6.2! Conclusion and Future Work ...................................................... 139!
- vi - 
 
References ................................................................................................ 146!
Appendix ................................................................................................... 166!
 
  
- vii - 
 
List of Figures 
Figure 1.1. The endocytic pathway and delivery to lysosomes ...................... 5!
Figure 1.2. Phosphoinositide conversion by the kinase PIKfyve and the 
phosphatase Sac3 ...................................................................... 9!
Figure 1.3. Domain organisation of LYST and mammalian BEACH proteins
 .................................................................................................. 19!
Figure 1.4. Proposed lytic granule maturation steps and associated proteins
 .................................................................................................. 34!
Figure 1.5. Functions of proteins that are defective in diseases affecting lytic 
granules .................................................................................... 37!
Figure 3.1. Characterisation of beige and SCID fibroblasts ......................... 69!
Figure 3.2. Immortalisation of beige fibroblasts with SV40T ........................ 70!
Figure 3.3. The enlarged vesicles of beige cells are lysosomes .................. 72!
Figure 3.4. The enlarged vesicles of beige have varying LysoTracker 
accumulation ............................................................................. 74!
Figure 3.5. LC3B-associated puncta formation and LC3B processing in 
beige and SCID fibroblasts ....................................................... 77!
Figure 3.6. PtdIns(4,5)P2 localisation in beige fibroblasts ............................ 79!
Figure 3.7. Abundance of PLCγ and PKCβ in beige fibroblasts ................... 81!
Figure 4.1. siRNA-mediated silencing of Lyst expression causes 
accumulation of large cytoplasmic vesicles in 3T3-J2 fibroblasts
 .................................................................................................. 92!
Figure 4.2. Concentration- and time-dependent Lyst mRNA expression and 
vesicular phenotype in siLyst 2-transfected J2-3T3 fibroblasts . 95!
Figure 4.3. Viability assay of siLyst 2-transfected 3T3-J2 fibroblasts ........... 97!
Figure 4.4. The large vesicles in siLyst 2-silenced 3T3-J2 fibroblasts are 
lysosomes ................................................................................. 99!
Figure 4.5. LC3B puncta formation in siLyst 2-silenced 3T3-J2 fibroblasts 100!
Figure 4.6. Cell size is increased in siLyst 2-transfected 3T3-J2 fibroblasts
 ................................................................................................ 102!
Figure 4.7. Growth arrest and SA-β-Gal activity in siLyst 2-transfected 3T3-
J2 fibroblasts ........................................................................... 104!
- viii - 
 
Figure 4.8. Nuclear defects in siLyst 2-transfected cells ............................ 107!
Figure 4.9. Failure to initiate cytokinesis precedes formation of aberrant 
nuclei and cell enlargement in siLyst 2-transfected cells ........ 110!
Figure 4.10. Reduced expression of Tcf7l1 and Tcf7l2 mRNA transcripts in 
siLyst 2-transfected cells ......................................................... 110!
Figure 4.11. Lyst mRNA expression and vesiculation analysis of additional 
siLyst sequences ..................................................................... 112!
Figure 5.1. YM201636 induces enlarged endosomes in 3T3-J2 cells ........ 122!
Figure 5.2. YM201636-treated NK-92 cells are viable ............................... 124!
Figure 5.3. PIKfyve inhibition causes endosome enlargement in NK-92 cells
 ................................................................................................ 126!
Figure 5.4. PIKfyve activity is required for NK cell degranulation but not 
cytokine secretion ................................................................... 127!
Figure 5.5. PIKfyve inhibition does not affect conjugate formation or granule 
polarisation .............................................................................. 130!
Figure 5.6. The proposed function of PIKfyve in the NK lytic granule 
maturation pathway ................................................................. 135!
 
 
  
- ix - 
 
List of Tables 
Table 1.1. Cells containing secretory lysosomes and their function ............. 14!
Table 1.2. Specific functions of known BEACH family members ................. 24!
Table 2.1. Cell lines used in this study, their origin and complete culture 
medium ..................................................................................... 42!
Table 2.2. Sequences of siRNA used in this study ...................................... 46!
Table 2.3. Primary antibodies for immunofluorescence and Western blotting
 .................................................................................................. 50!
Table 2.4. Secondary antibodies for immunofluorescence and Western 
blotting ....................................................................................... 51!
Table 2.5. Antibodies and isotype controls used for flow cytometry ............. 55!
Table 2.6. Buffers and gels used for quantification of protein expression by 
Western blotting ........................................................................ 62!
Table 2.7. Chemicals used for preparation of buffers for Western blotting .. 63!
Table 2.8. TaqMan® gene expression primers used for qRT-PCR .............. 66!
 
  
- x - 
 
Abbreviations 
14-3-3τ Tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, theta polypeptide 
7-AAD  7-amino-actinomycin D 
α   Alpha 
A-SMase  Acid sphingomyelinase 
AKAP550  A kinase anchor protein 550 
ALFY   Autophagy-linked FYVE protein 
AP-1   Adaptor protein 1  
AP-2   Adaptor protein 2  
AP-3   Adaptor protein 3 
AP-4   Adaptor protein 4 
AP-5   Adaptor protein 5 
AP3B1  Adaptor-related protein complex 3, beta 1 subunit 
APS   Ammonium persulphate 
ARM   Armadillo 
ArPIKfyve  Associated regulator of PIKfyve 
Β   Beta 
BEACH  Beige and Chédiak-Higashi syndrome 
BSA   Bovine serum albumin 
C12FDG  5-dodecanoylaminofluorescein di-β-D-
galactopyranoside 
CaCl2   Calcium chloride 
CD-MPR  Cation-dependent mannose-6-phosphate receptor 
CD107a  Cluster of differentiation 107a 
CD11a  Cluster of differentiation 11a  
CD28   Cluster of differentiation 28 
CD63   Cluster of differentiation 63 
- xi - 
 
CDC42  Cell division control protein 42 
cDNA   Complementary deoxyribonucleic acid  
CENPJ  Centromere protein J 
CHS   Chédiak-Higashi syndrome    
CI-MPR  Cation-independent mannose 6-phosphate receptor 
CK2β   Casein kinase II beta 
CO2   Carbon dioxide 
ConA   Concanavalin A 
cSMAC  Central supramolecular activation cluster 
Ct   Cycle threshold 
CTL   Cytotoxic T lymphocyte 
DAG   1,2-Diacylglycerol 
DAPI   4',6-Diamidino-2-phenylindole 
dH20   Deionised water 
ddH20   Double distilled water 
DMSO  Dimethyl sulphoxide 
DNA   Deoxyribonucleic acid 
dATP   Deoxyadenosine triphosphate 
dCTP   Deoxycytidine triphosphate 
dGDP   Deoxyguanosine triphosphate 
dNTP    Deoxyribonucleoside triphosphate 
dTTP   Deoxythymidine triphosphate 
EDTA   Ethylenediaminetetracetic acid 
EEA1   Early endosome antigen 1 
EGF   Epidermal growth factor 
EGTA Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-
tetraacetic acid 
ELISA   Enzyme-linked immunosorbent assay 
F-actin  Filamentous actin 
FACS   Fluorescence-activated cell sorting  
- xii - 
 
FAN   Factor associated with neutral sphingomyelinase activity 
FCS   Foetal calf serum 
FHL   Familial hemophagocytic lymphohistiocytosis 
FHL-3   Familial hemophagocytic lymphohistiocytosis type 3 
FHL-4   Familial hemophagocytic lymphohistiocytosis type 4 
FHL-5   Familial hemophagocytic lymphohistiocytosis type 5 
FITC   Fluorescein isothiocyanate 
FSC   Forward scatter 
FSP1   Fibroblast-specific protein 1 
FYVE    Fab 1, YOTB, Vac 1 and EEA1 
GAPDH  Glyceraldehyde 3-phosphate dehydrogenase 
GFP   Green fluorescent protein 
GLUT4  Glucose transporter type 4 
GTP    Guanosine-5'-triphosphate  
Gy   Gray, unit of radiation 
HCL   Hydrochloric acid 
HEAT Huntingtin, elongation factor 3, protein phosphatase 2A 
and target of rapamycin kinase 1 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HOPS Homotypic fusion and vacuole protein sorting 
Hprt1   Hypoxanthine phosphoribosyltransferase 1 
HPS   Hermansky-Pudlak syndrome 
HPS-2  Hermansky-Pudlak syndrome type 2 
HRS Hepatocyte growth factor-regulated tyrosine kinase 
substrate 
hVps34 Human vacuolar protein sorting 34  
I   Ionomycin 
IFNγ    Interferon gamma 
IL-15   Interleukin 15 
IL-2   Interleukin 2 
- xiii - 
 
ILVs   Intraluminal vesicles 
Ins(1,4,5)P3  Inositol 1,4,5-trisphosphate 
IU   International unit 
K2EDTA  Potassium ethylenediaminetetraacetic acid  
kDa   Kilodaltons 
LAMP1  Lysosome-associated membrane protein 1 
LAMP2  Lysosome-associated membrane protein 2 
LDCV   Large dense core vesicle 
LIMP2   Lysosome integral membrane protein 2 
LRBA Lipopolysaccharide-responsive vesicle trafficking, beach 
and anchor containing 
LvsA   Large volume sphere A 
LvsB   Large volume sphere B 
LYST   Lysosomal trafficking regulator 
M   Molar 
mg   Milligram 
MgCl2   Magnesium chloride 
MHC   Major histocompatability complex 
mL   Millilitre  
mm   Millimetre 
mM   Millimolar 
MPR   Mannose-6-phosphate receptor 
MTOC  Microtubule organising centre 
Munc13-4   Unc-13 homolog 4 
Munc18-2   Unc-13 homolog 2 
MVB   Multivesicular body 
N-SMase  Neutral sphingomyelinase 
NaCl   Sodium chloride 
ng   Nanograms 
NH4Cl   Ammonium chloride 
- xiv - 
 
NK   Natural killer 
nM   Nanomolar 
PBMCs  Peripheral blood mononuclear cells 
PBS   Phosphate buffered saline 
PE   Phycoerythrin 
pH   -log10 concentration of hydrogen ions 
PH   Pleckstrin homology 
PHD   Plant homeodomain 
PI3K   Phosphoinositide 3-kinase 
PIKfyve Phosphoinositide kinase for 5 position containing a 
FYVE finger domain 
PIP5Kβ Phosphatidylinositol 4-phoshate 5-kinase beta 
PIPES  Piperazine-N,N′-bis(2-ethanesulfonic acid) 
PIs   Phosphoinositides 
PKA   Protein kinase A 
PKC   Protein kinase C 
PKCβ   Protein kinase C, beta isoform 
PLC   Phospholipase C 
PLCγ1  Phospholipase C gamma 1 
PLCγ2  Phospholipase C gamma 2 
PLK2   Polo-like kinase 2 
PLK4   Polo-like kinase 4 
PMA   Phorbol 12-myristate 13-acetate  
Pmol   Picomol 
PS   Phosphatidylserine 
pSMAC  Peripheral supramolecular activation cluster 
PtdIns   Phosphatidylinositol  
PtdIns(3)P  Phosphatidylinositol 3-phosphate  
PtdIns(3,4,5)P3 Phosphatidylinositol 3,4,5-trisphosphate  
PtdIns(3,5)P2  Phosphatidylinositol 3,5-bisphosphate  
- xv - 
 
PtdIns(4)P  Phosphatidylinositol 4-phosphate 
PtdIns(4,5)P2 Phosphatidylinositol 4,5-bisphosphate  
Q   Glutamine  
qRT-PCR  Quantitative real-time polymerase chain reaction 
R   Arginine 
Rab27a  Ras-related protein Rab-27A 
Rab5   Ras-related protein Rab-5 
RNA   Ribonucleic acid 
RNAi   Ribonucleic acid interference 
ROI   Region of interest 
RPMI   Roswell Park Memorial Institute  
S100-A4  S100 calcium binding protein A4 
S1P    Shingosine-1-phosphate  
SA-β-Gal  Senescence-associated β-Galactosidase  
SD   Standard deviation 
SDS   Sodium dodecyl sulphate 
siRNA   Small-interfering ribonucleic acid 
Slp1    Synaptotagmin-like protein 1 
Slp2a   Synaptotagmin-like protein 2a  
SM   Sphingomyelin 
SMAC   Supramolecular activation cluster 
SMase  Sphingomyelinase  
SNAP23  Synaptosomal-associated protein of 23 kilodaltons 
SNAP25  Synaptosomal-associated protein of 25 kilodaltons 
SNARE Soluble N-ethylmaleimide sensitive factor attachment 
protein  
SV40   Simian vacuolating virus 40 
SV40T  Simian vacuolating virus 40 T antigen 
TEMED  Tetramethylethylenediamine 
TFEB   Transcription factor EB 
- xvi - 
 
TGN   Trans-Golgi network 
TNF   Tumour necrosis factor 
TNFα   Tumour necrosis factor alpha 
V   Volts 
V-ATPase  Vacuolar type H+-adenosine triphosphatase 
VAMP7  Vesicle-associated membrane protein 7 
v/v   Volume per volume 
w/v   Weight per volume 
WASp   Wiscott-Aldrich syndrome protein 
WD   Tryptophan-aspartic acid 
WIDL   Tryptophan, isoleucine, aspartic acid, leucine 
Wnt   Wingless and Int 
X-gal   5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
YAC   Yeast artificial chromosome 
YM   YM201636  
YOTB   SPBc2 prophage-derived uncharacterized protein YotB 
γ   Gamma 
U   Enzyme unit 
µg   Microgram 
µL   Microlitre 
µm   Micrometre 
µM   Micromolar 
 
- 1 - 
 
Chapter 1 
Introduction 
1.1 Conventional and Secretory Lysosomes  
Lysosomes are dynamic membrane-bound organelles found in all eukaryotic 
cells. Characterised by an acidified lumen containing many soluble 
lysosomal hydrolases, the lysosome is the primary degradative compartment 
of the cell. The term lysosome - meaning ‘digestive body’ - was coined by 
Christian de Duve in 1955 who serendipitously discovered the organelle 
through subcellular fractionation whilst investigating the hydrolase glucose-
6-phosphatase (Duve et al., 1955). The lysosome participates in a wide 
variety of cellular functions aside from bulk degradation, including pathogen 
defence, autophagy, antigen processing, cell signalling, initiation of 
apoptosis and plasma membrane repair (Saftig and Klumperman, 2009). 
Lysosomes are abundant throughout the cytoplasm but cluster proximal to 
the nucleus in the region of the microtubule organising centre (MTOC), 
where they traffic to and from endosomal compartments along microtubules 
(Matteoni and Kreis, 1987). An acidified environment is an absolute 
requirement for the function of lysosomal hydrolases and luminal pH is 
maintained at a range of 4.5–5.0, primarily via the action of a proton-
translocating vacuolar type H+ ATPase (V-ATPase) (Beyenbach and 
Wieczorek, 2006). Lysosomal hydrolases engage in the catabolism of 
macromolecules into their monomeric constituents that are then translocated 
into the cytosol by members of a second class of proteins – the integral 
lysosomal membrane proteins. The translocated monomers can then be 
recycled. The lysosomal membrane also contains a set of highly 
glycosylated proteins, the most abundant of these are the lysosome-
associated membrane protein 1 (LAMP1), LAMP2 and lysosomal integral 
membrane protein type 2 (LIMP2); these molecules are commonly used as 
markers for distinguishing lysosomes from their endosomal counterparts. 
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Specialised secretory cells contain secretory vesicles that fuse with the 
plasma membrane to release their contents in response to external stimuli, 
whilst maintaining a separate lysosomal compartment. However, in a few 
cell types these two functions are merged together into one organelle: a fully 
functioning degradative compartment with similar pH, morphology and 
protein composition to lysosomes, but modified with additional machinery to 
enable them to participate in regulated exocytosis. These bifunctional 
organelles – termed secretory lysosomes – are a type of lysosome-related 
organelle found primarily in haematopoietic cells, but also in melanocytes. 
Examples of such secretory lysosomes include the major histocompatability 
complex (MHC) class II compartments of antigen presenting cells, the lytic 
granules of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, 
basophil granules and platelet dense granules. They are generally 
distinguishable from conventional lysosomes by the presence of specialised 
proteins required for their function and for their secretory capacity, although 
conventional lysosomes are also capable of plasma membrane fusion in a 
Ca2+-dependent manner during plasma membrane repair (Reddy et al., 
2001). 
Several genetic diseases have been described which selectively impair 
secretory lysosome function (Clark and Griffiths, 2003), demonstrating that 
these organelles are equipped with specialised machinery to enable 
secretory function. Studying these diseases has helped to identify vital 
components of the secretory machinery, but their exact functions are not 
fully understood and many proteins are yet to be discovered or 
characterised. The secretory lysosomes of the immune system in particular 
have been characterised in detail, not least because of the readily 
recognisable disease phenotypes, such as susceptibility to infection. Hence, 
investigating the fundamental pathways that underlie the biogenesis and 
exocytosis of secretory lysosomes is important for understanding the 
mechanisms that govern immune responses. 
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1.1.1 Targeting of Newly Synthesised Lysosomal Proteins to 
Lysosomes 
The majority of newly synthesised luminal lysosomal hydrolases and some 
lysosomal membrane proteins are routed through the ‘direct’ pathway from 
the trans-Golgi network (TGN) to the endosome, and subsequently to 
lysosomes. Others adopt an alternative ‘indirect’ pathway of constitutive 
secretion to the cell surface, subsequent internalisation, followed by delivery 
to lysosomes through the endocytic pathway (Bonifacino and Traub, 2003). 
The majority of lysosomal hydrolases are modified in the cis-Golgi by the 
addition of mannose-6-phosphate, and following binding to the mannose-6-
phosphate receptor (MPR) at the TGN, are packaged into clathrin-coated 
intermediates for endosomal delivery (Waguri et al., 2003). Two mannose-6-
phosphate receptors exist: a 46 kDa protein and a 300 kDa protein. Both 
bind mannose-6-phosphate independent of divalent cations, but the small 
receptor binds with greater affinity in the presence of cations. Thus, they are 
named cation-independent (CI)- and cation-dependent (CD)-MPR 
accordingly (Kornfeld and Mellman, 1989). Upon arrival at the late 
endosome, hydrolases dissociate from MPRs at the low pH and continue 
onwards to lysosomes, leaving MPRs free to recycle back to the TGN. 
Mechanisms of endosome-to-TGN retrograde transport will not be discussed 
here in detail but are reviewed in Bonifacino and Rojas (2006). MPR is 
distributed between the Golgi, plasma membrane, early endosomes and late 
endosomes, yet steady-state localisation of the majority of MPR differs 
according to cell type (Griffiths et al., 1990, Geuze et al., 1988, Waguri et al., 
2003).  
Newly synthesised lysosomal membrane proteins on the other hand, are not 
modified with mannose-6-phosphate in the Golgi and instead rely on their C-
terminal sorting motifs for trafficking to lysosomes, either directly or indirectly 
via the plasma membrane. Two well-studied sorting motifs are the tyrosine-
based (YXXØ; where Ø is a bulky hydrophobic amino acid), and dileucine-
based ([E/D]XXXL[L/I]) motifs. These serve as binding domains for subunits 
of the heterotrimeric adaptor protein (AP) complexes AP-1, -2, -3 and -4 
which mediate protein incorporation into transport vesicles at different post-
- 4 - 
 
Golgi compartments (Braulke and Bonifacino, 2009). For many years it was 
presumed there were four AP complexes, mediating the bidirectional 
trafficking of membrane proteins between early endocytic compartments. 
However, proteins facilitating trafficking out of late endosomes and 
lysosomes are less well-characterised. Recently, a fifth complex was 
identified, AP-5, that is a likely candidate for mediating budding from the late 
endosome and its depletion significantly disrupts endocytic trafficking (Hirst 
et al., 2011). The lack of knowledge regarding mechanisms involved in the 
trafficking of late endocytic compartments, coupled with this recent 
discovery, tells us that there is still much to learn about the complex and 
dynamic processes that govern the endosomal and lysosomal systems.  
1.1.2 Endosome Maturation 
Endocytosed plasma membrane proteins, such as receptors (with or without 
their bound ligands), reach the early endosome where they dissociate from 
any bound ligand due to mildly acidic lumenal pH. Early endosomes function 
to sort endocytosed material either for degradation or recycling back to the 
plasma membrane. Morphologically, they are described as having two 
distinct regions: a vacuolar part and a tubular part. The latter is commonly 
referred to as the tubular sorting endosome and is comprised of branching 
tubules that emanate from the vacuolar part (Figure 1.1, Tooze and 
Hollinshead, 1991). Internalised molecules can recycle to the plasma 
membrane directly from the early endosome, or via a distinct subpopulation 
of vesicles; recycling endosomes. Recycling endosomes are typically 
localised to the MTOC where they can form a point of intersection for both 
the endocytic and exocytic pathways (Ménager et al., 2007). The association 
of early endosome-specific proteins such as Ras-related protein 5 (Rab5) 
and human vacuolar protein sorting 34 (hVps34) are essential for preserving 
the identity and function of the organelle. The type III phosphatidylinositol 3-
kinase, hVps34, converts phosphatidylinositol (PtdIns) to phosphatidyl-
inositol 3-phosphate (PtdIns[3]P) (Schu et al., 1993). PtdIns(3)P is central to 
the recruitment of a number of effector proteins to the early endosomal 
membrane.  
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Figure 1.1. The endocytic pathway and delivery to lysosomes 
A basic schematic representation of the endosome maturation pathway and 
delivery of cargo to lysosomes. Endocytosed plasma membrane proteins are 
delivered to the early endosome where they are sorted for further trafficking (1). 
Proteins destined for recycling enter the tubular sorting endosome to be recycled 
back to the plasma membrane directly or via recycling endosomes, or to the trans-
Golgi network (TGN). Proteins destined for degradation are retained in the vacuolar 
sorting endosome for delivery to lysosomes. Proposed mechanisms for endosome 
maturation include gradual acidification (indicated by the transition from orange 
through to pink), loss of Rab5 in exchange for Rab7, conversion of PtdIns(3)P to 
PtdIns(3,5)P2 and intraluminal vesicle (ILV) formation (2). Late endosome-lysosome 
fusion permits the degradation of the delivered molecules (3). Autophagosomes (4), 
formed from double membranes that engulf portions of the cytoplasm and 
organelles, fuse with lysosomes for degradation and nutrient recycling during 
starvation. Similarly, engulfed pathogens contained within phagosomes (5) are 
degraded by the lysosome. Newly synthesised lysosome-resident proteins are 
delivered from the TGN to early and late endosomes for subsequent transit to 
lysosomes, or via the plasma membrane (not shown) for subsequent re-
internalisation and endocytic delivery.  
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One such protein is early endosomal antigen 1 (EEA1) that binds PtdIns(3)P 
through its FYVE (Fab 1, YOTB, Vac 1 and EEA1) domain (Gillooly et al., 
2003) and is important for various endosomal trafficking and fusion events 
(Johnson et al., 2006, Roth, 2004).  
Early endosomes undergo a multitude of changes that eventually lead to 
their maturation into late endosomes. The exact modifications and 
mechanisms vary according to cell type but include acidification, 
vesiculation, conversion of PtdIns(3)P to PtdIns(3,5)P2, protein exchange, 
change in morphology and the acquisition of newly synthesised lysosomal 
hydrolases and membrane proteins (Figure 1.1; Huotari and Helenius, 
2011). The inward budding of the endosomal membrane at discrete domains 
internalises ubiquitinated membrane-bound cargo into intraluminal vesicles 
(ILVs) ensuring their degradation upon delivery to the lysosomal lumen. The 
mechanisms mediating the transition from early- to late-endosomes are 
highly debated and several models have been proposed. One possibility is 
that early endosomes undergo protein remodelling; losing endosomal 
markers Rab5 and EEA1 in exchange for late endosomal markers such as 
Rab7. Evidence for such a transition comes from studies of Caenorhabditis 
elegans whereby early endosomes undergo a Rab5-to-Rab7 ‘switch’ that 
mediates their maturation to late endosomes (Poteryaev et al., 2010). An 
alternative model is that early and late endosomes exist as discrete entities 
with material passed between the organelles via transport carrier vesicles 
(Vonderheit and Helenius, 2005). Mesaki and colleagues, however, report 
the detachment of the entire tubular endosome from the vacuolar endosome, 
triggering the acidification and maturation of the remaining vacuolar part 
(Mesaki et al., 2011). It is conceivable that both direct maturation and 
exchange of content between organelles occurs. Carrier vesicles may be 
utilised for transporting cargo from early endosomes that requires rapid 
transit to late endosomes for the degradation pathway, for example viruses 
(Vonderheit and Helenius, 2005), whilst the early endosome undergoes a 
relatively slower and complex maturation process. Regardless of the 
mechanisms of formation, late endosomes become refractory to fusion with 
early endosomes, yet continue to receive newly synthesised lysosomal 
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hydrolases and membrane proteins from the TGN, such as LAMP1 and 
CD63 (Ihrke et al., 2004). 
Late endosomes are often referred to as multivesicular bodies (MVBs) 
because of their numerous ILVs. ILV formation begins with early endosomes 
and continues during endosome maturation (Futter et al., 1996). ILV 
formation is mainly co-ordinated by four ESCRT complexes (endosomal 
sorting complexes required for transport); ESCRT-0, -I, -II and –III, together 
with a number of accessory proteins (Hurley, 2010). The role of ESCRTs is 
to sort ubiquitinated membrane proteins into discrete domains of the 
endosome limiting membrane and generate inward budding vesicles. 
Phosphoinositides (PIs) are critical for MVB-dependent cargo sorting as 
several ESCRT proteins are recruited to endosomes by PtdIns(3)P, and to a 
lesser extent by PtdIns(3,5)P2 (Hurley, 2010). Similar to the Rab ‘switch’, the 
conversion of PtdIns(3)P to PtdIns(3,5)P2 is important for endosome 
maturation and is coordinated by the action of specific kinases and 
phosphatases. PtdIns(3,5)P2 is central to endosomal homeostasis as 
depletion of PtdIns(3,5)P2 causes the gross swelling of early and/or late 
endosomes (Ikonomov et al., 2006, Jefferies et al., 2008, Osborne et al., 
2008). The role of PtdIns(3,5)P2 is discussed in more detail in section 1.1.4. 
1.1.3 Delivery of Cargo to Lysosomes 
Several models have been proposed for the delivery of endocytosed cargo 
from late endosomes to lysosomes. These include vesicular transport, late 
endosome-lysosome maturation and fusion of the two organelles (Luzio et 
al., 2007). Based on substantial evidence provided by studies utilising time-
lapse microscopy that describe late endosome-lysosome fusion in live cells, 
this is currently the most widely accepted mechanism for content delivery to 
lysosomes (Futter et al., 1996, Bright et al., 1997, Mullock et al., 1998, Bright 
et al., 2005).  
Time-lapse confocal microscopy of normal rat kidney fibroblasts revealed 
that fusion can be transient, whereby late endosomes and lysosomes 
engage in temporary fusion, exchanging luminal content before separating in 
a process termed ‘kiss-and-run’. Or it can be direct, producing a single 
‘hybrid’ organelle (Bright et al., 2005). In the same study, content mixing also 
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occurred via tubular extensions that emanated from either organelle. 
Following the complete fusion of a late endosome and lysosome and the 
bulk degradation of macromolecules, it is proposed that retrieval of late-
endosomal proteins and membrane from the hybrid organelle permit the 
reformation of a fully condensed and acidified lysosome (Bright et al., 1997, 
Mullock et al., 1998). Evidence supporting this comes from studies which 
observe the budding and detachment of vesicles away from the hybrid 
organelle shortly after formation (Bright et al., 2005).  
Fusion between closely proximal late endosomes and lysosomes requires 
tethering, likely mediated by the mammalian homotypic fusion and vacuole 
protein sorting (HOPS) complex, and transmembrane soluble N-
ethylmaleimide sensitive factor attachment protein receptors (SNAREs) 
together with Ca2+ (Pryor and Luzio, 2009). SNARE proteins from opposing 
membranes form a trans-SNARE complex composed of a four-helix bundle; 
three of which contain a glutamine (Q) residue and one an arginine (R) 
residue. They are therefore referred to as Q-SNARES and R-SNARES 
respectively (Pryor and Luzio, 2009). 
Lysosomes also receive material for degradation from the autophagic and 
phagocytic pathways by fusing with autophagosomes and phagosomes 
respectively (Figure 1.1). Autophagosomes are organelles that form during 
periods of nutrient starvation when a double membrane envelops and 
sequesters a portion of the cytoplasm which may contain whole organelles 
(Mizushima and Komatsu, 2011). The subsequent fusion with lysosomes to 
form a hybrid organelle, called the autolysosome, permits the degradation 
and recycling of sequestered material and the release of nutrients back into 
the cytoplasm. Autophagosome-lysosome fusion is dependent on the acidic 
pH of the lysosome, as raising lysosomal pH (for example, with chloroquine) 
prevents the formation of autolysosomes, resulting in the build-up of 
autophagosomal structures in the cytoplasm (Kawai et al., 2007). Similarly, 
the fusion of lysosomes with phagosomes containing engulfed extracellular 
pathogens is essential for the protection against microorganisms (Huynh et 
al., 2007). 
- 9 - 
 
1.1.4 PtdIns(3,5)P2 in the Endolysosomal System  
PtdIns(3,5)P2 is generated by the phosphatidylinositol 3-phosphate 5-kinase 
PIKfyve (Phosphoinositide kinase for 5-position containing a FYVE finger 
domain) which catalyses the phosphorylation of PtdIns(3)P on the 5-position 
of the inositol ring (Sbrissa et al., 1999). PtdIns(3,5)P2 is essential for 
endomembrane homeostasis as depletion of PtdIns(3,5)P2 causes extensive 
vacuolation of the cytoplasm (Jefferies et al., 2008). Inhibition of PIKfyve 
activity, either through expression of kinase-dead mutants, RNA interference 
(RNAi) or pharmacological inhibition, causes the initial enlargement of early 
endosomes, followed by the appearance of grossly enlarged early 
endosomes, large endosomes or both (Rutherford et al., 2006, Jefferies et 
al., 2008, Osborne et al., 2008). The origin of the affected vesicles and the 
extent of enlargement varied according to different studies, likely due to the 
method of PIKfyve depletion (dominant negative, RNAi or pharmacological 
inhibition) and the cell type being investigated. PIKfyve is located both in the 
cytoplasm and on vesicle membranes, targeted to PtdIns(3)P-rich 
membranes via its FYVE domain. It forms a tetrameric complex with its 
scaffolding regulator ArPikfyve and the PtdIns(3,5)P2 phosphatase Sac3 
(Sbrissa et al., 2008). This complex, known as PAS (for PIKfyve, ArPikfyve 
and Sac3), enables the rapid turnover of PtdIns(3,5)P2 at sites of synthesis 
(Figure 1.2, Sbrissa et al., 2008).  
 
 
Figure 1.2. Phosphoinositide conversion by the kinase PIKfyve and the 
phosphatase Sac3 
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A role for PIKfyve and PtdIns(3,5)P2 in the morphogenesis and function of 
late endosomes comes from studies in human embryonic kidney cells 
overexpressing dominant-negative kinase-deficient PIKfyve, which display 
enlarged late endosomes containing a reduced number or ILVs (Ikonomov et 
al., 2003a). However, the mechanisms underlying this function of PIKfyve 
are unclear. Initially, the expression of kinase-deficient PIKfyve results in the 
formation of EEA1-positive large endosomes. At later time points this is 
followed by the appearance of large perinuclearly clustered vesicles positive 
for CI-MPR that are described as late endosomes (Ikonomov et al., 2001, 
Ikonomov et al., 2003a). Similarly, both early- and late-endosomal 
enlargement occurs during PIKfyve silencing (Rutherford et al., 2006). 
Several studies have also demonstrated a role for PIKfyve in endosomes-to-
TGN retrograde protein trafficking (Rutherford et al., 2006, de Lartigue et al., 
2009), although the reports concerning trafficking of CI-MPR to the TGN are 
conflicting. Pharmacological inhibition of PIKfyve does not significantly affect 
CI-MPR trafficking (Jefferies et al., 2008) whereas trafficking of CI-MPR to 
the TGN is delayed upon silencing of PIKfyve (Rutherford et al., 2006). 
These discrepancies are likely attributed to the differences in cell types used 
and the duration of suppressed PIKfyve activity, with longer suppression 
achieved by PIKfyve silencing. Furthermore, the exact localisation of PIKfyve 
remains elusive, as the abundance of PIKfyve in many cell types is too low 
for robust detection by antibodies. Overexpressed wild-type PIKfyve was 
found to localise to late endosomes in COS cells, but to early endosomes in 
HeLa cells (Shisheva et al., 2001). It is suggested that PIKfyve cycles 
between membranes depending on their PtdIns(3)P/PtdIns(3,5)P2 content 
and that the rate of conversion differs between cell types, resulting in the 
variable localisation of PIKfyve (Shisheva, 2008). Nonetheless, these studies 
support a role for PIKfyve-mediated PtdIns(3,5)P2 synthesis in regulating 
endosome fusion/fission events and in maintaining correct endosomal 
trafficking.  
In addition to endocytic trafficking, PIKfyve also functions in glucose 
transport and regulated exocytosis (Ikonomov et al., 2002b, Osborne et al., 
2008). Insulin-induced translocation of the glucose transporter type 4 
(GLUT4) to the cell surface is reduced upon expression of a kinase-deficient 
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PIKfyve mutant in adipocytes (Ikonomov et al., 2002b, Ikonomov et al., 
2007). Although the mechanism by which this occurs is undefined, these 
studies suggest PIKfyve positively regulates the insulin-stimulated 
translocation of GLUT4 storage vesicles to the plasma membrane. 
Conversely, nicotine-stimulated exocytosis of large dense core vesicles 
(LDCV) is upregulated in neurosecretory cells during pharmacological 
inhibition of PIKfyve, suggesting that PIKfyve negatively regulates the 
exocytosis of these vesicles (Osborne et al., 2008). The generation of 
PtdIns(3)P on LDCV membranes is considered a priming factor for plasma 
membrane fusion (Osborne et al., 2008). Upon nicotine stimulation of PC12 
cells, PIKfyve was recruited to a subpopulation of LDCVs where it is 
proposed to prevent the over-secretion of a pool of primed granules through 
the depletion of PtdIns(3)P (by conversion to PtdIns[3,5]P2; Osborne et al., 
2008). It is likely that the function of PIKfyve with regards to vesicle 
exocytosis varies according to cell type, the secretory organelle and the 
mechanism of organelle biogenesis. Nonetheless, the relocation of PIKfyve 
to secretory vesicles from the cytoplasm upon extracellular stimuli appears 
important for its function. Further work examining the effect of PIKfyve on 
exocytosis in other cell types is required before the extent of PIKfyve-
mediated secretory regulation becomes clear.  
PIKfyve was recently shown to be responsible for the synthesis of the total 
intracellular pool of PtdIns(3,5)P2 (Zolov et al., 2012). It is also the major 
source of PtdIns(5)P synthesis through the phosphorylation of PtdIns 
(Ikonomov et al., 2011). Currently no other kinases are known to contribute 
to the synthesis of these two lipids. The disrupted endosomal morphology 
observed during PIKfyve activity suppression is mediated solely through the 
loss of PtdIns(3,5)P2, as micro-injection of PtdIns(3,5)P2, but not PtdIns(5)P, 
into vacuolated cells reversed the phenotype (Ikonomov et al., 2002a). The 
functional importance of cellular PtdIns(5)P is less well documented than for 
PtdIns(3,5)P2. PIKfyve is vital in early embryonic development as 
conventional mouse knockout causes early embryonic lethality (Ikonomov et 
al., 2011). Mutations in PIKfyve are associated with Francois-Neetens 
corneal fleck dystrophy, an autosomal dominant syndrome characterised by 
numerous white flecks throughout the stroma and the presence of enlarged 
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vesicles within keratinocytes (Li et al., 2005). The disease is non-progressive 
and relatively asymptomatic, resulting from predominantly frame-shift or 
nonsense mutations within the PIKFYVE gene which are predicted to be 
protein-truncating (Li et al., 2005). Interestingly, although complete knockout 
of Pikfyve is lethal in mice, a single functional Pikfyve allele in heterozygotes 
is sufficient to support normal development into adulthood and mice lack the 
pathology of corneal fleck dystrophy (Ikonomov et al., 2011).  
Mutations in the other PAS complex genes, Arpikfyve and Sac3, produce 
more severe phenotypes. ArPIKfyve functions as a scaffold for PIKfyve and 
is essential for PIKfyve-mediated PtdIns(3,5)P2 production (Sbrissa et al., 
2008). Arpikfyve-null mice die within two days after birth and exhibit severe 
neurodegeneration (Zhang et al., 2007b). The function of the phosphatase 
Sac3 is opposite to that of PIKfyve and reduces PtdIns(3,5)P2 levels 
(Sbrissa et al., 2008). Interestingly, loss of Sac3 results in an unexpected 
loss of stead-state PtdIns(3,5)P2, rather than an increase. Similar to 
Arpikfyve-null mice, ‘pale tremor’ Sac3-null mice exhibit neurodegeneration 
as well as diluted pigmentation and die within the first six weeks of life 
(Chow et al., 2007). Furthermore, mutations in human Sac3 are associated 
with a form of the peripheral nerve disorder Charcot-Marie-Tooth disease 
type 4. The reason for reduced PtdIns(3,5)P2 in the absence of Sac3 is as 
yet undetermined, but these findings emphasise the functional requirement 
of a full PAS complex for PIKfyve-mediated PtdIns(3,5)P2 production, and 
that loss of either ArPIKfyve and Sac3 result in neuropathy associated with 
decreased PtdIns(3,5)P2.  
Despite extensive investigation, the exact roles of PtdIns(3,5)P2 and PIKfyve 
in the endolysosomal system remain unclear. The lack of PtdIns(3,5)P2-
specific probes and the pleiotropic functions of PIKfyve make it difficult to 
draw definitive conclusions regarding the mechanistic link between PIKfyve 
suppression and endosomal morphology/trafficking.  
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1.1.5 Secretory Lysosomes 
Only a few cell types rely on secretory lysosomes to carry out their specific 
effector functions (Table 1.1). These can be distinct organelles that coexist 
with conventional lysosomes, as in melanocytes (Raposo et al., 2001), or the 
sole degradation compartment, as in NK cells and CTLs (Burkhardt et al., 
1990, Peters et al., 1991). The effector function of NK cells and CTLs 
requires the exocytosis of their secretory lysosomes (termed lytic granules in 
these cells) to release cytolytic proteins that initiate apoptosis in recipient 
cells (de Saint Basile et al., 2010). Lytic granules and the molecular 
machinery required for their secretion will be discussed in detail in Section 
1.3. Much of our insight into the biogenesis, regulation and secretion of 
secretory lysosomes has been gained from the study of genetic diseases in 
humans and mammals. Many of theses diseases have similar clinical 
phenotypes, such as hypopigmentation and immunodeficiency, owing to the 
defective function of immune cells and melanocytes.  
Hermansky-Pudlak syndrome (HPS) is an autosomal recessive disease with 
eight causative genes identified in humans (Wei, 2006). It is characterised 
by hypopigmentation, immunodeficiency and bleeding diathesis due to 
abnormal synthesis and/or vesicular trafficking of melanosomes, lytic 
granules and platelet dense granules, respectively, indicating that the 
affected proteins are common to all secretory lysosomes. Mutations in the 
AP3B1 gene encoding the β3A subunit of AP-3 are the cause of HPS type 2 
(HPS-2) and result in the miss-sorting of lysosomal and secretory lysosomal 
proteins such as LAMP1 and LAMP2 (Dell'Angelica et al., 1999). HPS-2 
patients also suffer immunodeficiency as a result of defective NK cell and 
CTL cytotoxicity (Clark et al., 2003). Chédiak-Higashi syndrome (CHS) is a 
similar disorder characterised by hypopigmentation, immunodeficiency and 
neurologic dysfunction that arise from mutations in the lysosomal trafficking 
regulator (LYST) gene (previously known as CHS1, Perou et al., 1996).  
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Cell Type Cell-Specific Secretory Lysosome Specific Content Function  Reference 
NK cell Lytic granule Granzymes, perforin Cell-mediated cytotoxicity de Saint Basile et al., 2010 
CTL Lytic granule Granzymes, perforin Cell-mediated cytotoxicity de Saint Basile et al., 2010 
Platelet Platelet dense granule Aggregation factors Clotting McNicol and Israels, 1999 
Mast cell Mast cell granule Histamine, serotonin Inflammation Marone et al., 1997 
Basophil Basophil cell granule Histamine, serotonin Inflammation Marone et al., 1997 
Neutrophil Azurophil granule Chemoattractants Inflammation, phagocytosis Kjeldsen et al., 1998 
Macrophage MHC class II compartment MHC class II Antigen presentation Phagocytosis Harding, 1995 
Dendritic cell MHC class II compartment MHC class II Antigen presentation Harding, 1995 
B cell MHC class II compartment MHC class II Antigen presentation Harding, 1995 
Osteoclast  Acid hydrolases Bone remodelling Stenbeck, 2002 
Melanocyte Melanosome Melanin Skin pigmentation  Raposo et al., 2001 
Table 1.1. Cells containing secretory lysosomes and their function 
This table provides examples of well-studied secretory lysosomes, but is not an exhaustive list. Secretory lysosomal content differs depending on 
cell type and function. The major protein constituents of each secretory lysosome type, their associated functions and relevant references are 
shown. Melanosomes are the pigment granules of melanocytes that are the site of synthesis and storage of melanin. They translocate to the cell 
periphery via microtubule-based transport where they pass from melanocyte dendrites to keratinocytes in a poorly understood mechanism. 
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Osteoclasts mediate bone remodelling through exocytosis of their secretory 
lysosomes (there is no specific term for these organelles in osteoclasts) and the 
released lysosomal hydrolases degrade the bone. Platelet dense granules (also 
known as delta granules or dense bodies) contain factors which mediate platelet 
aggregation and the formation of the haemostatic plug. Stimulation of basophils and 
mast cells causes the release of histamine and serotonin from secretory lysosomes 
that initiate an inflammatory response. MHC class II compartments are found within 
the professional antigen presenting cells B cells, macrophages and dendritic cells 
and contain proteins important for antigen processing and binding of the resulting 
peptides with MHC class II molecules. Natural killer (NK) cells and cytotoxic T 
lymphocytes (CTLs) exocytose their lytic granules to release cytolytic proteins that 
initiate apoptosis in recipient cells. Adapted from Blott and Griffiths, 2002. 
 
The exact function of LYST is unknown, but it is thought to regulate protein 
and vesicular trafficking to and from lysosomes and secretory lysosomes, as 
these organelles are grossly enlarged in CHS patients cells (Burkhardt et al., 
1993). The role of LYST in lysosome and secretory lysosome morphology 
will be reviewed in detail in Section 1.2. 
Patients with Griscelli syndrome type 2 exhibit a similar clinical presentation 
to CHS patients, presenting with hypopigmentation of the skin, 
immunodeficiency and neurologic dysfunction (Ménasché et al., 2000). 
Autosomal recessive mutations in RAB27A encoding a member of the Rab 
family of small GTPases involved in membrane trafficking are the cause of 
Griscelli syndrome type 2. Through the recruitment of different effector 
proteins in each cell type, Rab27a (Ras-related protein Rab-27A) mediates 
the transfer of melanosomes from microtubules to the plasma membrane in 
melanocytes (Hume et al., 2001) and the docking of lytic granules to the 
plasma membrane in CTLs and NK cells (Neeft et al., 2005). The inability of 
lytic granules to dock at the plasma membrane means they are not secreted 
and the cells lack cytotoxic function (Neeft et al., 2005).  
Defects in lysosomal pathways that arise through single gene mutations, are 
the cause of many rare and severe human genetic diseases. CHS, HPS-2 
and Griscelli syndrome type 2 all share a common clinical phenotype of 
albinism and immunodeficiency, arising from the selective dysfunction of 
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cells with secretory lysosomes, suggesting common mechanisms for 
biogenesis and function shared by these organelles. Dissecting the 
molecular mechanisms underlying these conditions has revealed many 
novel proteins and continues to provide invaluable insight into the processes 
behind cellular function. Uncovering cell-specific mechanisms in lysosome 
and secretory lysosome biogenesis/homeostasis is essential to further our 
understanding of this complex process and to help fill the gaps in our current 
knowledge. 
1.2 The LYST Protein 
1.2.1 Chédiak-Higashi Syndrome 
CHS was first described over 70 years ago and is named after the Cuban 
serologist Alejandro Moisés Chédiak and the Japanese paediatrician 
Otokata Higashi. CHS is a rare childhood autosomal recessive disorder 
characterised by partial oculocutaneous albinism, bleeding diathesis, 
immunodeficiency and neurologic dysfunction which present within the first 
decade of life. The hallmark of this disease at the cellular level is a 
remarkable clustering of abnormally large lysosomes proximal to the nucleus 
(Abe et al., 1982, Burkhardt et al., 1993). Although the ‘giant’ lysosomes are 
present in all cells, the clinical symptoms arise from the impaired exocytosis 
of cells with secretory lysosomes, such as melanocytes, platelets, CTLs and 
NK cells (Baetz et al., 1995, Targan and Oseas, 1983). The condition is 
often fatal in early childhood, usually as a result of recurrent or severe 
infections or from hemophagocytic lymphohistiocytosis; a widespread 
infiltration of lymphocytes and histiocytes into major organs, often referred to 
as the ‘accelerated phase’ of the disease (Shiflett et al., 2002). Central to the 
patho-physiology of hemophagocytic lymphohistiocytosis is the defective 
cytotoxicity of NK and CTLs (Targan and Oseas, 1983, Baetz et al., 1995, 
Barrat et al., 1999). This failure of cytotoxicity results in the persistence of 
the pathogen, with sustained but abortive attempts at clearance resulting in 
prolonged activation and proliferation of CTLs and the sustained secretion of 
cytokines, thus culminating in the massive infiltration of macrophages and 
dendritic cells into tissues (Jordan et al., 2004). Treatment consists of 
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prophylactic antibiotics and bone marrow transplantation to alleviate the 
immunological defects (Eapen et al., 2007). Despite this, patients who 
receive bone marrow transplantation and live past adolescence later develop 
neurologic dysfunction (Tardieu et al., 2005). Approximately 10% of all 
sufferers exhibit a milder form of CHS and survive to adulthood without bone 
marrow transplantation. Nonetheless, these patients also develop neurologic 
symptoms. Neurologic degeneration is not thought to occur from lymphocyte 
infiltration into the central nervous system, but instead from defective LYST 
function in neurons and glial cells (Tardieu et al., 2005). CHS can often be 
confused with HPS-2 and Griscelli syndrome type 2 given the similar initial 
clinical presentations of hypopigmentation and immunologic dysfunction. 
Distinction can be made easily with a peripheral blood smear that reveals 
giant granules in polymorphonuclear leukocytes in CHS.  
1.2.2 Identification of the LYST/beige Gene and Protein 
Characteristics 
LYST is located on chromosome 1 and the murine homologue beige is 
located on chromosome 13 (Barrat et al., 1996, Justice et al., 1990). LYST is 
one of the largest genes in the human genome; containing 55 exons with a 
corresponding protein of 3801 amino acids and a predicted molecular weight 
of 429 kDa. Human and mouse LYST share 85% amino acid identity and the 
beige mouse has long been studied as a model of CHS because of the 
similar cellular and pathological characteristics: hypopigmentation, bleeding 
and immune cell dysfunction together with the presence of giant lysosomes 
(Burkhardt et al., 1993). Perou and colleagues observed that fusion of wild-
type fibroblasts with beige fibroblasts complemented the lysosomal defect, 
but complementation was not observed between beige and CHS fibroblasts, 
confirming that the defects originated from orthologous genes (Perou and 
Kaplan, 1993a). The 5’ and 3’ ends of the beige sequence were 
independently cloned by two groups in 1996 using positional cloning 
techniques and in vitro yeast artificial chromosome (YAC) complementation 
(Barbosa et al., 1996, Perou et al., 1996). The full length human LYST gene 
was soon afterwards identified by Nagle and colleagues, confirming that the 
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two sequences previously identified belonged to the same gene (Nagle et 
al., 1996).  
LYST is predicted to be cytosolic based on the absence of identifiable 
transmembrane domains. LYST belongs to the BEACH (for beige and CHS) 
family of proteins, which in mammals includes FAN (factor associated with 
neutral sphingomyelinase), neurobeachin, LRBA (lipopolysaccharide-
responsive vesicle trafficking, beach and anchor-containing) and ALFY 
(autophagy-linked FYVE protein). All of which carry BEACH and WD40 
domains in their C-terminals (Figure 1.3). Although the function of the 
BEACH domain is unknown, it is highly conserved across several species 
and contains the amino acid sequence WIDL (tryptophan, isoleucine, 
aspartic acid, leucine), in addition to other conserved amino acids (Figure 
1.3). BEACH proteins with known function are implicated in vesicle 
trafficking, membrane dynamics, autophagy and receptor signalling (Kwak et 
al., 1999, Wang et al., 2000, Montfort et al., 2010, Filimonenko et al., 2010). 
The WD40 domain of LYST contains seven tandem WD40 repeats (Nagle et 
al., 1996). WD40 repeats are short (typically 40 amino acids) sequences that 
form β-sheets, often ending with tryptophan and aspartic acid (WD). Tandem 
repeats fold into multi-bladed β-propeller structures that are thought to 
mediate protein-protein interactions (Li and Roberts, 2001). LYST also 
contains a perilipin domain (potentially lipid binding) and a series of 
hydrophobic helices which resemble ARM (armadillo) and HEAT (Huntingtin, 
Elongation factor 3, protein phosphatase 2A and TOR1) motifs (Figure 1.3, 
Nagle et al., 1996). ARM and HEAT motifs are also thought to mediate 
protein-protein interactions and are found in proteins with a diverse array of 
functions, including some involved in vesicular trafficking (Andrade et al., 
2001).  
Crystal structure analyses of the BEACH domain from neurobeachin and 
LRBA have revealed the presence of a novel pleckstrin homology (PH) 
domain; the sequence of which is weakly conserved among many BEACH 
proteins, including LYST (Figure 1.3, Jogl et al., 2002, Gebauer et al., 2004). 
PH domains can be phospholipid binding (important in recruiting proteins to 
membranes; Haubert et al., 2007), or protein binding (Yao et al., 1994).  
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Figure 1.3. Domain organisation of LYST and mammalian BEACH 
proteins 
All members of the BEACH family contain a BEACH domain of unknown function 
and a varying number of WD40 repeats, thought to mediate protein-protein 
interactions. The perilipin domain of LYST is potentially lipid-binding and the 
concanavalin A (conA)-like lectin domain identified in several BEACH family 
members may mediate oligosaccharide binding. The pleckstrin homology (PH) 
domain closely associated with the BEACH domain is thought to function as single 
unit in Neurobeachin, LRBA and FAN. ALFY is the only mammalian BEACH protein 
that contains the PtdIns(3)P-binding domain FYVE.  
 
Structural analysis and protein binding assays demonstrate a strong 
interaction between the PH and BEACH domains. Mutating the PH domain 
reduces the BEACH-dependent signalling activity of FAN (Jogl et al., 2002), 
suggesting that the PH domain is required for BEACH domain function. 
Although structural analysis for LYST is not available, the strong interactions 
demonstrated between the PH and BEACH domains of FAN, LRBA and 
neurobeachin suggest a similar interaction might occur in LYST. 
Recently, a concanavalin A-like lectin domain was identified in LYST that is 
also present in other BEACH family members (Figure 1.3, Burgess et al., 
2009). The authors propose that the domain may mediate oligosaccharide 
binding and trafficking of vesicle fusion machinery components, due to the 
significant similarity of the domain with the concanavalin A-like lectin domain 
of clostridial neurotoxins which carry out a similar function (Burgess et al., 
2009). In support of this hypothesis, LYST has been found to interact with 
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hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), a 
protein which binds and inhibits SNAP25 (synaptosomal-associated protein 
of 25 kDa), a component of the SNARE fusion complex required for synaptic 
vesicle exocytosis (Tchernev et al., 2002). Furthermore, evidence that the 
concanavalin A-like lectin domain is important for LYST function is 
demonstrated by the finding that mutations in this domain are associated 
with CHS (Karim et al., 2002).  
While mutations spanning the entire human LYST gene are reported, the 
clinical phenotype of CHS varies according to the mutation. Karim and 
colleagues found that severe early-onset disease was associated with 
truncating mutations predicted to abolish expression of the full-length 
peptide, whereas missense mutations that likely encode proteins with partial 
function, gave rise to a milder disease phenotype with a delayed onset and 
survival to adulthood (Karim et al., 2002). Although several beige mutant 
alleles have been identified, the two most frequently studied are Lystbg and 
Lystbg-J. The Lystbg allele arose from the radiation-induced retrotransposition 
of a LINE1 element into the Lyst gene and is predicted to encode a 
truncated protein product missing 1442 amino acids from the C-terminus that 
contains the BEACH and WD domains (Perou et al., 1997b). The Lystbg-J 
allele carries a three base pair deletion resulting in the loss of isoleucine at 
position 3741, predicted to disrupt the seventh WD40 repeat of the encoded 
protein (Trantow et al., 2009).  
LYST/beige is the only gene to be associated with CHS and identification of 
several functional protein domains has not provided an explanation as to the 
function of this large and highly conserved protein. The following section will 
discuss the effect of LYST deficiency at the cellular level and discuss recent 
work surrounding its proposed function. 
1.2.3 Cellular Defects of CHS and LYST Function 
The abnormal enlargement and clustering of lysosomes and lysosome-
related organelles is a hallmark of CHS. Although the abnormal morphology 
occurs in all cells, the clinical manifestations of the disease are associated 
with the defective biogenesis and/or secretion of lysosome-related 
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organelles (Ward et al., 2000, Ward et al., 2002, Kaplan et al., 2008). 
Unfortunately, the large size of the LYST gene and protein render it difficult 
to study as a whole by many conventional molecular approaches, impeding 
the gain of useful functional information. Furthermore, the low expression 
level of LYST and lack of a specific working antibody have made 
determining the cellular localisation difficult.  
Although lysosomes are enlarged and fewer in number in CHS/beige cells, 
the total volume of acidic compartments per cell is the same as in wild type 
cells (Burkhardt et al., 1993). Therefore, the reduced lysosome number is 
attributed to either increased heterotypic lysosome fusion or reduced fission, 
rather than reduced biosynthesis. Initial studies suggested that the giant 
organelles form as a result of aberrant heterotypic lysosome fusion (White 
and Clawson, 1980, Willingham et al., 1981, Perou and Kaplan, 1993b). 
Studies of CTLs from CHS patients indicated that lytic granule biogenesis is 
normal, but as the granules mature, they grow in size and become less 
numerous (Stinchcombe et al., 2000). It is difficult to distinguish from these 
studies whether vesicle enlargement is due to increased fusion or reduced 
fission, as vesicle fission events were not examined. Compelling evidence 
that lysosomal enlargement in CHS/beige cells is the result of reduced 
fission rates comes from a study in which overexpression of murine Lyst in 
fibroblasts results in the presence of very small lysosomes located near the 
cell periphery (Perou et al., 1997a). The lysosomes were smaller in size than 
those observed in cells with normal Lyst protein levels, strongly supporting 
the hypothesis that Lyst positively regulates lysosome fission. This was 
recently substantiated by Durchfort and colleagues, who, using live-cell time-
lapse microscopy, found a decreased rate of lysosome fission in beige 
macrophages, while the rate of fusion remained unchanged (Durchfort et al., 
2012). This is the only study to date which specifically examines fission 
events in Lyst-deficient cells. Studies in other cell types examining fission in 
such detail are required before a definitive conclusion can be drawn about 
the role of LYST in vesicle fusion/fission.  
The hypothesis that LYST is required for the exocytosis of secretory 
lysosomes comes from studies that observed defective function of cells 
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containing secretory lysosomes, in particular NK cells and CTLs (Targan and 
Oseas, 1983, Baetz et al., 1995). NK cells were normal in number, but 
lacked the ability to kill target cells because of a failure to exocytose their 
lytic granules. For exocytosis to occur, granules must migrate along 
microtubules to the MTOC, which polarises toward the target contact zone, 
known as the immunological synapse (Orange, 2008). It was previously 
thought that the granules failed to mobilise to the synapse because of a 
microtubule defect. Perou and Kaplan demonstrated that enlarged beige 
macrophages were able to migrate to and from the cell periphery in 
response to phorbol esters and acidifying agents, albeit slower than their 
wild type counterparts (Perou and Kaplan, 1993b). Their data indicated that 
microtubule-based motility was intact in the absence of Lyst. However, the 
authors noted that very large lysosomes were immobile, suggesting that the 
large size may hinder the vesicle’s migration through the filamentous 
meshwork of the cytoplasm. This did not seem to be the case for lytic 
granules of CHS CTLs, as granules polarised normally at the immunological 
synapse (Baetz et al., 1995, Barrat et al., 1999, Stinchcombe et al., 2000). 
Thus, it seems possible that LYST is required for secretory lysosome 
docking or fusion at the plasma membrane.  
LYST is proposed to coordinate vesicle and/or protein trafficking to secretory 
lysosomes (Introne et al., 1999). Zhang and colleagues found that absence 
of LYST resulted in the abnormal appearance of endoplasmic reticulum-
resident proteins in lysosomal membranes (Zhang et al., 2007a). Although 
this may indicate inappropriate trafficking of proteins to lysosomes, it may 
also suggest that LYST is required for the removal of proteins from the 
lysosome following vesicle fusion events, for example, after formation of a 
hybrid organelle. It is conceivable that the inappropriate presence of non-
lysosomal proteins in secretory lysosome membranes could interfere with 
their capacity to fuse with the plasma membrane during exocytosis, 
however, this has not been directly assessed. Defective transport from the 
TGN or early endosomes to late multivesicular endosomes was observed in 
CHS B-cells that resulted in reduced levels of MHC class II molecules and 
LAMP proteins in late endosomes (Faigle et al., 1998). However, the 
trafficking of lytic granule proteins in CTLs from CHS patients was intact, as 
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granzymes, perforin and the lysosomal hydrolase cathepsin D were all 
targeted normally to lytic granules (Baetz et al., 1995, Stinchcombe et al., 
2000). It is possible that the function of LYST differs according to cell type. 
The range of cellular defects described in the literature and seemingly 
conflicting reports certainly seem to suggest this is the case.  
The BEACH domain sequence is highly conserved, yet the diverse range of 
functions of other BEACH-containing proteins has not helped identify a 
common function for the domain (Table 1.2). Dictyostelium large volume 
sphere B (LvsB) is required for the maturation and secretion of a lysosome-
derived compartment (referred to as the postlysosome) while LvsA regulates 
the size of the contractile vacuole and is required for daughter cell 
separation during cytokinesis (Charette and Cosson, 2007, Kwak et al., 
1999).  
ALFY is not implicated in lysosome homeostasis, instead it is required for 
autophagic clearance of aggregate proteins (Filimonenko et al., 2010). It 
appears to recruit and scaffold a multiprotein complex required for the 
formation of autophagosomes around the protein aggregates (Filimonenko 
et al., 2010). Neurobeachin is a member of the AKAP (A kinase anchor 
protein) family of proteins that bind protein kinase A (PKA). It is selectively 
expressed in neurons and endocrine cells and associates with neuronal 
tubulovesicular endomembranes (Wang et al., 2000). A study using neurons 
from heterozygous neurobeachin knockout mice suggest neurobeachin is 
required for the direct targeting of neurotransmitter receptors to the cell 
surface for synaptic transmission (Nair et al., 2013).  
LRBA (previously referred to as CDC4L) has a wide tissue distribution 
similar to LYST (Wang et al., 2001). When macrophages are stimulated with 
lipopolysaccharide, cytosolic LRBA becomes associated with lysosomes as 
well as the plasma membrane (Wang et al., 2000). The authors of the study 
propose a ‘two-signal’ model for the function of LRBA in vesicle trafficking. In 
this model, they suggest that LRBA binds to PKA after lipopolysaccharide 
stimulation (the first signal), enabling its association with vesicles through its 
BEACH domain.  
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Organism Protein Function Reference 
Mammals 
FAN 
TNF-induced N-SMase activation and generation of ceramide, TNF-
induced CDC42-dependent cytoskeletal remodelling and filipodia 
formation, lysosome homeostasis 
Montfort et al., 2010 
Neurobeachin Protein Kinase A anchor protein involved in neuronal synaptic vesicle secretion Wang et al., 2000,  
LRBA Protein Kinase A anchor protein involved polarized vesicle secretion, autophagy 
Wang et al., 2001 
Lopez-Herrera et al., 2012 
ALFY Elimination of aggregated proteins by autophagy Filimonenko et al., 2010 
Drosophila 
melanogaster  
AKAP550 Protein Kinase A anchor protein involved in vesicular release in polarized cells Han et al., 1997 
Mauve Maturation of autophagosomes during nutrient deprivation Rahman et al., 2012 
Caenorhabditis elegans SEL-2 Protein Kinase A anchor protein involved in endosomal trafficking  de Souza et al., 2007 
Dictyostelium 
discoideum 
LvsA Regulation of the contractile vacuole and separation of daughter cells during cytokinesis Kwak et al., 1999 
LvsB Maturation and secretion of postlysosomes Charette and Cosson, 2007 
Table 1.2. Specific functions of known BEACH family members 
Several characterised BEACH proteins and their cellular functions are listed, together with relevant references. FAN, Factor associated with N-
sphingomyelinase; LRBA, Lipopolysaccharide-responsive and beige-like anchor protein; ALFY, autophagy-linked FYVE-protein; AKAP550, A 
kinase anchor protein 550; LvsA, large volume sphere A; LvsB, large volume sphere B; N-SMase, neutral sphingomyelinase; CDC42, cell division 
control protein 42. 
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This is supported by the finding that a green fluorescent protein (GFP)-fusion 
peptide carrying only the C-terminal portion of LRBA (containing the 
BEACH/WD40 domain) localised to vesicular structures in response to 
lipopolysaccharide; this was proposed to tether vesicles to microtubules for 
transport to the plasma membrane. A second signal that triggers the 
interaction of LRBA with proteins at the plasma membrane is proposed to 
result in vesicle fusion, thus providing a mechanism for polarised secretion in 
neuronal cells (Wang et al., 2001). A similar mechanism for LYST-mediated 
exocytosis of secretory lysosomes is plausible. Like LRBA, LYST is reported 
to be cytosolic in macrophages (Perou et al., 1997a), yet is capable of 
associating with punctate structures that partially align along microtubules 
(Faigle et al., 1998). In immune cells such as CTLs and NK cells, LYST may 
associate with secretory lysosomes upon target cell interaction. Although 
LYST is not required for granule movement (granules polarise to the plasma 
membrane independently of LYST in response to target ligation; Barrat et 
al., 1999, Clark and Griffiths, 2003), its association may be important for 
mediating granule docking or fusion events upon arrival at the plasma 
membrane. For example, LYST might interact with plasma membrane 
proteins at the immunological synapse, perhaps through its WD40 domains, 
and mediate the recruitment of fusion machinery components, such as 
SNAREs, to the granule membrane.  
The PH domain of BEACH proteins is not thought to be phospholipid 
binding, based on the crystal structure of Neurobeachin that indicates that 
the two phospholipid binding pockets of the domain are otherwise occupied; 
one by an α-helix and the other by residues of the BEACH domain (Jogl et 
al., 2002). Gebauer and colleagues later showed that the PH domains of 
LRBA, neurobeachin and FAN did not bind any of the phospholipids tested 
in a lipid binding assay (Gebauer et al., 2004). FAN is the smallest protein 
belonging to the BEACH family and an adaptor protein important for 
mediating downstream responses to tumour necrosis factor (TNF). It binds 
to TNF receptor and activates neutral sphingomyelinase (N-SMase) to 
generate the lipid signalling molecule ceramide and is thought to be 
important for mediating inflammatory cellular reactions in response to TNF 
(Adam-Klages et al., 1996). FAN is also required for TNF-induced actin 
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reorganisation (Haubert et al., 2007). Haubert and colleagues showed that 
the PH domain of FAN binds to PtdIns(4,5)P2, targeting FAN to the plasma 
membrane where it promotes CDC42 (cell division control protein 42) 
activation to induce cytoskeletal reorganisation (Haubert et al., 2007). 
Expression of a GFP-FAN mutant lacking the PH domain abolished 
membrane localisation, whereas deletion of the BEACH or WD domains had 
no effect on membrane localisation. PtdIns(4,5)P2 was not included in the 
lipid overlay assay performed by Gebauer and colleagues (2004), thus, it is 
possible that neurobeachin, LRBA and indeed LYST, may also bind 
PtdIns(4,5)P2 at the plasma membrane and this may be important for their 
function. It is interesting to note that PtdIns(4,5)P2 is mislocalised in beige 
fibroblasts; Ward and colleagues reported a nuclear PtdIns(4,5)P2 staining 
pattern in wild type fibroblasts that was absent in beige fibroblasts (Ward et 
al., 2000). Plasma membrane PtdIns(4,5)P2 is required for regulated 
exocytosis of synaptic vesicles (Koch and Holt, 2012), mast cell granules 
(Hammond et al., 2006) and NK lytic granules (Capuano et al., 2012), 
however, the effect of PtdIns(4,5)P2 mislocalisation on secretory lysosome 
exocytosis in CHS/beige cells has not been examined.  
Lysosomal enlargement in CHS cells has been linked to altered protein 
kinase C (PKC) levels. PKC activity is down-regulated in beige 
polymorphonuclear leukocytes, NK cells and fibroblasts (Ito et al., 1989, Ito 
et al., 1988b, Tanabe et al., 1998, Tanabe et al., 2000). The down-regulation 
is attributed to enhanced proteolysis of PKC by calpain. Calpain is a cysteine 
protease that cleaves PKC into an inactive form (Nishizuka 1986). Addition 
of calpain inhibitors such as E-64-d have been shown to correct the lowered 
PKC activity and to correct other cellular defects of CHS/beige, such as the 
giant lysosomes in fibroblasts and the defective NK cell-mediated killing of 
target cells (Ito et al., 1989, Tanabe et al., 2000 Tanabe et al., 2009). The 
link between LYST and PKC activity is difficult to determine given that an 
association between PKC and LYST has not been established. Ceramide 
levels are increased in beige cells (Tanabe et al., 2000). Tanabe and 
colleagues demonstrated that ceramide promotes calpain mediated 
proteolysis of PKC, and suggest that increased ceramide in beige fibroblasts 
is responsible for PKC down-regulation (Tanabe et al., 1998, Tanabe et al., 
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2000). Furthermore, addition of exogenous C2-ceramide promotes lysosomal 
enlargement in normal fibroblasts, that is reversed upon treatment with E-64-
d (Tanabe et al., 2000). Ceramide is generated by SMase-mediated 
hydrolysis of sphingomyelin (SM) and functions as a signalling lipid with 
important roles in cell proliferation and induction of apoptosis (Montfort et al., 
2010). Activity of both acid-SMase (A-SMase) and N-SMase is enhanced in 
beige cells and stimulation with phorbol ester induces further ceramide 
production (Tanabe et al., 2000, Cui et al., 2001). Exactly why LYST 
deficient cells have elevated SMase activity is unknown, as is the 
mechanism by which ceramide mediates down-regulation of PKC in 
CHS/beige cells. It is interesting to note that deficiency of FAN results in 
reduced N-SMase activity (Adam-Klages et al., 1996), while deficiency of 
LYST appears to be linked to enhanced SMase activity, suggesting 
opposing functions of these two proteins regarding ceramide generation. 
Although SMase has not been identified as a binding partner of LYST, it is 
possible that LYST regulates ceramide levels by binding SMase under 
specific conditions, such as stimulated exocytosis. This may be important for 
controlling membrane fluidity and raft formation during vesicle exocytosis. It 
remains to be determined if reduced levels of PKC is an immediate 
biochemical defect resulting from loss of LYST, or whether the effects on 
PKC represent a more downstream effect.  
1.2.4 LYST-Interacting Proteins 
Twenty-four LYST-binding proteins were identified in a yeast two-hybrid 
screen (Tchernev et al., 2002). Three of these interactions were confirmed 
using in vitro binding assays: casein kinase IIβ (CK2β), HRS and tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein, theta 
polypeptide (14-3-3τ). The binding of LYST to HRS is of particular interest 
because HRS has been shown to bind and inhibit SNAP25, a component of 
the SNARE fusion machinery. Overexpression of HRS inhibits Ca2+-
dependent exocytosis of dense-core secretory vesicles in PC12 cells 
(Kwong et al., 2000). Thus, binding of LYST to HRS may release inhibition of 
SNAP25 and enable exocytosis of secretory lysosomes. Interestingly, 
several proteins identified as LYST-binding partners by Tchernev and 
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colleagues are implicated in cell cycle regulation and mitosis. CK2β forms 
the two regulatory subunits of the CK2 heterodimer that is required for 
progression through G1 and G2/M cell cycle checkpoints (Hanna et al., 
1995). 14-3-3τ promotes proliferation by permitting cell cycle progression 
through degradation of p21 (Wang et al., 2010). Two other LYST binding 
proteins, centromere protein J (CENPJ) and centrobin are required for 
normal spindle formation during mitosis (Wang et al., 2010, Jeffery et al., 
2010, Zou et al., 2005, McIntyre et al., 2012). These findings are compatible 
with the possibility that LYST functions in cellular pathways other than those 
governing secretory lysosome biogenesis and exocytosis.  
Despite the prominent cellular defects associated with CHS and extensive 
investigation into the underlying biochemical defects, the molecular 
pathways governing LYST-mediated regulation of secretory lysosomes 
remain unknown. One reason for this is that LYST presents a technical 
challenge to investigators attributed to its large size. The majority of studies 
concerning LYST function have primarily addressed lysosomal enlargement 
- the most striking cellular defect of CHS/beige. On the basis of its large size 
and the diverse roles of potential binding partners, LYST is likely to have 
multiple functions and these may have been overlooked in previous studies. 
Moreover, one aspect of the CHS/beige phenotype has not been addressed: 
the effect of mislocalised PtdIns(4,5)P2. In addition, other BEACH family 
members ALFY, LRBA and mauve are implicated in the autophagic pathway 
(Filimonenko et al., 2010, Lopez-Herrera et al., 2012, Rahman et al., 2012), 
yet investigation of the autophagic pathway in CHS/beige is limited to a 
single study (Zhang et al., 2010). Although the authors report similar levels 
of autophagy in beige and control fibroblasts, the effect of LYST depletion on 
the autophagic pathway cannot be concluded from one study alone, and 
requires further investigation. Closer examination of the CHS/beige 
phenotype, beyond the enlarged lysosomes, could identify important 
pathways of LYST function and the regulation of secretory lysosomes.  
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1.3 Natural Killer Cells 
NK cells are lymphocytes of the innate immune system that form a first line 
of defence against pathogens. Their main function is the clearance of tumour 
cells and virus-infected cells by a mechanism known as cell-mediated 
cytotoxicity (de Saint Basile et al., 2010). Unlike CTLs, NK cells do not 
require prior sensitisation and provide host protection during the period when 
the adaptive immune response is developing (Kiessling et al., 1975). NK cell 
cytotoxicity involves the stimulated secretion of cytolytic effector molecules 
towards the recipient cell following direct contact and the ligation of specific 
NK cell receptors. The effector molecules are housed within specialised 
secretory lysosomes – the lytic granules – that function as degradative 
organelles but with the added capacity to engage in regulated exocytosis in 
response to extracellular stimuli (de Saint Basile et al., 2010).  
1.3.1 Natural Killer Cell Function 
NK cells express an array of germline encoded receptors that detect 
alterations in host cell surface molecules. The receptors fall into one of two 
groups: activating receptors that stimulate a cytolytic response, or inhibitory 
receptors that prevent a cytolytic response. Inhibitory receptors recognise 
MHC class I molecules on the surface of healthy cells, while ligands for 
activating receptors are upregulated in stressed, infected or malignant cells 
(Scott et al., 2008). Unstressed ‘healthy’ cells escape death by NK cells 
based on their expression of MHC class I, while cells with down-regulated 
MHC class I expression (such as during certain viral infections or 
malignancy) concomitantly expressing stress-induced ligands fail to initiate 
inhibitory signals and result in NK cell activation. An effector response is 
mounted based on the overriding signal received from many receptor 
molecules (Vivier et al., 2011).  
NK cells contain numerous lytic granules that are packaged with cytotoxic 
effector proteins that initiate apoptosis in the target cell. Upon NK cell 
activation, the granules traffic to the immunological synapse with the target 
cell where they fuse with the plasma membrane. This results in the release 
of granule contents into the synaptic cleft and the externalisation of granule-
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resident proteins such as LAMPs on the plasma membrane, in a process 
known as degranulation (Stinchcombe and Griffiths, 2007, Alter et al., 2004). 
The major effector proteins are granzymes and perforin. Granzymes (A, B, 
H, K and M in humans) are serine proteases that initiate target apoptosis 
primarily via the activation of the caspase cascade (Bots and Medema, 
2006). Perforin is a pore-forming protein that oligomerises into 
transmembrane channels within the target cell membrane and facilitates the 
cytosolic delivery of granzymes by several proposed mechanisms (Lopez et 
al., 2012). A second essential function of NK cells is the secretion of 
immunomodulatory chemokines and cytokines, such as tumour necrosis 
factor alpha (TNFα) and interferon gamma (IFNγ). These recruit and activate 
inflammatory cells and other immune cells, coordinating both innate and 
adaptive immune responses (Vivier et al., 2011). Cytokines are contained 
within conventional secretory vesicles and are secreted in a pathway distinct 
from that of perforin and granzymes (Reefman et al., 2010).  
The induction of an NK cell effector response requires a tight association 
with the target cell. Tight association ensures that the delivery of perforin 
and granzymes is spatially restricted to the intended cell, thus limiting 
inadvertent lysis of bystander cells. The formation of the immunological 
synapse and subsequent degranulation event follow several discrete stages.  
1.3.2 Formation of the Immunological Synapse 
Despite differences in target cell recognition, the mechanism by which NK 
cells and CTLs destroy target cells is similar and much of what we assume 
of the mechanisms governing NK cytotoxicity was first derived from the 
study of CTLs. 
Once activated, the NK cell must develop a firm adhesion with the target and 
this is achieved via the integrin family of adhesion molecules (Bryceson et 
al., 2006). Studies of the mature synapse in CTLs reveal that receptors and 
adhesion molecules are organised into distinct clusters at the contact zone 
called supramolecular activation clusters (SMAC), comprised of a central 
SMAC (cSMAC) and a peripheral SMAC (pSMAC) (Stinchcombe and 
Griffiths, 2007). A similar receptor organisation is proposed for NK cells and 
is thought to be important for robust signalling (Giurisato et al., 2007). Also 
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critical to synapse maturation is the accumulation of filamentous actin (F-
actin), which is dependent on CDC42 and Wiscott-Aldrich syndrome protein 
(WASp) that promote F-actin branching (Orange et al., 2002). Similarly, the 
enrichment of certain lipids into organised membrane domains (lipid rafts) is 
found at the synapse (Capuano et al., 2012) and may be important for co-
ordinated signalling. The formation of a mature synapse in the initial stage of 
an effector response not only ensures tight contact with target cells, but 
serves as a platform for signalling and exocytic events during the effector 
stage of NK function.  
1.3.3 Mechanisms of Granule Exocytosis  
The delivery of granules to the immunological synapse involves several 
stages: the polarisation of granules to the immunological synapse, docking 
of granules at the plasma membrane and priming of the granules to facilitate 
fusion (reviewed in Orange, 2008). Granule polarisation requires both the 
minus-ended movement of granules along microtubules towards the MTOC 
and polarisation of the MTOC to the synapse. The kinetics of granule 
migration and the associated motor proteins have only recently been 
identified. Dynein is an essential motor protein required for movement of lytic 
granules towards the MTOC. Overexpression of dynein mutants results in 
peripheral granules that fail to converge after target conjugation (Mentlik et 
al., 2010). It was previously assumed that granule convergence occurred 
simultaneously with MTOC reorientation (Orange, 2008), however, Mentlik 
and colleagues argue that granule convergence is a prerequisite for MTOC 
polarisation (Mentlik et al., 2010). In their study, they observed that upon NK 
cell activation, granules rapidly clustered at the MTOC, and that a gradual 
reorientation of the MTOC to the synapse followed. Using antibodies 
directed against the activating receptor CD28 or integrin CD11a in the NK 
cell-like YTS cell line, they further demonstrated that activation can initiate 
granule convergence without MTOC polarisation or cytotoxicity. They 
propose that rapid granule clustering following NK cell activation serves to 
assemble the granules ready for delivery whilst a mature synapse is formed 
and a robust activation signal generated (Mentlik et al., 2010). This would 
ensure that granules are delivered in synchrony to the immunological 
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synapse following MTOC polarisation, thus guaranteeing a precise lethal hit 
to the recipient.  
MTOC polarisation serves only to bring the granules into proximity with the 
immunological synapse. Further steps are required to deliver the granules to 
the plasma membrane. The importance of F-actin accumulation at the 
synapse for cytotoxicity is well recognised and agents that block actin 
polymerisation also block degranulation (Orange et al., 2002). However, the 
dense cortical actin also poses a barrier to lytic granule access to the 
plasma membrane. The current model proposes that clearance of a large (1-
4 µm) but discrete region of actin within the cSMAC occurs to provide 
unobstructed access to the membrane prior to degranulation (Orange, 
2008). This model is challenged by studies which demonstrate the actin 
motor protein myosin IIA is required for granule delivery to the plasma 
membrane (Sanborn et al., 2009). These apparently conflicting observations 
were recently clarified in study that exploited microscopy techniques with 
improved resolution to those previously employed. In the study, the authors 
report a region at the synapse where actin is hypodense, but not fully 
cleared from the plasma membrane (Rak et al., 2011). Within this region 
they observed that granules at the synapse were in close association with 
the actin network and secreted through minimal clearances that were just 
large enough to accommodate the organelle (Rak et al., 2011). This 
scenario would facilitate myosin IIA-mediated delivery of granules along 
actin filaments to the site of fusion. Docking of the granule at the plasma 
membrane might then trigger clearance of the remaining actin in the vicinity 
of the granule, permitting fusion and release. It is likely that granule 
membrane-associated proteins might trigger actin reorganisation to mediate 
this clearance.  
A number of proteins are recruited to the granule prior to degranulation that 
mediate the terminal stages of exocytosis. These enable docking of the 
granules at the plasma membrane, priming to regulate secretion, and fusion 
of the two membranes to release granule contents into the synaptic cleft. 
Many of the proteins characterised share a common function in CTLs and 
NK cells but the mechanisms proposed remain mostly hypothetical. Two 
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essential molecules of the granule exocytosis machinery are Rab27a 
(mutated in Griscelli syndrome type 2, as described in Section 1.1.5) and 
unc-13 homolog 4 (Munc13-4). Rab27a associates with granule membranes 
and facilitates their docking at the plasma membrane, while Munc13-4 is 
implicated in a SNARE-mediated priming step that renders granules 
competent to fuse with the plasma membrane (Neeft et al., 2005, Ménager 
et al., 2007, Feldmann et al., 2003). Furthermore, a direct interaction 
between Munc13-4 and Rab27a is required for cytotoxicity (Ménager et al., 
2007). Interestingly, it has been shown in CTLs that many components of 
the granule fusion machinery are not associated with perforin and granzyme-
containing vesicles until just prior to exocytosis, indicating that additional 
granule maturation steps are required to deliver the fusion machinery to the 
granule. In the study by Ménager and colleagues, Munc13-4 was found to be 
localised to Rab11-positive recycling endosomes and mediated the 
association of recycling endosomes with Rab27-positive late endosomes, 
which fused together to form an ‘exocytic vesicle’ carrying secretory 
machinery components. Upon target recognition, the exocytic vesicles 
simultaneously polarised to the immunological synapse together with 
perforin-containing lytic granules, where they fused together immediately 
before secretion (Figure 1.4, Ménager et al., 2007). This fusion step confers 
Munc13-4 and Rab27a to the membranes of lytic granules, rendering them 
competent to dock and fuse with the plasma membrane (Ménager et al., 
2007). Munc13-4 and Rab27a were also found to independently but 
simultaneously polarise to the synapse with perforin in NK cells, however, 
the endocytic localisations of Rab27a and Munc13-4 were not investigated 
(Wood et al., 2009). Together, these findings support the notion that 
heterotypic fusion of endocytic vesicles contributes to lytic granule 
maturation. In their study in NK cells, Reefman and colleagues observe a 
partial colocalisation of perforin with Rab11 (Reefman et al., 2010). Although 
disrupting the recycling endosome did not significantly impair perforin 
secretion, it did retard granule reformation or the filling of immature granules 
with perforin.  
- 34 - 
 
Figure 1.4. Proposed lytic granule maturation steps and associated 
proteins 
Munc13-4 located on recycling endosomes mediates the association of recycling 
endosomes with Rab27-positive late endosomes, which fuse together to form an 
‘exocytic vesicle’ (1st maturation step). Upon target conjugation, the exocytic 
vesicles simultaneously polarise to the immunological synapse together with 
perforin-containing lytic granules, where they fuse together to form a mature lytic 
granule (2nd maturation step). This confers exocytic machinery components to the 
membranes of lytic granules, including Munc13-4 and Rab27a. Rab27a recruits its 
effector proteins synaptotagmin-like protein 2a (Slp2a, and possibly Slp1) to the 
granule which tethers granules to the plasma membrane through their C2 domains 
(docking). Munc13-4 engages with plasma membrane proteins in a post-docking 
step that promotes assembly of the SNARE complex (priming). In the final stage in 
the granule exocytosis pathway, fusion of the two membranes permits the release 
of perforin and granzymes into the synaptic cleft.  
 
These findings suggest that interaction between recycling endosome 
proteins and the lytic granule is important for a mature secretory granule. In 
this study, the authors relied on phorbol ester stimulation to induce NK cell 
lytic granule exocytosis (Reefman et al., 2010). The combination of phorbol 
ester and ionomycin evokes a mass degranulation event which bypasses 
receptor activation and many of the sequential steps of exocytosis induced 
by target conjugation (Alter et al., 2004). Thus, the exact functional 
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significance of the recycling endosome on target-induced lytic granule 
maturation and secretion in NK cells remains to be determined. 
Two proteins, synaptotagmin-like protein 1 (Slp1) and Slp2a, have recently 
been identified as effectors of Rab27a in CTLs and NK cells (Holt et al., 
2008, Ménasché et al., 2008). In CTLs, Slp2a is recruited to Rab27a-positive 
vesicles but remains distinct from perforin-containing vesicles. Upon 
conjugation, it partially colocalises with perforin-containing granules and is 
carried to the synapse where it associates with the plasma membrane via its 
C2 domain (Ménasché et al., 2008). This recruitment of Slp2a to lytic 
granules appears to mediate docking at the plasma membrane via a 
Rab27a/Slp2a complex that is important for cytotoxicity. However, Slp2a 
depletion does not impair lytic granule secretion, suggesting that additional 
Rab27a effectors can compensate for the loss of Slp2a. Slp1 has been 
suggested as a candidate effector, as depletion of both Slp2a and Slp1 
impair CTL cytotoxicity (Holt et al., 2008).  
The final step in lytic granule exocytosis requires fusion with the plasma 
membrane and is mediated by SNAREs. The SNARE proteins vesicle-
associated membrane protein 7 (VAMP7), syntaxin 11 and synaptosomal-
associated protein of 23 kDa (SNAP23) appear to be the main proteins 
mediating lytic granule fusion in NK cells (Bryceson et al., 2007, Marcet-
Palacios et al., 2008). Syntaxin 11 and its accessory protein unc-13 homolog 
2 (Munc18-2) are both essential for NK granule secretion, as mutations in 
either of these two proteins result in immunodeficiency (discussed in Section 
1.3.4; Bryceson et al., 2007, Cote et al., 2009). Once the lytic vesicles are 
docked at the plasma membrane, Munc13-4 is thought to exert its priming 
function by triggering syntaxin 11 to adopt an open conformation which could 
facilitate binding to SNAP23 and promote SNARE complex formation (de 
Saint Basile et al., 2010), although this has not been formally demonstrated. 
Formation of a stable SNARE complex drives the fusion of the two 
membranes and granule contents are released into the synaptic cleft where 
they are taken up by the recipient cell, initiating apoptosis.  
The multiple stages of NK lytic granule maturation and exocytosis provide 
several points at which degranulation can be regulated. Such tight regulation 
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likely serves to prevent the inappropriate elimination of normal healthy cells. 
The functions of many proteins implicated in lytic granule biogenesis and 
secretion were identified through studying primary immunodeficiency 
diseases arising from single gene mutations, such as CHS, resulting in 
defective cytotoxicity.  
1.3.4 Lessons from Genetic Diseases 
CHS, HPS-2 and Griscelli syndrome type 2 are similar disorders exhibiting 
impaired secretion of both melanosomes and lytic granules, resulting in the 
clinical symptoms of hypopigmentation and immunodeficiency. Individuals 
with HPS-2 have enlarged lytic granules that are unable to migrate along 
microtubules and therefore do not reach the immunological synapse (Clark 
et al., 2003). HPS-2 patients lack activity of the adaptor protein AP-3. This 
adaptor appears to be required for the correct sorting of an unidentified 
protein to the lytic granule, that mediates the attachment of granules to 
microtubules and their transport in response to target conjugation (Figure 
1.5, Clark et al., 2003). 
As described previously (Section 1.2.1), the accelerated phase of CHS 
results in a systemic inflammatory syndrome, hemophagocytic 
lymphohistiocytosis, resulting from defective NK cell and CTL cytotoxicity. 
Diseases caused by mutations in several components of the lytic granule 
exocytic machinery also result in inherited forms of hemophagocytic 
lymphohistiocytosis, such as familial hemophagocytic lymphohistiocytosis 
(FHL) and Griscelli syndrome type 2. Similar to CHS, Griscelli syndrome 
type 2 is characterised by immunodeficiency and hypo-pigmentation, 
resulting from mutations in the RAB27A gene (Ménasché et al., 2000). 
Studies from CTLs derived from Griscelli syndrome type 2 patients show 
granules polarise to the immunological synapse but are unable to dock at 
the plasma membrane (Stinchcombe et al., 2001). This is likely due to a 
failure to recruit the docking protein Slp2a, as Slp2a remains cytoplasmic in 
CTLs from Griscelli syndrome patients and is thus unable to mediate granule 
docking at the plasma membrane (Figure 1.5, Ménasché et al., 2008).  
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Figure 1.5. Functions of proteins that are defective in diseases 
affecting lytic granules 
Mutations in AP-3 or LYST result in defective granule biogenesis and cause 
Hermansky-Pudlak syndrome and Chédiak-Higashi syndrome, respectively. AP-3 
sorts a protein to the granule which allows attachment or minus-ended movement 
along microtubules to the microtubule organising centre (MTOC), following target 
conjugation. Granule docking at the membrane is mediated by Rab27a and 
synaptotagmin-like proteins Slp1/Slp2. Rab27a is mutated in patients with Griscelli 
syndrome type 2. Docked granules interact with the plasma membrane SNARE 
syntaxin 11 and its accessory protein Munc18-2 at the plasma membrane. Priming 
by Munc13-4 is proposed to change syntaxin 11 from a closed to an open 
conformation. The formation of a SNARE complex (not shown) composed of 
syntaxin 11, VAMP7 and SNAP23 triggers membrane fusion and the release of 
granule contents. Mutations in Munc13-4, syntaxin 11 and Munc18-2 inhibit granule 
fusion and cause familial hemophagocytic lymphohistiocytosis type 3 (FHL-3), FHL-
4 and FHL-5, respectively. LYST may also be required to mediate fusion at the 
plasma membrane.  
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Interestingly, the addition of the cytokine interleukin-2 (IL-2) to Rab27a-
deficient NK cells partially restores cytotoxicity (Plebani et al., 2000), 
suggesting there may be other as yet uncharacterised proteins which can 
substitute for Rab27a to mediate granule docking at the plasma membrane.  
FHL type-3 (FHL-3), -4 (FHL-4) and -5 (FHL-5) are caused by mutations in 
the genes encoding the granule fusion machinery components Munc13-4, 
syntaxin 11 and Munc18-2, respectively (Figure 1.5, Feldmann et al., 2003, 
Bryceson et al., 2007, Cote et al., 2009). In the absence of Munc13-4, 
granules are observed docked at the plasma membrane but are not 
secreted, resulting in defective cytotoxicity (Feldmann et al., 2003). It is from 
these observations that Munc13-4 is implicated in priming granules for 
membrane fusion. 
Similar to Munc13-4-deficiency, NK cells deficient in the SNARE protein 
syntaxin 11 polarised normally at the synapse but failed to fuse with the 
plasma membrane (Bryceson et al., 2007). However, activation with IL-2 
prior to exposure to targets stimulated degranulation in FHL-4 cells, partially 
restoring cytotoxicity, indicating that syntaxin 11-deficiency can be 
compensated by other proteins induced by cytokine activation (Bryceson et 
al., 2007). Mutations in Munc18-2 were only recently identified as a new 
genetic form of FHL, FHL-5, and led to the discovery of Munc18-2 as a 
regulator of syntaxin 11 (Cote et al., 2009).  
Despite recent advances in our knowledge of the complex mechanisms 
involving lytic granule biogenesis and exocytosis, there is still much to learn. 
The role of LYST, for example, in lytic granule biogenesis and secretion 
remains elusive and despite their critical role in many intracellular trafficking 
events, the contribution of PIs to NK granule exocytosis is largely 
unexplored. Moreover, the heterotypic fusion events co-ordinating the 
maturation of lytic granules into secretion-competent vesicles are not well 
established in NK cells. Lytic granules share common features with other 
secretory lysosomes, the majority of which are found in cells of the immune 
system. The impact of defective secretory lysosome exocytosis is evident 
from the severity of diseases involving such organelles, which is not just 
limited to immunological dysfunction, but neurologic dysfunction also. A 
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better understanding of these organelles is required if we are to fully 
comprehend the mechanisms which govern our immune system.  
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1.4 Aims 
Many questions still remain unanswered regarding the mechanisms that 
govern the biogenesis and exocytosis of secretory lysosomes. CHS is a 
lethal disorder that affects the function of cells with secretory lysosomes and 
arises from mutations in the LYST gene. The role of LYST is poorly 
understood despite its identification 16 years ago, and the technical 
challenge that such a large gene and protein presents has hindered the 
elucidation of the pathway(s) in which it functions. Furthermore, several 
aspects of the CHS/beige phenotype remain relatively unexplored. To this 
end, the specific aims of the study are: 
• To investigate the contribution of both PtdIns(4,5)P2 and autophagy to 
the cellular defect of CHS and to identify proteins downstream of 
LYST that may also function in exocytosis of secretory lysosomes. 
• To model the CHS/beige phenotype using RNA interference and 
explore the function of LYST. 
• To examine the contribution of PIKfyve to the biogenesis and 
exocytosis of NK cell lytic granules.  
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Chapter 2 
Materials and Methods 
2.1 Culture of Mammalian Cell Lines 
The cell lines used in this study were obtained from laboratory collections. 
Cell lines and their respective culture media are listed in Table 2.1. 
2.1.1 Cell Line Maintenance  
All cell lines were maintained at 37 °C and 5% CO2 in a humidified incubator 
and passaged every 3-4 days using standard aseptic techniques. Foetal calf 
serum (FCS; Sigma-Aldrich, USA) was heat inactivated at 56 °C for 30 
minutes before use. During routine passage, adherent cells were washed 
with phosphate buffered saline (PBS) and detached with trypsin (0.25% w/v 
trypsin and 0.2 % w/v ethylenediaminetetraacetic acid [EDTA] in PBS) for 2-
5 minutes at 37 oC. Cells were then washed in culture media, centrifuged for 
5 minutes at 300 x g and the pellets resuspended in fresh culture medium.  
2.1.2 Storage and Recovery 
For long term storage, with the exception of human NK cells, cells harvested 
by trypsin were pelleted by centrifugation at 300 x g for 5 minutes and 
resuspended in cell-specific complete medium (Table 2.1) containing 10% 
v/v dimethyl sulphoxide (DMSO; Sigma-Aldrich, USA). Cells were then 
frozen at -80 oC for 2 days before being transferred to liquid nitrogen.  
For recovery, cells were thawed rapidly in a 37 oC water bath, diluted with 
complete culture medium, centrifuged at 300 x g for 5 minutes and the pellet 
resuspended in complete culture medium. Cells were transferred to tissue 
culture flasks and allowed to recover for at least 5 days before use.  
 
 
 
- 42 - 
 
Cell Line Origin Type Culture Medium 
NK-92MI 
Derived from the human 
natural killer cell line (NK-92), 
stably expressing human IL-2 
from the retroviral MFG-hIL-2-
IL-2 vector (Tam et al., 1999) 
Suspension RPMI 1640 
supplemented with 
1% L-glutamine and 
10% FCS 
K562 Human erythromyeloblastoid leukemia Suspension 
3T3-J2 Swiss mouse embryonic fibroblasts Adherent 
DMEM 
supplemented with 
1% L-glutamine and 
10% FCS 
Table 2.1. Cell lines used in this study, their origin and complete 
culture medium 
Roswell Park Memorial Institute (RPMI) 1640 and Dulbecco’s Modified Eagle 
Medium (DMEM) were obtained from Sigma-Aldrich, USA. 
2.2 Human NK Cells 
Human NK cells were isolated from peripheral blood using Ficoll density 
gradient separation, followed by magnetic-activated cell sorting (MACS). 
Ethical approval was granted by the Leeds East Research Ethics 
Committee; reference number 06/Q1206/106, for the use of human blood 
samples. Peripheral blood samples were obtained from consenting healthy 
volunteers and obtained by venepuncture and collected into sterile 
potassium ethylenediaminetetraacetic acid (K2EDTA)-coated vacuum tubes 
(BD Biosciences, USA).  
2.2.1 Isolation of Peripheral Blood Mononuclear Cells  
Peripheral blood mononuclear cells (PBMCs) were isolated from peripheral 
blood by density gradient separation. Whole blood was diluted with an equal 
volume of sterile PBS, layered over Lymphoprep™ (Axis-Shield,UK) and 
centrifuged at 800 x g for 20 minutes, with the brake disabled. PBMCs were 
collected from the blood plasma/Lymphoprep™ interface and washed with 
PBS. Cells were counted using a haemocytometer and resuspended in cold 
MACS buffer (0.5% w/v bovine serum albumin [BSA] and 2 mM sodium 
EDTA in PBS). 
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2.2.2 Isolation of NK Cells 
Isolation of untouched NK cells from PBMCs was achieved using NK Cell 
Isolation Kit II (Miltenyi Biotech, Germany) according to the manufacturer’s 
protocol. Briefly, PBMCs were labelled using a cocktail of biotin-conjugated 
monoclonal antibodies against the non-NK cell fraction. Magnetically labelled 
anti-biotin antibodies were added and the cells passed through a 40 µm cell 
strainer (Thermo Fisher Scientific, USA). Cells were passed through a 
MACS® cell separation column, which was placed within the magnetic field 
of a MACS® separator stand (both Miltenyi Biotech, Germany). Magnetically 
labelled non-NK cells were retained in the column. The eluted fraction, 
containing the unlabelled NK cells, was washed with PBS before 
centrifugation at 200 x g for 10 minutes. Isolated NK cells were assessed by 
flow cytometry using anti-CD3 and anti-CD56 antibodies (Table 2.5) and the 
purity of the CD56+CD3- fraction (corresponding to NK cells) was found to be 
> 90%.  
2.2.3 NK Cell Maintenance 
Cells were maintained in culture medium (DMEM, 10% AB serum, 2 mM L-
glutamine, 50 µg/mL penicillin, 50 µg/mL streptomycin) containing 50 U/mL 
recombinant human IL-2 (Miltenyi Biotech, Germany) for 6-10 days before 
use. 
2.2.4 NK Cell Stimulation 
For target cell stimulation, primary NK or NK-92 cells were co-incubated with 
K562 cells (NK:target ratio of 1:1), in a 96-well plate at 37 oC for 1 hour. NK-
92 cells were chemically stimulated with 50 ng/mL phorbol 12-myristate 13-
acetate (PMA) in combination with 500 ng/mL ionomycin and incubated for 
30 minutes at 37 oC. 
2.3 Murine Fibroblasts 
Dermal fibroblast cultures were established from ear explants and animal 
work was performed under licence and following local ethical review. 
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2.3.1 Mice 
Female Fox Chase SCID® (CB17/Icr-Prkdcscid/IcrIcoCrl; Strain Code 236) 
and Fox Chase SCID® Beige (CB17.Cg-PrkdcscidLystbg/Crl; Strain Code 250) 
mice (4-11 weeks old) were purchased from Charles River Laboratories 
International, USA. Mice were culled on arrival by cervical dislocation in 
accordance with Schedule 1 Code of Practice, UK Animals Scientific 
Procedures Act 1986.  
2.3.2 Establishment of Fibroblast Cultures 
Ears were surgically excised from mice and washed in PBS several times. 
The epidermis was removed mechanically by scraping across the dermal 
explants using a scalpel and the skin washed in PBS. The skin was cut into 
small squares (2-3 mm), placed in wells of a 6-well tissue culture plate and 
sandwiched with sterile 22 mm glass coverslips. Complete growth medium 
(DMEM plus 10% FCS, 1% L-glutamine, 10 nM HEPES, 10 mM of each 
non-essential amino acid [glycine, L-alanine, L-asparagine, L-aspartic acid, 
L-glutamic acid, L-proline, L-serine], 50 IU/mL penicillin, 50 µg/mL 
streptomycin, 1 mM sodium pyruvate) was added and the explants 
incubated in a humidified incubator at 37 oC, 5% CO2. Medium was changed 
every 3-4 days until confluency was attained, then cells were routinely 
passaged according to Section 2.1.1.  
2.3.3 Fibroblast Purity and Maintenance 
The expression of fibroblast-specific protein 1 (FSP1) was used to determine 
the purity of fibroblast cultures and was assessed by immunofluorescence 
microscopy (Section 2.8) after the 3rd passage. Frozen stocks were then 
prepared and fresh or thawed cells were used until the 12th passage then 
discarded. Phase contrast images were acquired with an Olympus CKX41 
inverted light microscope (Olympus Corporation, Japan). 
2.4 SV40T Transfection 
The plasmid pBSV-early containing DNA encoding simian vacuolating virus 
40 T antigen (SV40T) was a kind gift from Professor GE Blair (University of 
Leeds, UK. At the 5th passage, beige cells were seeded into wells of a 6-well 
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plate at a density of 2.5 x 105 cells per well, 24 hours prior to transfection. 
Plasmid DNA (2 µg) diluted in 200 µL Opti-MEM® I medium (Life 
Technologies, USA), was mixed with 4 µL Lipofectamine™ 2000 transfection 
reagent (Life Technologies, USA) diluted in 200 µL Opti-MEM® I and 
incubated for 20 minutes at room temperature. The mixture was added to 
beige cells containing 2 mL of fresh culture medium and the cells incubated 
at 37 oC. The expression of SV40T was assessed 27 days later by 
immunofluorescence microscopy using the anti-SV40T mouse monoclonal 
antibody PAb419 (Section 2.8). 
2.5 YM201636 Treatment 
6-amino-N-[3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-
yl]phenyl]-3-pyridinecarboxamide (YM201636; CAS number 371942-69-7) is 
a potent small molecule inhibitor of mammalian PIKfyve and was purchased 
from Merck KGaA, Germany. YM201636 was solubilised in DMSO and cells 
were treated with either YM201636 or DMSO alone (control) at the 
concentration and time specified.  
2.6 Gene Silencing Using Small Inhibitory RNA (siRNA) 
Small inhibitory RNA (siRNA) molecules against murine LYST were 
purchased from Life Technologies, UK (siLyst 1-4) and Thermo Fisher 
Scientific, USA (siLyst 5-8). A negative control sequence with no known 
sequence homology to mouse genes (siControl) was purchased from Life 
Technologies, UK (sequences are listed in Table 2.2). 3T3-J2 cells were 
seeded in 12-well plates at a density of 2 x 104 cells per well in 1 mL 
complete culture medium, 24 hours prior to transfection. Cells were 
transfected with either siLyst 1-8 or siControl, at the specified concentration. 
For each well, the desired concentration of siRNA was prepared in 100 µL 
(final volume) Opti-MEM® I medium (Life Technologies, USA). This was 
added to a solution containing 2 µL Lipofectamine™ RNAiMAX transfection 
reagent (Life Technologies, USA) and 98 µL Opti-MEM® I and incubated for 
20 minutes at room temperature. The transfection mixture was added to 
cells, giving a final volume of 1.2 mL/well. All transfections were performed 
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alongside a mock control, in the absence of siRNA. Cells were incubated for 
24-96 hours before use. For cells requiring immunofluorescence microscopy 
analysis, cells were seeded onto coverslips prior to transfection.  
 
Cell Line Origin 
siLyst 1 
Sense:             CCUUUUUCGAAAAAUCAGGtt 
Antisense:       CCUGAUUUUUCGAAAAAGGtt 
siLyst 2 
Sense:             GGAAAGAAGAAGAAGAGGAtt 
Antisense:       UCCUCUUCUUCUUCUUCCCtg 
siLyst 3 
Sense:             GGAUUUAGUGUUUCUCUUGtt 
Antisense:       CAAGAGAAACACUAAAUCCtt 
siLyst 4 
Sense:             CGAGGAUUUCUGUUACUUAtt 
Antisense:       UAAGUAACAGAAAUCCUCGtc 
siLyst 5 
Sense:             GCAUUAGCACUGCGGGUUA 
Antisense:       UAACCCGCAGUGCUAAUGC 
siLyst 6 
Sense:             CCGAGAAGUUUGUAGAUCA 
Antisense:        UGAUCUACAAACUUCUCGG 
siLyst 7 
Sense:             CAGAAUGGAGAGCGGGUUA 
Antisense:        UAACCCGCUCUCCAUUCUG 
siLyst 8 
Sense:             GAAGAUUGCUAGCGCAUAU 
Antisense:       AUAUGCGCUAGCAAUCUUC 
Table 2.2. Sequences of siRNA used in this study 
 
2.7 Quantification of Vesiculated Phenotype 
For vesiculation analysis, phase contrast images were acquired with an 
Olympus CKX41 inverted light microscope using a 20X objective and 
analysed using ImageJ public domain software version 1.46r 
(http://rsb.info.nih.gov/ij/; National Institutes of Health, USA) as described in 
Sections 2.8.3, 2.11 and 2.18. Images were converted to 8-bit greyscale and 
the threshold pixel brightness was set to the same value for all images using 
the ‘threshold’ function. Threshold pixels were converted to binary and a 
region of interest was drawn around each cell. Particles with an area greater 
than 2 µm2 and a circularity value greater that 0.65 were counted for each 
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cell using the ‘analyse particle’ function. Cells were deemed positive for a 
vesiculated phenotype if they contained at least four or more vesicles with 
an area greater than 2 µm2. 
2.8 Immunofluorescence  
Indirect immunofluorescence was used to assess the subcellular localisation 
of various proteins. All antibody incubations were performed in a humidified 
chamber at room temperature, unless otherwise stated. For specific 
information regarding the antibodies used for immunofluorescence, see 
Table 2.3. 
2.8.1 Indirect Immunofluorescence 
For immunofluorescence analysis of beige, SCID or 3T3-J2 fibroblasts, cells 
were seeded directly onto sterile coverslips in 12-well plates. 3T3-J2 cells 
were either transfected with siRNA (Section 2.6), or treated with YM201636 
(Section 2.5) for the times specified. NK-92 cells were resuspended in 
growth medium supplemented with either 1 µM YM201636 or an equivalent 
volume of DMSO for 90 minutes. NK-92 cells were then seeded onto 
microscope slides coated with poly-L-lysine (Sigma-Aldrich, USA) and 
allowed to adhere for a further 30 minutes (2 hours total YM201636 
incubation time). All cells were washed with PBS, fixed with 4% w/v 
paraformaldehyde in PBS for 20 minutes and permeabilised with 0.1% v/v 
Triton X-100 (Sigma-Aldrich, USA) in PBS for 15 minutes. Cells were 
washed with PBS, blocked with 1% w/v BSA in PBS for 30 minutes then the 
solution discarded. Primary antibodies were prepared in PBS containing 
0.1% Triton X-100 and 1% BSA and the cells incubated with 200 
µL/coverslip for 1 hour. Cells were washed three times with PBS and 
incubated with 200 µL/coverslip of the appropriate AlexaFluor-conjugated 
secondary antibody (prepared in PBS containing 0.1% Triton X-100 and 1% 
BSA) for 1 hour. For cells requiring staining of F-actin, 50 nM Texas Red®-X 
Phalloidin (Life Technologies, USA) was included in the secondary antibody 
incubation step. Cells were washed once with PBS, stained with 0.5 µg/mL 
4',6-diamidino-2-phenylindole (DAPI) for 10 minutes, then washed three 
times in PBS before mounting with Vectashield® mounting medium (Vector 
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Laboratories, USA). Cells were stored at 4 oC prior to imaging with a 
confocal microscope. (Section 2.9) 
2.8.2 Immunofluorescence Analysis of NK-92-K562 Conjugates 
K562 cells (1.5 x 106) were washed and resuspended in 1 mL medium 
containing 5 µM Cell Trace Far Red DDAO-SE (Life Technologies, UK) and 
incubated for 90 minutes at 37 oC. NK-92 cells (3 x 106) were washed and 
resuspended in 1 mL medium containing 235 nM Hoechst and incubated for 
30 minutes at 37 oC. K562 and NK cells were then washed three times in 
PBS and resuspended in medium containing either 1 µM YM201636 or an 
equivalent volume of DMSO for 20 minutes. NK and K562 cells were mixed 
together (NK-92:K562 ratio of 2:1) and centrifuged gently for 5 minutes at 20 
x g to encourage conjugate formation. Conjugates were incubated at 37 oC 
for 10 minutes, then gently resuspended. Volumes of 100 µL were pipetted 
onto poly-L-lysine-coated microscope slides within a circle drawn in 
hydrophobic ink (Pap Pen, Sigma Aldrich, USA). Cells were allowed to 
adhere for 15 minutes at room temperature in a humidified chamber. Slides 
were gently dipped in PBS to remove non-adherent cells, fixed with 4% w/v 
paraformaldehyde in PBS for 20 minutes and permeabilised with 0.1% v/v 
Triton X-100 in PBS for 15 minutes. Cells were washed by gentle immersion 
in PBS containing 1% BSA and 0.1% saponin (Sigma-Aldrich, USA; PBS/S) 
three times, then blocked with PBS/S for 30 minutes. Primary antibodies 
were prepared in PBS/S and incubated with cells for 1 hour. Cells were 
washed by gentle immersion three times in PBS/S, then incubated with the 
appropriate Alexa Fluor-conjugated secondary antibody prepared in PBS/S 
for 1 hour. Cells were washed by gentle immersion twice in PBS, then once 
in water before coverslips were mounted onto the cells using Vectashield®. 
Cells were stored at 4 oC prior to imaging with a confocal microscope 
(Section 2.9). 
2.8.3 Plasma Membrane PtdIns(4,5)P2 
SCID and beige fibroblasts were seeded into wells of an 8-well chamber 
slide (Merck KGaA, Germany) at a density of 1 x 104 cells per well and 
allowed to adhere overnight at 37 oC. Cells were washed with PBS and fixed 
with 4% w/v methanol-free formaldehyde (Thermo Fisher Scientific, USA) 
- 49 - 
 
and 0.2% v/v electron microscopy grade gluteraldehyde (VWR International, 
USA) in PBS for 15 minutes at room temperature. Cells were then rinsed 
three times with PBS containing 50 mM ammonium chloride (NH4Cl), to 
remove unreacted aldehydes. Slides were then placed on a metal plate in a 
deep ice bath and chilled for a minimum of 5 minutes. All subsequent steps 
were performed on ice and solutions were pre-chilled. Cells were blocked 
and permeabilised for 45 minutes with staining buffer (20 mM piperazine-
N,N′-bis[2-ethanesulfonic acid] [PIPES] pH 6.8, 137 mM NaCl and 2.7 mM 
KCl) containing 5% v/v goat serum (Sigma-Aldrich, USA), 0.5% w/v saponin 
and 50 nM NH4Cl. Anti-PtdIns(4,5)P2 antibody (Table 2.3) was applied in 
staining buffer containing 5% goat serum and 0.1% saponin for 1 hour. Cells 
were washed twice with staining buffer and incubated for 1 hour with an 
appropriate Alexa Fluor-conjugated secondary antibody prepared in 
PtdIns(4,5)P2-staining buffer containing 5% goat serum and 0.1% saponin. 
Slides were washed four times with 50 nM NH4Cl, then post-fixed with 2% 
formaldehyde in PBS for 10 minutes. Cells were allowed to adjust to room 
temperature and washed three times with 50 mM NH4Cl before staining with 
0.5 µg/mL DAPI for 10 minutes. Cells were rinsed twice with 50 mM NH4Cl 
and once with dH20 before mounting with coverslips using Vectashield®. 
To determine the plasma membrane/cytoplasmic ratio of PtdIns(4,5)P2, the 
fluorescence intensities of regions of interest (ROI) both over the plasma 
membrane and in the adjacent cytoplasmic area (close to the plasma 
membrane) were determined using ImageJ software version 1.46r. 35 ROI 
pairs from a total of 18 different cells were averaged and the background 
fluorescence (determined from ROIs in control areas without cells) was 
subtracted from all other values.  
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Table 2.3. Primary antibodies for immunofluorescence and Western 
blotting 
IF, Immunofluorescence; WB, Western blotting 
 
Immunogen Host [Clone] 
Working Dilution 
Manufacturer  
IF WB 
β-Actin Mouse - 1:10,000 Sigma-Aldrich, USA 
CI-MPR Rabbit 1:200 - Abcam, UK 
EEA1 Rabbit 1:200 1:1000 Cell Signalling Technology, USA 
FSP1 Rabbit 1:500 - Abcam, UK 
GAPDH Mouse [6C5] - 1:2000 Life Technologies, USA 
LAMP1 Rat [G2a] 1:500 1:1000 BD Biosciences, USA 
LAMP1 
Mouse 
[1D4B] 
1:500 
1:1000 
Abcam, UK 
LC3B Rabbit 1:200 1:1000 Cell Signalling Technology, USA 
PIP5K3 
(PIKfyve)  Rabbit 1:300 - Novus Biologicals, USA 
PLCγ1 Rabbit 1:200 1:1000 Cell Signalling Technology, USA 
PLCγ2 Rabbit - 1:500 Cell Signalling Technology, USA 
PtdIns(4,5)P2  
Mouse 
[2C11] 1:100 
- Abcam, UK 
PRKCB 
(PKCβ) Rabbit - 1:1000 Proteintech Group, USA 
SV40T Mouse [Pab419] 1:1 - 
Eric Blair, University of Leeds, 
UK 
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Table 2.4. Secondary antibodies for immunofluorescence and Western 
blotting 
 
2.8.4 LysoTracker Staining 
Acidified organelles were visualized using LysoTracker® Red DND-99 (Life 
Technologies, USA). Culture media was aspirated from beige and SCID 
fibroblasts (seeded onto sterile coverslips the previous day) and replaced 
with 0.5 mL medium containing 100 nM LysoTracker®. Cells were incubated 
at 37 oC for 1 hour, then washed once with PBS. Cells were then stained 
with 0.5 µg/mL DAPI for 10 minutes, washed three times in PBS and 
mounted onto microscope slides using Vectashield® (Vector Laboratories, 
USA). Slides were stored at 4 oC prior to imaging with a confocal microscope 
(Section 2.9). 
 
Immunogen Conjugate Host [Clone] Working Dilution Manufacturer 
Mouse IgG  Alexa Flour 488 Goat 1:500 
Life Technologies, 
USA 
Mouse IgG  Alexa Flour 594 Goat 1:500 
Life Technologies, 
USA 
Rabbit IgG  Alexa Flour 488 Goat 1:500 
Life Technologies, 
USA 
Rabbit IgG  Alexa Flour 594 Goat 1:500 
Life Technologies, 
USA 
Rabbit IgG  Alexa Flour 405 Goat 1:500 
Life Technologies, 
USA 
Rat IgG  Alexa Flour 488 Donkey 1:500 
Life Technologies, 
USA 
Rat IgG  Alexa Flour 594 Donkey 1:500 
Life Technologies, 
USA 
Rabbit IgG  Horseradish peroxidase Goat 1:10,000 Sigma-Aldrich, USA 
Mouse IgG  Horseradish peroxidase Sheep 1:10,000 Sigma-Aldrich, USA 
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2.9 Confocal Microscopy 
Images of immunofluorescently labelled cells were acquired using a Nikon 
A1R confocal microscope with Plan Apo VC objectives (40X, numerical 
aperture 1.3 or 60X oil immersion, numerical aperture 1.4) using NIS 
Elements software version 4.00.07 (all Nikon Instruments, UK). Images were 
analysed using ImageJ software, version 1.46r and figures were created 
using Adobe® Photoshop CS6 (Adobe systems, USA). Where appropriate, 
and as indicated in the figure legends, increased image brightness was 
achieved in Photoshop CS6 using the ‘brightness/contrast’ function 
2.10 Live-Cell Time-Lapse Microscopy 
3T3-J2 cells were seeded at a density of 6 x 104 in 35 mm glass bottom 
dishes (MatTek, USA) and immediately transfected with 50 nM siLyst 2 or 
siControl siRNA according to Section 2.6. The medium was replaced after 
six hours with phenol red-free CO2-independent medium (Life Technologies, 
USA) supplemented with 10% FCS and 2 mM L-glutamine. The cells were 
then placed in a BioStation IM-Q microscope with a 37 oC humidified 
chamber (Nikon Instruments, UK). Phase contrast images were acquired at 
several points with a 20X objective every 60 seconds.  
2.11 LC3B Puncta Quantification  
Beige and SCID fibroblasts or siRNA-transfected 3T3-J2 cells (Section 2.6), 
seeded onto sterile coverslips, were washed in PBS. Cells were treated with 
10 µM (beige and SCID) or 25 µM (3T3-J2) chloroquine (Cambridge 
Bioscience, UK) or an equivalent volume of DMSO. After 24 hours, the 
presence of LC3B puncta was determined by immunofluorescence and 
confocal microscopy using an anti-LC3B antibody, according to Sections 2.8 
and 2.9. The number and size of puncta per cell were determined from 
confocal images using ImageJ software version 1.46r. Images were split into 
red, green and blue channels and the green channel (corresponding to 
LC3B fluorescence) was converted to 8-bit greyscale. The fluorescence 
intensity threshold was set using the ‘threshold’ function (constant for all 
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image analysis) and the threshold pixels converted to binary format. A region 
of interest was drawn around each cell and particles greater than 0.2 µm2 
were counted for each cell using the ‘analyse particle’ function.  
2.12 Lipid-Overlay Assay 
To test the binding specificity of anti-PtdIns(4,5)P2 antibody (Table 2.3), a 
lipid overlay assay was performed using a PIP Strip™ membrane (Life 
Technologies, USA). Each strip contains 100 pmol of 15 different 
phospholipids spotted onto a nitrocellulose membrane. The membrane was 
blocked in TBS/T (10 mM Tris-HCL pH 8.0, 150 mM NaCl, 0.1% v/v Tween 
20) containing 3% fatty acid-free BSA (Sigma-Aldrich, USA) for 1 hour at 
room temperature with gentle agitation. The membrane was then incubated 
with 0.5 µg/mL anti-PtdIns(4,5)P2 antibody prepared in TBS/T containing 3% 
fatty acid-free BSA for 1 hour at room temperature. The membrane was 
washed with TBS/T three times using gentle agitation for 10 minutes each. 
The membrane was then incubated with a horseradish peroxidase-
conjugated sheep anti-mouse IgG secondary antibody (Table 2.3) diluted 
1:5000 in TBS/T containing 3% fatty acid-free BSA, for 1 hour at room 
temperature. The membrane was then washed with TBS/T three times for 10 
minutes each with gentle agitation and the bound protein was detected using 
Amersham enhanced chemiluminescence reagent (GE Healthcare, UK). The 
membrane was transferred to a light proof cassette and developed using CL-
XPosure film (Thermo-Fisher Scientific, USA) and an automated Konica 
SRX 101A X-ray developer (Konica, UK). The densities of the spots were 
analysed using Quantity One software (Bio-Rad Laboratories, USA) and the 
area of the membrane containing no lipid (blank) was used for background 
correction.  
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2.13 Degranulation Assay  
LAMP1 (also known as CD107a) surface expression was used to measure 
NK cell degranulation following chemical- or target cell-stimulation and 
assessed by flow cytometry. Primary NK or NK-92 cells were treated with 
YM301636 or DMSO (in triplicate) at the concentrations specified and 
incubated at 37 oC for 20 minutes, prior to the degranulation assay. Cells 
were stimulated with K562 cells or PMA/ionomycin according to Section 
2.2.4. Cells were then stained with anti-LAMP1-FITC monoclonal antibody 
(1:100) or isotype-FITC (Table 2.5), together with GolgiSTOP™ (1:1000 v/v; 
BD Biosciences, USA) and incubated at 37 oC for a further 2 hours. Cells 
were subsequently stained with anti-CD56-PE antibody (1:200) or isotype 
(Table 2.5) for 15 minutes at room temperature to distinguish NK cells from 
K562 cells. Cells were pelleted at 300 x g for 3 minutes, washed twice with 
ice-cold FACS buffer (PBS containing 0.5% BSA, and 0.05% sodium azide) 
and resuspended in cold FACS buffer before being analysed by an LSR II 
flow cytometer running FACSDiva™ software, version 6.2 (both BD 
Biosciences, USA). Forward and side scatter parameters were used to gate 
for single cells, eliminating dead cells and debris from the analysis. A 
minimum of 1 x 104 cell events were recorded per sample. NK-92 cells 
stained with FITC-isotype control were used to set the threshold between 
bright and dim FITC fluorescence. Cells with FITC fluorescence above this 
threshold were deemed to be positive for surface LAMP1 and therefore to 
have undergone degranulation. This population of cells was expressed as a 
percentage of the total number of cells. Unstimulated and untreated cells 
were analysed for basal LAMP1 surface expression and single stained 
controls were included to allow for compensation. The degranulation 
response was expressed relative to the degranulation induced in the 
absence of YM201636. 
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Table 2.5. Antibodies and isotype controls used for flow cytometry 
 
2.14 Enzyme-Linked Immunosorbent Assay (ELISA) 
To quantify IFNγ secreted from NK-92 cells in response to target cell 
stimulation, a sandwich ELISA was performed. NK-92 cells were plated into 
wells of a 96 well plate at a density of 1 x 105. YM201636 or DMSO (vehicle) 
was added for 20 minutes at 37 oC at the concentrations specified. Cells 
were then co-incubated with K562 target cells as outlined in Section 2.2.4 for 
4 hours at 37 oC. Cells were pelleted at 300 x g for 3 minutes, the 
supernatants collected and either used immediately or stored at -20 oC. 
ELISA plates were prepared by coating MaxiSorp™ 96 well plates (Thermo 
Fisher Scientific, USA) with mouse monoclonal anti-IFNγ antibody (BD 
Biosciences, USA) at 4 µg/mL in coating buffer (0.1 M NaHCO3, pH 8.2) 
overnight. Plates were washed three times with PBS containing 0.05% v/v 
Tween-20 (PBS/T) and blocked with PBS containing 10% FCS for 1 hour at 
room temperature. Plates were washed three times with PBS/T, and 
undiluted supernatants were added to plates in triplicate wells for 2 hours at 
room temperature. Supernatants from unstimulated NK and K562 cells were 
plated to measure background IFNγ secretion. Fresh media was used as a 
background control. Serial dilutions of recombinant IFNγ (BD Biosciences, 
USA) were plated alongside samples and used to prepare a standard curve. 
Plates were washed six times with PBS/T and mouse monoclonal anti-IFNγ 
Immunogen Fluoro-chrome Host [Clone] Manufacturer  
CD3 FITC Mouse [UCHT1] BD Biosciences, USA 
CD56 PE Mouse [AF127H3] Miltenyi Biotech, 
Germany 
LAMP1 (CD107a) FITC Mouse [H4A3] BD Biosciences, USA 
Mouse IgG1 
(Isotype)  
PE [IS5-21F5] Miltenyi Biotech, 
Germany 
Mouse IgG1 
(Isotype) 
FITC [MOPC-21] BD Biosciences, USA 
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detection antibody (BD Biosciences, USA) was added at 2 µg/mL in PBS 
containing 10% FCS for 1 hour at room temperature. Plates were then 
washed six times with PBS/T and incubated with ExtrAvidin®-alkaline 
phosphatase (Sigma-Aldrich, USA; 1:5000 in PBS/T) for 1 hour at room 
temperature. Plates were washed three times with PBS/T then three times 
with double distilled water (ddH2O) before adding SIGMAFAST™ substrate 
solution (1 mg/mL p-Nitrophenyl phosphate, 0.2 M Tris buffer, 5 mM 
magnesium chloride; Sigma-Aldrich, USA). The absorbance at 405 nm was 
measured using a plate reader (Multiskan EX, Thermo-Fisher Scientific, 
USA) after 30 minutes. The background absorbance generated by the 
medium was subtracted from all other sample values and the amount of 
basal IFNγ secreted from resting untreated cells was deducted from all other 
samples. 
2.15 Assessment of Cell Viability 
The translocation of phosphatidylserine (PS) from the inner- to the outer- 
leaflet of the plasma membrane during early apoptosis allows the binding of 
fluorochrome-labelled Annexin V protein. Counterstaining with propidium 
iodide allows the discrimination of late apoptotic and necrotic cells from cells 
in early apoptosis. Approximately 1 x 105 YM201636-treated NK-92 cells or 
siRNA-transfected 3T3-J2 cells were washed twice in PBS and resuspended 
in 100 µL of Annexin V binding buffer (10 µM HEPES pH 7.4, 0.14 M NaCl, 
2.5 mM CaCl2; BD Biosciences, USA). Cells were stained with 5 µL of FITC-
Annexin V and propidium iodide (both BD Biosciences, USA) for 3T3-J2, or 
propidium iodide only for NK-92 and incubated at room temperature for 15 
minutes. Cells were washed and pelleted, the supernatant removed and the 
pellet resuspended in 400 µL of Annexin V binding buffer before analysing 
on an LSR II flow cytometer with FACSDiva™ software version 6.2 (both BD 
Biosciences, USA). Single stain controls were included to allow for 
compensation. 
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2.16 Gamma (γ)-Radiation to Induce Senescence 
To generate a senescent population of 3T3-J2 cells, 2 x 104 cells were 
plated in wells of a 12-well plate and allowed to adhere overnight. The next 
day, in parallel to siRNA-transfections, cells were subjected to 80 Gray γ-
radiation for 60 minutes and incubated for 24 hours at 37 oC, before use. 
2.17 Senescence-Associated β-Galactosidase Activity 
Senescence-associated β-Galactosidase (SA-β-Gal) activity was determined 
by measuring the activity of β-galactosidase at pH 6.0 in fixed (colourimetric 
assay) or live cells (flow cytometric- assay).  
2.17.1 X-Gal Colourimetric Assay 
5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) was cleaved by 
SA-β-Gal to yield an insoluble blue product that was readily detectable by 
phase contrast microscopy. 3T3-J2 cells, seeded into 12-well plates, were 
transfected according to Section 2.6 or irradiated according to Section 2.16 
and incubated for 48 hours. Cells were stained with the Senescence β-
Galactosidase Staining Kit (Cell signalling Technology, USA) according the 
manufacturer’s instructions. Briefly, cells were washed with PBS, fixed with 
1X fixative solution (2% v/v formaldehyde and 0.2% v/v gluteraldehyde in 
PBS) for 15 minutes at room temperature and washed twice with PBS. Cells 
were stained with 500 µL X-Gal staining solution (2.45 µM X-Gal in N,N-
dimethyformamide, 5 nM potassium ferrocyanide, 5 nM potassium 
ferricyanide, 40 mM citric acid/sodium phosphate (pH 6.0), 150 mM sodium 
chloride, 2 mM magnesium chloride; pH 5.9-6.1). The blue colour was 
evident 2-4 hours after staining and phase contrast images were acquired 
after 12-16 hours (when colour was maximal) using an Olympus CKX41 
inverted light microscope. 
2.17.2 C12FDG Flow Cytometric Assay  
5-dodecanoylaminofluorescein di-beta-D-galactopyranoside (C12FDG, 
Sigma-Aldrich, USA) is a non-fluorescent membrane-permeable substrate of 
β-galactosidase, which after hydrolysis of the galactosyl residues becomes 
- 58 - 
 
fluorescent and is sequestered intracellularly. 3T3-J2 cells transfected in 
triplicate according to Section 2.6 or irradiated according to Section 2.16, 
were washed with PBS after 48 hours and pre-treated with 100 nM 
bafilomycin A1 (BioViotica, Germany) in culture medium, for one hour at 37 
oC in a humidified 5% CO2 incubator to raise the lysosomal pH to 6.0. 
C12FDG was then added to the culture medium at a final concentration of 33 
µM and cells incubated for two hours at 37 oC. After washing three times 
with PBS, the cells were harvested using trypsin, centrifuged at 300 x g for 
10 minutes at 4 oC and resuspended in cold FACS buffer (0.5% BSA and 
0.05% sodium azide in PBS). Cells were analysed immediately using an 
LSR II flow cytometer with FACSDiva™ software, version 6.2. Forward and 
side scatter parameters were used to gate for single cells, eliminating dead 
cells and debris from the analysis. A minimum of 1 x 104 cell events were 
recorded per sample. Untreated 3T3-J2 cells stained with C12FDG were 
used to set the threshold between bright and dim C12FDG fluorescence. 
Cells with fluorescence above this threshold were deemed to be positive for 
C12FDG (and therefore positive for SA-β-Gal activity) and were expressed as 
a percentage of the total number of cells. Unstained controls were included 
for each sample analysed and used to determine the amount of 
autofluorescence emitted.  
2.18 Cell Size Analysis  
For analysis of cell size using confocal images, 3T3-J2 cells were 
transfected with siRNA and stained with 50 nM Texas Red®-X Phalloidin 
after 48 hours (Sections 2.6 and 2.8.1). Using phalloidin staining to delineate 
the cells, cell areas were determined from maximum intensity projections of 
confocal z-stacks using ImageJ analysis software (version 1.46r).  
The low-angle forward scatter of light that occurs when a cell passes through 
a laser beam is roughly proportional to the diameter of the cell, therefore the 
forward scatter parameter of a flow cytometer was used to determine the 
number of enlarged cells in siRNA-transfected or irradiated 3T3-J2 cells. 
3T3-J2 cells transfected with siRNA or irradiated according to Sections 2.6 
and 2.16 were harvested using trypsin after 48 hours, washed in PBS and 
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pelleted. Cell pellets were resuspended in cold FACS buffer (PBS containing 
0.5% BSA and 0.05% sodium azide) at a density of 1 x 106 cells/mL before 
being analysed by an LSR II flow cytometer with FACSDiva™ software 
version 6.2. Forward and side scatter parameters were used to gate for 
single cells, eliminating dead cells and debris from the analysis, and at least 
1 x 104 cell events were recorded per sample. Untreated 3T3-J2 cells were 
used to set the threshold between high and low forward scatter. Cells with 
forward scatter above this threshold were deemed to be enlarged and the 
number of enlarged cells were expressed as a percentage of the total 
number of cells. The number of enlarged cells in a mock-transfected siRNA 
population was deducted from the number of enlarged cells in the siLyst and 
siControl populations.  
2.19 Quantification of Aberrant Nuclei  
3T3-J2 cells transfected with siRNA or irradiated according to Sections 2.6 
and 2.16, were imaged with an Olympus CKX41 inverted light microscope 
using a 20X objective. Phase contrast images were used to score cells that 
displayed an abnormal nuclear morphology or number, and the number of 
aberrant cells were expressed as a percentage of the total number of cells 
counted.  
2.20 Quantification of Protein Expression by Western 
Blotting 
Protein expression was quantified by Western blotting of proteins extracted 
from cell lysates and separated by gel electrophoresis. Buffer recipes and 
the chemicals used for Western blotting are listed in Table 2.6 and Table 
2.7. 
2.20.1 Preparation of Cell Lysates 
Cells cultured in 10 mm dishes were detached with trypsin, washed twice in 
PBS and lysed on ice for 20 minutes with 300 µL RIPA buffer. Protease 
inhibitor cocktail (Sigma-Aldrich, USA) was added to the lysis buffer to 
prevent protein degradation. The lysate was centrifuged at 13,000 x g (5 
- 60 - 
 
minutes, 4 oC) and the soluble fraction was either used immediately or 
stored at -20 oC. The protein concentration of lysates was determined using 
the Pierce Coomassie Plus Protein Assay (Thermo Fisher Scientific, USA), 
following the manufacturer’s microplate protocol. Briefly, 300 µL of 
coomassie blue was added to 10 µL of lysate diluted 1:10 in PBS (in 
triplicate) and incubated at room temperature for 10 minutes. A series of 
protein standards (0 - 2000 µg/mL) were prepared using BSA and used to 
generate a standard curve. The absorbance was measured at 620 nm using 
a plate reader (Multiskan EX, Thermo-Fisher Scientific, USA) and the 
average absorbance of RIPA buffer (diluted 1:10 in PBS) was subtracted 
from all samples and standards.  
2.20.2 Sodium Dodecyl Sulphate-Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) 
For all proteins, with the exception of EEA1 and LAMP1, the following 
method was applied. According to cell size, an 8% or 10% sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) resolving gel with 
a 5% stacking gel (Table 2.6) was prepared, loaded into an XCell SureLock™ 
gel electrophoresis tank (Bio-Rad Laboratories, USA) and immersed in 1 x 
SDS-PAGE buffer (Table 2.6). Cell lysates were mixed with an equal volume 
of 2X Laemmli buffer (Table 2.6) supplemented with 5% β-mercaptoethanol, 
heated for 5 minutes at 95 oC and then cooled on ice for 2 minutes. Protein 
samples (20 µL at 1 µg/µL) were loaded into wells of the SDS-PAGE gel 
alongside a well containing 10 µL Precision Plus Protein™ Dual Colour 
Standard marker (Bio-Rad Laboratories, USA). A potential difference of 100-
120 V was applied across the gel for approximately 2 hours.  
For electrophoretic separation of EEA1 and LAMP1, pre-cast 3-8% Tris 
acetate gels (Life Technologies, USA) were used. 4X NuPAGE® LDS 
Sample Buffer (10 µL, Life Technologies, USA) was added to a sample 
lysate (26 µL at 0.77 µg/µL protein), together with 10X NuPAGE® Sample 
Reducing Agent containing 500 mM dithiothreitol (Life Technologies, USA). 
Samples were heated at 70 oC for 10 minutes then cooled on ice for 2 
minutes. Gels were assembled into an XCell SureLock™ gel electrophoresis 
tank and immersed in 1X NuPAGE® Tris-Acetate SDS Running Buffer 
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containing 0.25% v/v NuPAGE® Antioxidant (both Life Technologies, USA). 
Samples were loaded alongside 10 µL HiMark™ Pre-Stained High Molecular 
Weight protein standard (Life Technologies, USA) and subjected to a 
potential difference of 150V for 1 hour.  
Proteins were then transferred from the gel to polyvinylidene (PVDF) 
membranes by wet transfer (Section 2.20.3).  
2.20.3 Western Blotting 
Western blotting was performed by sandwiching the gel between a sheet of 
PVDF membrane and two pieces of Whatman™ 3MM Chr paper (both GE 
Healthcare, USA) that had been pre-soaked in transfer buffer (Table 2.6) for 
10 minutes. The proteins were transferred using an XCell SureLock™ Mini-
Cell fitted with an XCell II™ Blot Module (Life Technologies, USA). For 
membranes containing EEA1 and LAMP1, the tank was filled with 1X 
NuPage® Transfer Buffer containing 0.1% NuPAGE® Antioxidant (both Life 
Technologies, USA) and 10% v/v methanol. A potential difference of 20 V 
was applied to the system overnight at 4 oC. For all other membranes, the 
tank was filled with transfer buffer (Table 2.6) containing 20% methanol 
before transfer overnight as previously described. 
2.20.4 Probing  
Following the transfer of proteins to PVDF, membranes were blocked for 1 
hour at 4 oC in 1X Tris-buffered saline, 0.1% v/v Tween-20 (TBS/T; Table 
2.6) plus 10% w/v Marvel dried milk powder. The block was replaced with 
fresh TBS/T containing 1% dried milk powder, to which the primary antibody 
was added at the relevant dilution (Table 2.3). The membrane was 
incubated in the presence of primary antibody for 1 hour at room 
temperature or overnight at 4 oC, with continuous rocking. Membranes were 
washed in TBS/T (3 X 5 minutes) with continuous agitation. The secondary 
antibody was added at the relevant dilution (Table 2.4) in 5% dried milk 
powder for 1 hour at room temperature or overnight at 4 oC, with continuous 
rocking. Membranes were washed in TBS/T (3 X 5 minutes) with continuous 
agitation. The membrane was rinsed in dH20 and protein detected using 
Amersham enhanced chemiluminescence reagent (GE Healthcare, UK). 
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Membranes were transferred to a light proof cassette and developed using 
CL-XPosure film (Thermo-Fisher Scientific, USA) and an automated Konica 
SRX 101A X-ray developer (Konica, UK). The expression of β-actin or 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Table 2.3) was 
assessed to confirm equal loading of protein samples. 
 
Table 2.6. Buffers and gels used for quantification of protein 
expression by Western blotting 
*Acrylamide, N,N’-methylene- bis-acrylamide 37.5:1 
 
 
 
 
 
 
Buffer or Gel Contents 
RIPA buffer 
10 mM Tris-HCL pH 8, 1 mM EDTA, 0.5 mM EGTA, 
140 mM NaCl, 1% Triton X-100, 0.1% sodium 
deoxycholate, 0.1% v/v SDS, dH20  
8% resolving gel 
8% v/v Acrylamide*, 0.375 M Tris-HCL pH 8.8, 0.1% 
SDS, 0.6% v/v ammomium persulphate (APS), 0.1% v/v 
TEMED, dH20 
10% resolving gel 10% Acrylamide*, 0.375 M Tris-HCL pH 8.8, 0.1% SDS, 
0.6% APS, 0.1% TEMED, dH20 
5% stacking gel 5% Acrylamide*, 0.126 M Tris-HCL pH 6.8, 0.1% SDS, 
0.6% APS, 0.1% TEMED, dH20 
10X SDS-PAGE buffer  0.25 M Tris base, 0.19 M glycine, 1% SDS, dH20 
2X Laemmli buffer 
4% SDS, 20% glycerol, 0.02% w/v bromophenol blue, 
0.125 M Tris-HCL 
10X Transfer buffer  0.25 M Tris base, 0.19 M glycine, dH20, pH 8.3  
10X TBS buffer 0.25 M Tris base, 1.34 M sodium chloride, 54 mM 
potassium chloride, ddH20, pH 7.4 
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Table 2.7. Chemicals used for preparation of buffers for Western 
blotting 
*Acrylamide, N,N’-methylene-bis-acrylamide 37.5:1 
 
2.20.5 Densitometry Analysis of Western Blots 
ImageJ software (version 1.46r) was used to analyse the density of protein 
bands on scanned Western blotting film. Rectangular marquees were drawn 
around bands to be compared. Densitometry values were generated using 
the ‘analyse gel’ and ‘plot lane’ functions and the background subtracted 
from each value. 
2.21 Quantitative Real-Time Polymerase Chain Reaction 
(qRT-PCR) 
For gene expression analysis, quantitative real-time polymerase chain 
reaction (qRT-PCR) was performed to determine the level of mRNA 
following siRNA-mediated silencing according to the following procedure. 
Reagent Manufacturer 
Acrylamide* National Diagnostics, UK 
Bromophenol blue Sigma-Aldrich, USA 
Gycerol Sigma-Aldrich, USA 
Glycine Sigma-Aldrich, USA 
Potassium chloride VWR International, USA 
SDS  Sigma-Aldrich, USA 
Sodium chloride Sigma-Aldrich, USA 
Sodium deoxycholate Sigma-Aldrich, USA 
TEMED National Diagnostics, UK 
Tris base Sigma-Aldrich, USA 
Tris-HCL Sigma-Aldrich, USA 
Tween-20 Sigma-Aldrich, USA 
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2.21.1 RNA Extraction 
Roughly 1 x 106 cells per treatment were lysed for RNA extraction. Cells 
were detached with trypsin, washed in PBS and pelleted by centrifugation. 
Total RNA was extracted using GeneElute™ Mammalian Total RNA Miniprep 
Kit (Sigma-Aldrich, USA) according to the manufacturer’s instructions. All 
centrifugation steps were performed at 13,000 x g in a benchtop 
microcentrifuge. Briefly, cells were lysed with the supplied guanidine 
thiocyanate lysis solution containing β-mercaptoethanol and the lysate 
passed through a filtration column to remove cellular debris. An equal 
volume of 70% ethanol was added and the lysate/ethanol mixture passed 
through a binding column. RNA bound to the column was washed three 
times with the provided wash solutions and then centrifuged for 1 minute to 
remove residual traces of ethanol. Finally, the RNA was eluted in distilled 
water and immediately treated as described in Section 2.21.2. 
2.21.2 RNA Treatment and Quantitation 
Extracted RNA was treated to remove contaminating genomic DNA using 
DNA-free™ kit according to the manufacturer’s instructions (Life 
Technologies, USA). Briefly, 10X DNase buffer (100 mM Tris at pH 7.5, 
25mM MgCl2, 5 mM CaCl2) and 2 U of DNase I per 50µL of RNA was added 
to samples, followed by incubation at 37 oC for 20-30 minutes. DNase I was 
inactivated and removed by the addition of DNase inactivation reagent for 2 
minutes at room temperature. Samples were centrifuged at 10,000 x g for 2 
minutes, and the pellet discarded. RNase activity was inhibited to preserve 
the integrity of purified RNA by the addition of RNasin (Promega 
Corporation, USA) at 1 U/µL of RNA solution. The quantity of RNA was 
estimated using a spectrophotometer, measuring the absorbance at 260 nm. 
RNA purity was estimated from the ratio of absorbance at A260nm/A280nm, and 
a value of 1.8-2.1 was considered pure. RNA was used immediately for 
complementary DNA (cDNA) synthesis or stored at -80 oC. 
2.21.3 Complementary DNA (cDNA) Synthesis 
The synthesis of cDNA from extracted RNA was carried out in a reaction 
consisting of 1 µL random hexamers (50 µM; Life Technologies, USA), 2 µg 
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RNA, 1 µL deoxyribonucleos§ide triphosphate (dNTP) mix (10 mM each of 
dATP, dCTP, dGTP and dTTP) and sterile nuclease-free water to a final 
volume of 13 µL. The mixture was heated at 65 oC for 5 minutes and quickly 
chilled on ice to prevent secondary structure formation. A 4 µL aliquot of 5X 
First-Strand Buffer (250mM Tris-HCL, pH 8.3; 3.75 M KCl; 15mM MgCl2), 
together with 2 µL of 100 mM 1,4-Dithiothreitol (both Life Technologies, 
USA), was added to the sample and incubated for a further 2 minutes at 25 
oC. Finally, 1µL (200 U) of SuperScript II reverse transcriptase (Life 
Technologies, USA) was added, giving a final volume of 20 µL. The sample 
was incubated at 25 oC for 10 minutes, followed by 50 minutes at 42 oC. 
Reverse transcriptase was inactivated by heating at 70 oC for 15 minutes 
and the resulting cDNA was stored at -20 oC. A mock reaction (where 
reverse transcriptase was omitted) was performed and included in qRT-PCR 
reactions to assess for genomic DNA contamination. Samples of cDNA were 
stored at -80 °C. 
2.21.4 qRT-PCR 
Inventoried TaqMan® Gene Expression Assays (Table 2.8) were purchased 
from Life Technologies, USA. Reactions were performed in MicroAmp® 
Optical 96-well reaction plates (Life Technologies, USA). Each 20 µL 
reaction contained: 1X TaqMan® Gene Expression Master Mix, 1X TaqMan® 
Gene Expression Assay Mix, 20 ng of sample cDNA and deionised 
nuclease-free water,to a final volume of 20 µL. Negative controls included in 
each reaction plate consisted of a mock reverse transcription (‘no 
amplification control’, Section 2.21.3) to control for genomic DNA 
contamination, and a ‘no template control’ whereby cDNA was substituted 
with nuclease-free water, to assess for contamination of the reagents. Each 
sample was run in triplicate and the reaction was performed using a 7500 
Real-Time PCR thermal cycler running 7500 software version 2.0.3 (both 
Life Technologies, USA). The comparative cycle threshold (CT) method was 
used to determine mRNA expression. The CT values and baseline were 
automatically determined by the software for each transcript and were 
normalised to the expression level of the endogenous control, Hprt1 (mean 
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target gene CT - mean Hprt1 CT). The expression of the target gene relative 
to the non-silencing control was calculated by the value of 2-delta CT. 
 
Table 2.8. TaqMan® gene expression primers used for qRT-PCR 
All primers spanned an exon junction. Lyst, lysosomal trafficking regulator; Tcf7l1, 
transcription factor 7-like 1 [T-cell specific, HMG-box]; Tcf7l2, transcription factor 7-
like 2 [T-cell specific, HMG-box]; Hprt1, hypoxanthine phosphoribosyltransferase 1. 
 
2.22 Statistical Analysis 
Statistical analyses were performed using Prism 6 software (GraphPad 
Software, USA). Data pertaining to the relative mRNA level in response to 
siRNA-mediated silencing were analysed using a one sample t-test against a 
hypothetical mean of 100. All other data illustrating the difference between 
two groups were analysed using a two-tailed student’s t-test and are 
presented as the mean with error bars corresponding to the standard 
deviation (SD). The level of significance was set at P < 0.05 and exact P 
values are reported where appropriate.  
  
Gene Accession Number of mRNA Catalogue Number 
Lyst NM_010748.2 Mm00465000_m1 
Tcf7l1  NM_001079822.1, NM_009332.2 Mm01188711_m1 
Tcf7l2 
NM_001142918.1, NM_001142919.1, 
NM_001142920.1, NM_001142921.1, 
NM_001142922.1, NM_001142923.1, 
NM_001142924.1, NM_009333.3 
Mm00501505_m1 
Hprt1 NM_013556.2 Mm00446968_m1 
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Chapter 3 
Characterisation of the beige Phenotype 
3.1 Introduction 
The perturbed homeostasis of the endolysosomal system in CHS patients 
and beige mice has been studied in depth for almost three decades and 
considerable work has been devoted to pinpointing the underlying 
mechanisms. Despite this, the function of the highly conserved LYST 
remains to be determined, and is largely due to the technical challenge of 
manipulating a gene and protein of such large size. It is clear that LYST 
plays a fundamental role in the formation and exocytosis of secretory 
lysosomes, as the clinical manifestations of CHS all arise from the defective 
exocytosis of these organelles. Although several binding partners for LYST 
have been identified, no pathways have yet been established for LYST-
dependent secretory lysosomes biogenesis or exocytosis.  
Despite the autophagic and lysosomal pathways converging at the point of 
the autolysosome, few studies have explored the autophagic pathway in 
CHS. Similarly, phosphoinositide metabolism plays a pivotal role in 
membrane and vesicle trafficking, yet remains relatively unexplored in CHS. 
The first evidence to signal that such a pathway might be disrupted was 
presented by Ward et al., 2003, who reported a mislocalisation of 
PtdIns(4,5)P2 in both CHS and beige cells. Here, using the beige mouse 
model, The contribution of both PtdIns(4,5)P2 and autophagy to the cellular 
defect of CHS has been investigated; the central aim being to identify 
proteins downstream of LYST that may also function in exocytosis. 
3.2 Establishment of beige Fibroblast Cultures 
To study the CHS/beige phenotype, dermal fibroblasts from mice 
homozygous for the beige mutation (CB17.Cg-PrkdcscidLystbg) and from 
control SCID mice (CB17.Cg-Prkdcscid) were obtained from ears using a skin 
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explant culture system. In this system, dermal and epidermal fibroblasts and 
keratinocytes were allowed to migrate out from the edges of skin explants 
placed in plastic culture dishes (Figure 3.1A). The high growth rate of 
fibroblasts compared to keratinocytes was exploited to obtain cultures highly 
enriched in fibroblasts. Expression of fibroblast-specific protein 1 (FSP1, 
also known as S100-A4) is widely used to identify fibroblasts (Strutz et al., 
1995) and was used to assess the purity of the explant cultures. Substantial 
cytoplasmic expression of FSP1 was found in all cells from explant cultures 
after three passages, as determined by immunofluorescence microscopy 
(Figure 3.1B). Compared to SCID control fibroblasts, beige cells had greatly 
enlarged vesicles that were clustered proximal to the nucleus (Figure 3.1C). 
This feature is typical of CHS/beige fibroblasts and is well documented 
elsewhere (Burkhardt et al., 1993, Abe et al., 1982, Perou et al., 1997a). 
However, there was considerable variation in the morphology of beige 
vesicles. Enlarged vesicles were either non-refractive and of a granular 
appearance (Figure 3.1C, panel ii) or refractive and vacuole-like (Figure 
3.1C, panel iii). Many cells contained one or two grossly enlarged vesicles 
with heterogeneous content (Figure 3.1C, panel iv, arrowhead).  
Primary fibroblasts undergo a limited number of divisions before entering the 
non-replicative state of senescence (Hayflick, 1965). Expression of viral 
oncogenes such as Simian virus 40 large T antigen (SV40T) can 
significantly extend the replicative capacity of mammalian cells in vitro (Ali 
and DeCaprio, 2001, Ozer et al., 1996). A plasmid vector carrying SV40T 
was transfected into beige fibroblasts, in an attempt to prolong their 
replicative lifespan for continuous study. Following transfection of beige with 
SV40T, the cells became rapidly proliferative, whereas the growth rate of 
mock transfected cells or cells transfected with empty vector remained 
unchanged (data not shown). Immunofluorescent labelling of cells with anti-
SV40T antibody showed high expression of SV40T within nuclei of all cells, 
27 days post-transfection (Figure 3.2A). However, the morphology of the 
SV40T-transfected cells changed and cells no longer displayed the enlarged 
vesicle phenotype typical of beige when examined by light microscopy. 
Vesicles became smaller in size and less numerous after transfection 
(Figure 3.2B), and beige cells were indistinguishable from SCID cells. 
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Figure 3.1. Characterisation of beige and SCID fibroblasts 
A) Phase contrast image of cell outgrowth from mouse ear skin explant after 22 
days. Cells attach to the culture vessel and migrate outwards from edges of the 
explant (arrow). B) Confocal sections of SCID and beige cells immunofluorescently 
labelled with the fibroblast specific anti-FSP1 antibody (green) and counterstained 
with DAPI (blue) to visualise nuclei. C) Light micrographs of SCID (i) and beige (ii-
iv) cells. Beige cells displayed large vesicles clustered proximal to the nucleus, but 
the morphology of the vesicles varied considerably (ii-iv). Arrowhead in iv depicts a 
grossly enlarged vesicle with heterogeneous content. Scale bar: A, 500 µm; B, 50 
µm; C, 20 µm 
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Figure 3.2. Immortalisation of beige fibroblasts with SV40T 
Beige fibroblasts transfected with pBSV3-early plasmid containing SV40T DNA 
were examined 27 days post-transfection. A) SV40T expression was detected using 
anti-SV40T antibody (green) and found within nuclei counterstained with DAPI 
(blue). Images are single confocal sections. B) Phase contrast images of beige cells 
transfected with empty vector (control) or SV40T, 27 days-post transfection. Scale 
bar: A, 50 µm; B, 20 µm. 
 
A similar loss of phenotype is observed in beige-j fibroblasts maintained in 
long-term culture (Gow et al., 1993). beige-j fibroblasts cultured for more 
than 70 passages were indistinguishable from control fibroblasts based on 
vesicle size and this was concurrent with a decreased doubling time of 
beige-j fibroblasts (Gow et al., 1993). Lysosomal biogenesis is apparently 
normal in CHS cells, only becoming aberrant as the organelle matures, as is 
the case for mast cell and CTL secretory lysosomes (Chi and Lagunoff, 
1975, Stinchcombe et al., 2000). I postulated that the increased proliferation 
rate of SV40T-transformed beige cells reduces the number of vesicle fusion 
events that can occur between divisions, therefore thwarting the formation of 
large vesicles. For this reason, SV40T-expressing cells were rejected in 
favour of primary beige cells that were used throughout this study.  
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3.3 The Enlarged Vesicles of beige Fibroblasts are 
Lysosomes 
To determine the identity of the enlarged beige organelles, fibroblasts were 
immunofluorescently labelled with specific endocytic markers and examined 
by confocal microscopy. EEA1 is present exclusively in early endosomes 
(Mu et al., 1995) and CI-MPR is present in both early and late endosomes, 
but excluded from mature lysosomes (Griffiths et al., 1990). Labelling with 
antibodies against EEA1 and CI-MPR revealed a similar size and distribution 
pattern of these structures in beige and SCID fibroblasts (Figure 3.3A and 
C). Conversely, LAMP1 is present in lysosomal membranes but absent from 
the early endosome (Lewis et al., 1985). SCID cells displayed small LAMP1-
positive structures dispersed throughout the cytoplasm (Figure 3.3D). In 
stark contrast however, a dramatic increase in the size of LAMP1-positive 
structures was seen in beige, with the majority of large vesicles remaining 
clustered in the perinuclear region. The fluorescence intensity of beige cells 
labelled with anti-LAMP1 antibody was notably higher than in SCID cells 
(Figure 3.3D), raising the possibility that this protein is overexpressed in 
beige cells. Western blot analysis was carried out to test this. Equivalent 
amounts of SCID and beige lysates were analysed by SDS-PAGE and 
Western blot using the same anti-LAMP1 antibody as for the 
immunofluorescence studies. Results confirmed an elevated level of LAMP1 
protein in beige lysates (1.77 fold, Figure 3.3E), while the abundance of the 
180 kDa band detected with anti-EEA1 antibody was unaltered between 
beige and SCID lysates (Figure 3.3B). Furthermore, LAMP1 in the beige 
lysate was of a lower molecular weight than that detected in SCID lysate 
(Figure 3.3E), which may be due to differential N- and O-glycosylation.  
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Figure 3.3. The enlarged vesicles of beige cells are lysosomes 
A) SCID and beige fibroblasts were immunofluorescently labelled with anti-EEA1 
antibody (green) and counterstained with DAPI (blue) to visualise the nucleus. 
Enlarged vesicles were visualised in transillumination (trans) and are demarcated 
by the arrowhead. Contrast was increased equally across all transillumination 
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images to aid visualisation. B) SDS-PAGE and western blot analysis of lysates 
probed with anti-EEA1 and anti-β-actin antibodies. C) SCID and beige fibroblasts 
immunofluorescently labelled with anti-CI-MPR antibody (red). D) SCID and beige 
fibroblasts labelled with anti-LAMP1 antibody (green). The brightness of the 
indicated region within the SCID image (inset) has been increased to aid 
visualisation. E) LAMP1 protein level in SCID and beige lysates from SDS-PAGE 
and western blot analysis using anti-LAMP1 antibody. Fold change in LAMP1 
protein was calculated from the relative band densities: 1.77 ± 0.39. Fluorescence 
images are maximum intensity projections of confocal z-stacks. Western blots are 
representative of two independent experiments. Molecular masses indicated are in 
kDa. Scale bar = 10 µm; inset, D = 5 µm.  
 
As the enlarged organelles contained LAMP1 but not EEA1 or MPR, it was 
concluded that these vesicles were of lysosomal origin, consistent with 
current literature (Burkhardt et al., 1993, Abe et al., 1982, Perou et al., 
1997a).  
The acidified lumen of mature lysosomes is required for the proper function 
of lysosomal hydrolases. CHS/beige lysosomes are acidified and 
accumulate LysoTracker (Mohlig et al., 2007), an acidotropic dye which is 
used to label late endosomes and lysosomes (Huynh et al., 2007). 
LysoTracker accumulated in small punctate structures throughout the 
cytoplasm in SCID fibroblasts, and this pattern was consistent across all 
cells (Figure 3.4A). Despite considerable cell-to-cell variation in the 
LysoTracker staining pattern of beige fibroblasts (Figure 3.4B and C), large 
positively-stained vesicles clustered proximal to the nucleus were present in 
the majority of cells (Figure 3.4B). Interestingly, a number of cells with large 
vesicles that did not accumulate LysoTracker were observed. These 
negatively-stained vesicles were made visible by a ring of smaller positively-
stained organelles surrounding it (Figure 3.4C, bottom arrowhead). Grossly 
enlarged vesicles distant from the nucleus were occasionally observed and 
LysoTracker accumulation within these structures was irregular, appearing 
as dark, negatively-stained areas interspersed with brightly fluorescent 
regions (Figure 3.4C, top arrowhead). 
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Figure 3.4. The enlarged vesicles of beige have varying LysoTracker 
accumulation  
Beige and SCID fibroblasts were stained with 100 nM LysoTracker (red) to label 
acidified organelles. A) SCID fibroblast with punctate cytoplasmic distribution of 
LysoTracker. B and C) Beige fibroblasts displaying different LysoTracker staining 
patterns. Enlarged vesicles lacking LysoTracker (bottom arrowhead, C) or with 
heterogeneous LysoTracker accumulation (top arrowhead, C) were observed. Cells 
were counterstained with DAPI to visualise the nucleus (blue). Images are single 
optical sections. Scale bar = 20 µm.  
 
In conclusion, fibroblasts from the beige mouse exhibit the enlarged 
lysosomal phenotype of CHS and were used in further study of Lyst. 
3.4 Enhanced Constitutive Autophagy in beige Fibroblasts 
Autophagosomes are double membrane organelles which form around and 
selectively engulf portions of the cytoplasm containing organelles and 
proteins (Mizushima and Komatsu, 2011). As they mature, autophagosomes 
fuse heterotypically with lysosomes and form autolysosomes, whereby the 
contents are degraded and recycled. The enlarged vesicles of beige were 
found to be of lysosomal origin due to the presence of LAMP1. However, 
several large vesicles did not fully accumulate LysoTracker. A possible 
reason for this is that some lysosomes are not properly acidified, or they 
may in fact be autolysosomes. Since other BEACH family members are 
implicated in the autophagic pathway (Simonsen et al., 2004, Lopez-Herrera 
et al., 2012, Rahman et al., 2012), I assessed the contribution of autophagy 
to the large vesicle phenotype of beige fibroblasts. For this, an antibody 
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against the beta isoform of LC3, a well-known marker of autophagosomes, 
was employed to detect autophagosomes using fluorescence microscopy. 
LC3 is cleaved at the carboxy terminus immediately after synthesis to 
produce the cytosolic form, LC3-I. Upon induction of autophagy, this 
becomes lipidated with phosphatidylethanolamine to form LC3-II, which 
associates with autophagic membranes (Kabeya et al., 2000). Figure 3.5A 
shows the localisation of anti-LC3B antibody in beige fibroblasts under 
normal conditions. LC3B is visible as discrete puncta distributed throughout 
the cytoplasm in both SCID and beige cells. Many puncta were in close 
proximity to LAMP1-positive lysosomes and the location of LAMP1 and 
LC3B frequently overlapped, suggesting autophagosome formation. 
Importantly, anti-LC3B antibody did not label the very large lysosomes 
(Figure 3.5A, left arrowhead). Although discrete LC3B puncta were seen 
adjacent to the large lysosomes (Figure 3.5A, right arrowhead), LC3B 
fluorescence was predominantly absent from large vesicle membranes and 
did not form the ring-like patterns typical of membrane-association. This 
suggests that the large LAMP1-positive vesicles are not autophagosomes. 
Despite this finding, it does not rule out the possibility that increased 
autophagy might contribute to the increased size of beige lysosomes. To 
examine this, the number of LC3B puncta from immunofluorescent images 
was quantified under basal conditions and conditions where normal 
autophagic degradation is inhibited. Chloroquine raises lysosomal pH and 
inhibits fusion of autophagosomes with lysosomes through an unknown 
mechanism (Kawai et al., 2007). Thus, chloroquine inhibits autophagosome 
clearance and causes their accumulation within the cytoplasm. There was 
no difference in the size of LC3B puncta between beige and SCID fibroblasts 
(Figure 3.5B). Upon the addition of chloroquine, a modest increase in 
average puncta size was seen in beige cells but not in SCID (Figure 3.5B). 
Beige fibroblasts contained a higher average number of LC3 puncta per cell 
than SCID fibroblasts in the control treatment and further induction of puncta 
occurred upon addition of chloroquine (Figure 3.5B). The large variation 
between experimental replicates is likely attributed to differences in 
constitutive autophagy during cell propagation. Indeed, the confluency of the 
culture can affect basal autophagy levels, as reported by Wu et al., 2006.  
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Figure 3.5. LC3B-associated puncta formation and LC3B processing in 
beige and SCID fibroblasts 
A) LC3B-positive puncta in beige and SCID fibroblasts. Cells immunofluorescently 
labelled with anti-LC3B (green) and anti-LAMP1 (red) antibodies were 
counterstained with DAPI (blue). An overlay of the three fluorescent channels is 
shown (merge). Images in the bottom panel are magnifications of the demarcated 
areas in the middle panel. Scale bar: top and middle panels, 20 µm; bottom panel, 
10 µm. B) The mean puncta size (left panel) and mean number of puncta per cell 
(right panel) were quantified from immunofluorescent images of cells treated with 
10 µM chloroquine or DMSO for 24 hours, using ImageJ software. Mean values and 
SD are given (n = 2). C) Western blot analysis of LC3B-I and LC3B-II levels in 
Beige and SCID fibroblasts treated with 10 µM chloroquine, DMSO or serum 
starved for 24 hours. β-actin was used as a loading control. The ratio of LC3B-II to 
β-actin was calculated from the relative densities of the two bands using ImageJ 
software.  
 
Therefore, an alternative quantitative method employing a widely used 
immunoblotting technique (Proikas-Cezanne et al., 2007) was performed 
and the ratio of LC3B-II/β-actin calculated. As shown in Figure 3.5C, the 
abundance of the LC3B-I larger, but faster-migrating LC3B-II was greater in 
control-treated beige cells compared to SCID cells, with LC3B-II/β-actin 
ratios of 1.28 and 0.52, respectively. The addition of chloroquine induced 
further production of LC3B-II in both cell types, but was more pronounced in 
SCID cells. Interestingly, serum starvation, an autophagy stimulus, induced 
LC3B-II production in SCID cells but no such induction occurred in beige 
cells (Figure 3.5C). These results suggest beige fibroblasts have a higher 
level of constitutive autophagy. From these data alone it is unclear whether 
the increased number of LCB-II-associated autophagosomes are 
contributing to the enlarged lysosomal phenotype of beige.  
3.5 Altered Abundance of Lipid-Binding Proteins in beige 
PtdIns(4,5)P2 is a phosphoinositide that is enriched in subdomains of the 
inner leaflet of membrane bilayers. Ward and colleagues reported an altered 
localisation of PtdIns(4,5)P2 in CHS and beige fibroblasts, describing a 
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dramatic reduction in nuclear PtdIns(4,5)P2 that was restored in LYST-
complemented beige cells (Ward et al., 2003). Reduced nuclear 
PtdIns(4,5)P2 might therefore coincide with an increase PtdIns(4,5)P2 in an 
alternative subcellular compartment. I postulated that altered plasma 
membrane-associated PtdIns(4,5)P2, or atypical lysosome-associated 
PtdIns(4,5)P2 might disrupt PtdIns(4,5)P2-dependent signalling pathways or 
normal lysosome homeostasis, respectively. To test this, cells were 
immunofluorescently labelled using a monoclonal antibody against 
PtdIns(4,5)P2 (2C11). Cells were immunofluorescently labelled with 2C11 
antibody under conditions optimal for plasma membrane preservation, and 
the amount of PtdIns(4,5)P2 located at the plasma membrane was evaluated 
by confocal microscopy. PtdIns(4,5)P2 antibody labelling was generally 
diffuse but with some concentrated at plasma membrane in both SCID and 
beige cells (Figure 3.6A). Large areas of PtdIns(4,5)P2 staining appeared to 
coincide with LAMP1 in beige cells. However, this was due to 
autofluorescence emitted from some large lysosomes, and was detected 
across all channels. Dot blot analysis revealed the antibody also bound to 
PtdIns(3)P, PtdIns(4)P and phosphatidylinositol 3,4,5-trisphosphate 
(PtdIns(3,4,5)P3) as reported by others (Thomas et al., 1999, Ward et al., 
2003), as well as phosphatidylethanolamine and PtdIns(5)P (Figure 3.6B). 
Although the antibody bound to PtdIns(4,5)P2 with the highest affinity, 
binding to other PI species may contribute to the widespread labelling of 
anti-PtdIns(4,5)P2 antibody in these cells. Nonetheless, mean fluorescence 
intensities of defined regions from the plasma membrane and adjacent 
cytoplasm were used to calculate plasma membrane/cytoplasmic ratio of 
PtdIns(4,5)P2 and this was found to be higher in beige than in SCID 
fibroblasts (1.43 versus 1.1, Figure 3.6C). Given the lack of absolute 
specificity of the antibody for PtdIns(4,5)P2, it cannot be concluded whether 
the increase in fluorescence at the plasma membrane in beige fibroblasts is 
due to increased levels of PtdIns(4,5)P2 or other PI species.  
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Figure 3.6. PtdIns(4,5)P2 localisation in beige fibroblasts 
A) Immunofluorescent analysis of SCID and beige fibroblasts labelled with anti-
PtdIns(4,5)P2 (green) and anti-LAMP1 (red) antibodies. An overlay of the two 
colours is shown (merge) and the yellow colour indicates areas where both 
fluorescent signals are present. Images are maximum intensity projections of 
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confocal z-stacks. B) The binding specificity of anti-PtdIns(4,5)P2 antibody was 
assessed using a lipid-overlay assay (left). Densities of the spots were analysed 
and the ‘Blank’ used for background correction (right). C) The fluorescence 
intensities of ROIs at the plasma membrane and adjacent cytoplasm were used to 
calculate the plasma membrane/cytoplasmic ratio of PtdIns(4,5)P2, found to be 
elevated in beige cells. The ratios from at least 35 ROI pairs from 18 cells were 
averaged. S1P, Sphingosine-1-phosphate; PE, Phosphatidylethanol-amine. Scale 
bar = 20 µm. 
 
Attention was turned instead to the abundance of a PtdIns(4,5)P2-
hydrolysing protein, PLC, at the plasma membrane. Hydrolysis of 
PtdIns(4,5)P2 by PLC generates 1,2-diacylglycerol (DAG) and inositol 1,4,5-
trisphosphate (Ins[1,4,5]P3), both of which are necessary for regulated 
exocytosis in professional secretory cells.  
The abundance of two isoenzymes of the PLCγ subfamily, PLCγ1 and 
PLCγ2, was examined by Western blot in beige and SCID fibroblast whole 
cell lysates (Figure 3.7A). Surprisingly, beige fibroblasts displayed a 
moderate reduction in the level of both PLCγ1 and PLCγ2 proteins. Fold 
change in protein level was calculated from the relative band densities and 
found to be 0.59 ± 0.04 for PLCγ1 and 0.44 ± 0.15 for PLCγ2 (Figure 3.7A). 
The extra bands detected with PLCγ2 antibody are likely to be degradation 
products. Reduced levels of PLCγ1 was echoed in reduced immuno-
fluorescence in beige fibroblasts labelled with anti-PLCγ1 antibody (Figure 
3.7B). Successful immunolabelling of cells with PLCγ2 was not achieved. 
The serine/threonine kinase PKC is a downstream effector in the 
PtdIns(4,5)P2 signalling pathway, activated by DAG and Ca2+ to modulate 
regulated exocytosis (Morgan et al., 2005). Ito and colleagues (1989) 
reported a down-regulation of PKC in beige NK cells that was later linked 
with the formation of giant lysosomes in beige fibroblasts (Tanabe et al., 
2000). Western blot analysis with antibody against the beta isoform of PKC 
(PKCβ) revealed a modest reduction in PKCβ in beige fibroblasts, with a 
0.67 ± 0.21 fold reduction compared to SCID fibroblasts (Figure 3.7C). 
Taken together, these results suggest a perturbation of the PLCγ-dependent 
signalling pathway might occur in beige cells.  
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Figure 3.7. Abundance of PLCγ and PKCβ in beige fibroblasts  
A) Western blot analysis of SCID and beige lysates probed with anti-PLCγ1 and 
anti-PLCγ2 antibodies, showing reduced levels of both PLCγ1 and PLCγ2 protein in 
beige cells. β-actin and GAPDH were used as loading controls. B) Confocal images 
of SCID and beige fibroblasts immunofluorescently labelled with anti-PLCγ1 
antibody, showing reduced PLCγ1 staining in beige cells. C) Western blots analysis 
of SCID and beige lysates probed with anti-PKCβ antibody. β-actin was included as 
a loading control. Western blots are representative of two independent experiments. 
Molecular masses indicated are in kDa. Fold change in protein level was calculated 
from the relative band densities: PLCγ, 0.59 ± 0.04; PLCγ2, 0.44 ± 0.15; PKCβ, 
0.67 ± 0.21. Scale bar = 20 µm.  
3.6 Discussion 
The giant vesicle phenotype of CHS/beige is well documented but poorly 
characterised. In agreement with previously published findings (Burkhardt et 
al., 1993, Abe et al., 1982, Perou et al., 1997a), I find that the enlarged 
vesicles are lysosomes and not early or late endosomes. However, two 
aspects of the phenotype described here differ from those reported in the 
literature by Burkhardt et al., 1993. Firstly, considerable cell-to-cell variation 
occurred in the morphology and acidification of enlarged lysosomes, and 
secondly, exceptionally large organelles (>4 µm in diameter) in C57BL/6J-
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bgJ beige cells were reported to be relatively rare but were common in the 
cells analysed here.  
The basis of the differences in vesicle phenotype between this study and the 
previous reports is not known. One possibility is that the phenotype varies 
according to the beige mutant allele. Karim and colleagues reported that 
truncating mutations in LYST were associated with severe early-onset 
disease, whereas missense mutations were associated with a milder 
disease with delayed onset (Karim et al., 2002). The Lystbg-J mutation 
studied by Burkhardt and colleagues is predicted to disrupt one of the WD40 
repeats of LYST (Trantow et al., 2009). This domain is believed to mediate 
protein-protein interactions (Li and Roberts, 2001) and while some 
interactions may be abolished by this mutation, the large size of the LYST 
protein suggests that other LYST functions may be retained. In contrast, the 
mice used here carry the Lystbg allele, which arose from the 
retrotransposition of a LINE1 element and is predicted to encode a truncated 
protein product missing 1442 amino acids from the C-terminal that encodes 
the BEACH and WD40 domains (Perou et al., 1997b). BEACH domains are 
essential to the function of other BEACH domain-containing proteins, such 
as LvsA and FAN, as deletion of the domain abrogates their function (Wu et 
al., 2004, Adam-Klages et al., 1996). Furthermore, expression of truncated 
beige constructs lacking the BEACH and WD40 domains resulted in a 
dominant-negative effect and induced the beige phenotype in wild type cells 
(Ward et al., 2003). Differences in the vesicle phenotype of fibroblasts 
carrying the Lystbg-J and Lystbg alleles are not reported elsewhere. However, 
differences in their respective encoded proteins, in particular the truncation 
caused by the Lystbg allele used here, may account for the differences 
between the results presented here and those documented in previous 
reports. 
The beige and control fibroblasts used in the present study had the same 
genetic background (CB17.Cg-Prkdcscid). Although unlikely, it cannot be 
ruled out that the differences in vesicle morphology seen here are the result 
of an interaction between the beige and SCID mutations. More likely is the 
influence of the CB17 genetic background. The effect of genetic background 
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on the physiology of beige mice is demonstrated by work showing that high 
susceptibility to pneumonitis only occurs when the beige alleles are in the 
SB/Le background (Lane and Murphy, 1972). Furthermore, studies from the 
irises of beige mice revealed expression changes dependent on the genetic 
background (Trantow et al., 2009, Trantow et al., 2010). However, neither of 
these studies analysed the vesicle phenotype. Furthermore, the vesicle 
phenotype of the primary cells used in the present study may be more 
susceptible to the effects of different passage and culture conditions than the 
cell lines routinely used elsewhere (Burkhardt et al., 1993, Mohlig et al., 
2007, Huynh et al., 2004, Wilson et al., 2008).  
The LAMP proteins are highly glycosylated proteins resident in the 
lysosomal membrane (Kornfeld and Mellman, 1989). Western blot analysis 
and immunofluorescence microscopy showed a greater level of LAMP1 in 
beige compared to SCID fibroblasts and that the beige LAMP1 molecules 
were faster migrating, suggestive of reduced glycosylation (Figure 3.3E). It 
has been suggested previously that fusion between lysosomes and 
phagosomes in macrophages requires clustering of the organelles at the 
MTOC that is mediated by LAMP proteins (Huynh et al., 2007). The 
increased LAMP1 in beige cells could promote the clustering of vesicles at 
the MTOC, increasing the likelihood of fusion events between closely 
proximal vesicles and thus give rise to the grossly enlarged lysosomes 
documented here. Increased LAMP1 expression in beige or CHS is not 
reported elsewhere and the basis of the differential expression and 
glycosylation of LAMP1 in beige cells found here is unknown. LAMP 
glycosylation affords protection from lysosomal luminal proteases and 
deglycosylation of LAMP1 results in its rapid degradation (Kundra and 
Kornfeld, 1999). However, the reduced glycosylation of LAMP1 in beige was 
associated with increased LAMP1 expression (Figure 3.3D and E). LYST 
deficiency perturbs protein trafficking between the endoplasmic reticulum 
and lysosomes (Zhang et al., 2007a), therefore defective trafficking of 
glycosylation machinery may affect LAMP1 glycosylation in beige fibroblasts.  
The data provided here suggest that constitutive autophagy is enhanced in 
the absence of functional Lyst, revealed by an increase in LC3B-II in beige 
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cells that correlated with increased LC3B puncta formation (Figure 3.5). 
Increased LC3B-II levels can arise from either enhanced autophagosome 
synthesis or reduced degradation. The increased constitutive autophagy in 
beige cells appears to be the results of increased autophagosome synthesis, 
as blocking degradation using chloroquine resulted in further accumulation 
of LC3B-II and autophagic puncta. Interestingly, amino acid withdrawal did 
not induce further LC3B-II production, and the level of LC3B-II was 
comparable in beige and control cell lysates with this treatment. Zhang and 
colleagues also reported similar levels of LC3-II in beige-j and control 
fibroblast lysates under starvation conditions. However, they detected no 
LC3-II under basal conditions in either beige-j or control cell lysates (Zhang 
et al., 2010). Experimental conditions such as confluence are known to 
affect constitutive autophagy (Kimura et al., 2009). Therefore, differences in 
cell confluency levels may account for the inability of Zhang and colleagues 
to detect basal LC3-II.  
There are two likely explanations for the enhanced constitutive autophagy in 
beige fibroblasts. Either Lyst signals in the autophagic pathway or autophagy 
is secondary to perturbed membrane and vesicle trafficking in beige cells. 
On the basis that other BEACH family members, such as ALFY, LRBA and 
mauve, are implicated in the autophagic pathway (Filimonenko et al., 2010, 
Lopez-Herrera et al., 2012, Rahman et al., 2012), there is a compelling 
argument for a novel autophagic function of Lyst. ALFY is a 400 kDa protein 
that shares PH, BEACH and WD40 domains with LYST and is involved in 
the autophagic degradation of aggregated proteins (Simonsen et al., 2004, 
Filimonenko et al., 2010, Deretic, 2010). ALFY translocates out of the 
nucleus and is recruited to membranes containing PtdIns(3)P through its 
FYVE domain, where it functions as a scaffold adapter to link ubiquitinated 
cargo with nascent autophagosomes (Simonsen et al., 2004, Filimonenko et 
al., 2010). Silencing of ALFY with siRNA reduced the clearance of 
aggregated proteins, whereas overexpression of the C-terminal of ALFY 
containing the WD40 and FYVE domains enhanced aggregate clearance 
(Filimonenko et al., 2010). Interestingly, ALFY is reported to only participate 
in selective autophagic clearance of aggregated proteins, as siRNA-
mediated silencing of ALFY had little effect on the starvation response.  
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The link between the autophagic pathway and LYST was also recently 
shown in Drosophila; cells from flies carrying mutations in mauve, an 
orthologue of LYST, have enlarged lysosomes and these flies exhibit 
increased susceptibility to infections (Rahman et al., 2012). Mauve mutants 
possessed a significantly greater number of enlarged autophagosomal 
structures than wild type cells during serum-starvation (Rahman et al., 
2012). The underlying mechanism remains to be elucidated, however, it was 
proposed that mauve acts to restrict homotypic fusion of autophagosomes, 
allowing their proper maturation. The enhanced autophagy in beige cells 
suggests that Lyst may be involved in negatively regulating autophagy under 
basal conditions, but unlike mauve, it does not appear to function in 
autophagy that is induced by external stimuli such as nutrient deprivation.  
A PKA phosphorylation site has recently been discovered in LC3 that 
regulates its involvement in autophagy. An LC3 mutant incapable of being 
phosphorylated by PKA had greater LCB-II and enhanced autophagic 
puncta formation under basal conditions (Cherra et al., 2010). The similarly 
enhanced LC3B-II and autophagic puncta observed in beige fibroblasts 
suggests that LC3 modification might be dysregulated in the absence of 
LYST, possibly in a PKA-dependent manner. Proteins belonging to the 
AKAP family bind and scaffold PKA to its substrates at discrete cellular 
locations (Newlon et al., 1999). Several AKAP family members 
(Neurobeachin, LRBA and its Drosophila orthologue AKAP550) contain 
either a defined or putative AKAP domain (Wang et al., 2000, Wang et al., 
2001, Han et al., 1997). Of these three proteins, only LRBA is implicated in 
autophagy. LRBA-deficient cells accumulate autophagosomes but the 
mechanism underlying this is unknown (Lopez-Herrera et al., 2012). No such 
AKAP domain has been identified in LYST, though a PKA interaction 
mediated by its WD40 domain is possible. LYST could negatively regulate 
autophagy under basal conditions by promoting PKA-dependent 
phosphorylation of LC3, thus inhibiting autophagosome formation. However, 
we might expect further enhancement of LC3-II formation in response to 
autophagy inducers such as starvation, similar to reports by Cherra and 
colleagues who found LC3-II increased in response to rapamycin when a 
PKA inhibitor is also present (Cherra et al., 2010). However no further 
- 86 - 
 
increase in LC3B-II above basal levels was observed in beige fibroblasts 
during amino acid-starvation.  
The data presented here suggest that autophagy is enhanced in the 
absence of functional Lyst. Whether this is a direct result of the beige 
mutation, or occurs secondary to the perturbed membrane and vesicle 
trafficking in beige cells is not known and the exact role of beige in 
autophagic flux remains uncertain. Although LC3B did not appear to 
contribute to membrane staining of large beige vesicles as assessed by 
immunofluorescence and confocal microscopy, it remains to be determined 
whether the increased level of constitutive autophagy contributes to 
enlargement of beige lysosomes.  
PtdIns(4,5)P2 is primarily located at the plasma membrane (Watt et al., 2002, 
Hammond et al., 2009), where it is an intermediate in the DAG and 
Ins(1,4,5)P3 signalling pathway. Ward and colleagues reported an intense 
punctate nuclear localisation of PtdIns(4,5)P2 in normal fibroblasts that was 
absent in the majority of CHS and beige counterparts analysed, but total 
cellular PtdIns(4,5)P2 level remained unchanged (Ward et al., 2003). They 
postulated that reduced nuclear PtdIns(4,5)P2 would coincide with an 
increase in the lipid at an alternative subcellular compartment. This study 
aimed to establish whether beige cells have altered plasma membrane-
associated PtdIns(4,5)P2 or atypical lysosome-associated PtdIns(4,5)P2, 
which might disrupt PtdIns(4,5)P2-dependent signalling pathways or normal 
lysosome homeostasis, respectively. Using the same monoclonal antibody 
as Ward and colleagues (2003) together with a staining methodology 
optimized for preservation of the plasma membrane (Hammond et al., 2009), 
the level of plasma membrane-associated PtdIns(4,5)P2 appeared modestly 
elevated in beige fibroblasts compared to SCID controls. However, analysis 
of the specificity of this antibody revealed cross-reactivity with other lipids, 
making interpretation of the cellular staining difficult. Furthermore, strong 
autofluorescence from LAMP1-positive lysosomes in beige cells made 
assessing the presence of PtdIns(4,5)P2 at the lysosome problematic. 
Therefore, attention was turned instead to the PtdIns(4,5)P2-binding protein 
PLC.  
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I report for the first time that beige fibroblasts have decreased abundance of 
PLCγ as well as PKCβ, both of which are key players in the same lipid-
signalling pathway. The modest elevation of PtdIns(4,5)P2 at the plasma 
membrane could be attributed to the reduced abundance of PLCγ1 and 
PLCγ2, as PtdIns(4,5)P2 is a substrate for these enzymes. Hydrolysis of 
PtdIns(4,5)P2 by PLCγ yields two second messenger lipids, Ins(1,4,5)P3 and 
DAG (Carpenter and Ji, 1999). Ins(1,4,5)P3 is released into the cytosol and 
binds Ins(1,4,5)P3 receptors in the endoplasmic reticulum, triggering the 
release of Ca2+. DAG remains inserted in the lipid bilayer of the plasma 
membrane and facilitates the activation and translocation of PKC from the 
cytosol to the plasma membrane (Morgan et al., 2005). A well-characterized 
phenotype of CHS/beige is the defective exocytosis of cells containing 
secretory lysosomes, such as NK cells, CTLs and platelets (Roder and 
Duwe, 1979, Jessen et al., 2011, Stinchcombe et al., 2000, Shiraishi et al., 
2002a). PLC molecules and their products, Ins(1,4,5)P3 and DAG, have 
indispensable roles in stimulated exocytosis (Caraux et al., 2006, Hammond 
et al., 2006) and perturbation of this signaling pathway would undoubtedly 
affect the regulated secretion of secretory lysosomes. Shiraishi and 
colleagues noted that platelets from CHS cattle had defective collagen-
induced Ca2+ signalling and reduced exocytosis that they attributed to 
reduced PLCγ-dependent production of Ins(1,4,5)P3, explaining the bleeding 
tendency of CHS cattle (Shiraishi et al., 2002a, Shiraishi et al., 2002b). 
However, the abundance of PLCγ was not investigated. It will be of interest 
to evaluate the abundance of PLC isoenzymes in CHS/beige cells whose 
primary secretory function is blocked, such as CTLs and NK cells.  
PKC is central to the degranulation of NK cells (Ito et al., 1988a) and down-
regulated PKC activity in CHS/beige NK cells is thought to underlie the 
secretion defect (Ito et al., 1989, Tanabe et al., 1998). The down-regulation 
is attributed to enhanced proteolysis of PKC by calpain, as addition of 
calpain inhibitors such as E-64-d correct the lowered PKC activity. E-64-d 
also corrects other cellular defects of CHS/beige, such as giant lysosome 
formation in fibroblasts (Tanabe et al., 2000) and the defective NK cell-
mediated killing of target cells (Ito et al., 1989, Tanabe et al., 2009). Exactly 
why PKC proteolysis occurs in CHS/beige is not fully understood. PKC is 
- 88 - 
 
regulated by its phosphorylation status and Tanabe and colleagues suggest 
that the elevated ceramide level in CHS/beige cells stimulates 
autophosphorylation of PKCβ, rendering it susceptible to calpain proteolysis 
(Tanabe et al., 1998, Tanabe et al., 2000). An alternative explanation is that 
LYST scaffolds a protein complex involved in PKC phosphorylation. PKCβ is 
one of many substrates for phosphorylation by CK2β (Tominaga et al., 
1991). CK2β was identified as a LYST binding partner in a yeast-2-hybrid 
binding assay (Tchernev et al., 2002) and subsequently confirmed to bind 
the LYST WD40 domain in a GST pull-down assay (Trantow, 2009). LYST 
might bring CK2β into contact with PKC and when absent, the normal 
phosphorylation status of PKC would be altered, rendering it susceptible to 
autophosphorylation and proteolysis. Alternatively, decreased activation and 
recruitment of PKC to the plasma membrane as a result of lowered PLCγ-
mediated Ca2+ and DAG production, may result in PKC degradation.  
PI metabolism has also been linked to autophagy. A recent study by 
Decuypere and colleagues demonstrated that a Ins(1,4,5)P3-mediated Ca2+ 
release was critical for starvation-induced autophagy, because in its 
absence, starvation-induced LC3-puncta and LC3-II formation were 
abolished (Decuypere et al., 2011). Low Ins(1,4,5)P3 production as a result 
of decreased PLCγ activity may in part explain why a starvation-induced 
increase in LC3B-II formation and LC3B puncta above the basal level was 
not observed in beige fibroblasts. Analysis of Ins(1,4,5)P3 levels and 
Ins(1,4,5)P3-mediated signalling in beige cells would confirm this.  
The link between Lyst, mislocalised PtdIns(4,5)P2 and reduced PLCγ 
isoenzymes is unclear. Mounting evidence from studies of the BEACH and 
WD40 domains using expression constructs (Ward et al., 2003) and LYST 
homologues (Han et al., 1997, Wang et al., 2000) suggest LYST serves a 
scaffold for other protein interactions. LYST might be targeted to the plasma 
membrane through binding of its PH domain to PtdIns(4,5)P2 in a similar 
manner to FAN (Haubert et al., 2007), or through its HEAT and Armadillo-
like domains, that have recently been confirmed to be PtdIns(4,5)P2-binding 
modules using affinity-capture techniques (Catimel et al., 2008). Membrane 
targeting might serve to recruit and scaffold protein complexes such as 
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those involving PLCγ1 or PKCβ, at specific sites at the plasma membrane 
such as PtdIns(4,5)P2-rich lipid rafts. In the absence of a LYST scaffold, 
these proteins may become vulnerable to degradation, thus restricting 
unwarranted downstream signalling elsewhere. The present study 
documents for the first time that beige fibroblasts have decreased 
abundance of PLCγ and PKCβ, both of which are key players in the same 
signalling pathway that is fundamental to the later stages of secretory 
lysosome exocytosis, that is, the fusion with the plasma membrane. 
Examining the abundance of these proteins and the PIs with which they 
interact in CHS/beige cells with secretory lysosomes might shed some light 
on the mechanism behind their defective exocytosis.  
The data presented in this chapter suggest that Lyst may have roles in 
autophagy and lipid signalling. However, the mechanisms by which this 
might occur in beige cells is speculative, as information on the functional 
activity of Lyst is lacking. Any attempt to understand the functional role of 
Lyst will require a more detailed analysis of the pathways in which Lyst 
participates. In the next chapter, RNA interference was exploited to attempt 
to reveal these pathways in more detail.  
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Chapter 4 
Modelling the beige Phenotype Using RNA Interference 
4.1 Introduction 
The use of post-transcriptional gene silencing via RNA interference has 
revolutionised the study of mammalian gene function. However, to date, 
RNA interference has not been reported in the study of LYST. It is therefore 
of great interest to examine the effect of Lyst silencing as this might yield 
further information on the role of LYST and aid in the characterisation of 
proteins in the same functional pathway. Synthetic small interfering (si) 
RNAs are duplexes of 21-23 nucleotides in length that induce post-
transcriptional gene silencing in mammalian cells by an endogenous 
mechanism known as RNA interference (Elbashir et al., 2001). The duplexes 
are incorporated into the multiprotein RNA-induced silencing complex 
(RISC) which is targeted to the mRNA, directing its cleavage (Meister and 
Tuschl, 2004). The cleaved mRNA is then degraded, silencing the 
expression of the target gene. 
4.2 Reduction of Lyst Expression Causes Accumulation of 
Enlarged Cytoplasmic Vesicles 
Four siRNA sequences targeted to different and unique regions within the 
mouse Lyst mRNA sequence were purchased together with a non-targeting 
sequence with no known sequence similarity to mouse genes, to be used as 
a negative control. The sequences are herein referred to as siLyst 1-4 and 
siControl, respectively. To achieve maximal transfection efficiency with 
minimal cell death, preliminary experiments were carried out to determine 
the optimal conditions for liposome-mediated transfection of 3T3-J2 
fibroblasts using Lipofectamine™ RNAiMAX transfection reagent (data not 
shown). In the absence of an antibody to detect Lyst protein level, qRT-PCR 
was performed to quantify the expression of Lyst mRNA transcripts and the 
cells were monitored for the appearance of an enlarged vesicle phenotype. 
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siRNAs were transfected individually into 3T3-J2 cells at a concentration of 
50 nM and after 72 hours, total RNA was isolated from cell lysates and 
reverse transcription was used to generate cDNA. The cDNA was then PCR-
amplified with primers spanning a Lyst exon boundary to eliminate 
amplification of pre-mRNAs. Three out of the four siLyst sequences 
significantly reduced expression of Lyst transcripts compared with the 
control (Figure 4.1A). The greatest silencing was observed in siLyst 2-
transfected cells with Lyst mRNA reduced by 69% relative to the control, 
compared to 39.2%, 43.4% and 34.1% reduction in cells transfected with 
siLyst 1, -3, and -4 respectively. Increasing the concentration of siLyst 1, -2 
or -3 to 100 nM did not achieve further silencing and caused only modest 
further reduction of Lyst mRNA with siLyst 4. A mock transfection in which 
siRNA was omitted, had no effect on Lyst mRNA expression (data not 
shown). Transfection efficiency was estimated using a fluorescein-labelled 
double-stranded RNA oligomer (BLOCK-iT™), which was transfected into 
3T3-J2 under identical conditions to Lyst siRNA, and the fluorescence 
quantified by flow cytometry. The percentage of fluorescent cells was 76.3 ± 
6.9% (n = 3 independent experiments), 72 hours post-transfection with 50 
nM BLOCK-iT™ (data not shown). 
Examination of 3T3-J2 by phase contrast microscopy 72 hours post-
transfection, revealed distinct morphological differences between cells 
transfected with 50 nM siLyst 2 and siControl (Figure 4.1B). siLyst 2-
transfected cells contained numerous large refractive cytoplasmic vesicles 
that were not found in siControl- or mock-transfected cells. The vesicles 
were clustered around the nucleus and excluded from peripheral extensions. 
In the siLyst 4-transfected culture, cells appeared less confluent than the 
control culture (Figure 4.1B). However, enlarged vesicles were not observed 
in cells transfected with either siLyst 1, -3, -4 or siControl. 
As transfection with siLyst 2 stimulated the greatest reduction in mRNA and 
appearance of an enlarged vesicular phenotype, siLyst 2 was selected for 
further optimisation. The concentration of siLyst 2 was titrated (range 1 -  
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Figure 4.1. siRNA-mediated silencing of Lyst expression causes 
accumulation of large cytoplasmic vesicles in 3T3-J2 fibroblasts 
A) Real-time qRT-PCR measurements of the relative levels of Lyst mRNA in 3T3-J2 
fibroblasts transfected with 50 or 100 nM individual Lyst siRNA sequences (siLyst) 
or 50 or 100 nM non-targeting sequence (siControl), 72 hours post-transfection. 
Values are expressed as a percentage of the Lyst mRNA level in cells transfected 
with siControl and represent the means and SDs of three independent experiments. 
* = P<0.01; ns, not significant. B) Phase contrast images of 3T3-J2 fibroblasts 
transfected with 50 nM of individual siRNA sequences, 72 hours post-transfection. 
Scale bars = 20µm.  
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100 nM) and Lyst mRNA expression quantified 72 hours post-transfection. 
At the lowest concentration (1 nM), Lyst mRNA was reduced to 30.6 ± 6.9% 
of the siControl-transfected cells (Figure 4.2A). To determine the extent of 
vesiculation triggered by siLyst 2, phase contrast images were used to 
calculate the percentage of cells displaying an enlarged vesicle phenotype. 
Cells that contained four or more large vesicles (>2 µm2) were considered to 
be positive for the phenotype. Despite relatively similar levels of Lyst mRNA 
expression in cells transfected with 1nM and 50 nM siLyst 2, a three-fold 
greater percentage of cells carried the phenotype when treated with 50 nM 
(Figure 4.2B) Transfection with 1 nM and 25 nM induced a vesicle 
phenotype in 15.5% and 18.9% respectively, while 47.3% were vesiculated 
after transfection with 50 nM. These results indicate that 50 nM of siLyst 2 is 
sufficient to induce a vesiculated phenotype in half the cell population after 
72 hours.  
The duration of siRNA-mediated gene silencing and the corresponding 
phenotypic effects can vary significantly depending on the stability of the 
siRNA-mRNA complex and the half-life of the remaining protein. As the half-
life of Lyst is unknown, the effect of Lyst silencing was examined over 
several time points. Relative Lyst mRNA expression in cultures 24-96 hours 
after transfection and corresponding phase contrast images are shown in 
Figure 4.2C and Figure 4.2D, respectively. The reduction in Lyst mRNA 
expression was maximal at the earliest time point measured (24 hours after 
transfection, Figure 4.2C). Although large cytoplasmic vesicles were present 
in cells at this time point, large vesicles were also observed in siControl cells 
(Figure 4.2D). This was attributed to the introduction of siRNA into cells, as 
no vesiculation was observed in the mock-transfected culture (data not 
shown). The abundance of vesiculated cells in the siControl population 
decreased after 24 hours. The exhibition of vesiculated cells increased at 48 
hours (58.3%) and was maximal at 72 hours (68.3%, Figure 4.2E). No 
further increase in the number of vesiculated cells occurred at 96 hours. This 
may be due to a greater presence of Lyst protein, as Lyst mRNA transcripts 
were more abundant at 96 hours than at earlier time points.  
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Figure 4.2. Concentration- and time-dependent Lyst mRNA expression 
and vesicular phenotype in siLyst 2-transfected J2-3T3 fibroblasts  
A) Real-time qRT-PCR measurements of the levels of Lyst mRNA in 3T3-J2 
fibroblasts transfected with a range of concentrations of Lyst siRNA (1 - 100 nM) or 
siControl (100 nM), 72 hours post-transfection. Values are expressed as a 
percentage of the Lyst mRNA level in cells transfected with siControl and represent 
the means and SDs of three independent experiments. B) The percentage of cells 
exhibiting the vesiculated phenotype, calculated from phase contrast images of 
3T3-J2 fibroblasts, 72 hours post-transfection with siLyst 2 (1-50 nM) or 50 nM 
siControl. C) Real-time qRT-PCR measurements of the relative Lyst mRNA level at 
different time-points after transfection with 50 nM siLyst 2 or siControl. D) Phase 
contrast images of cells transfected as stated in C. E) The percentage of cells 
exhibiting the vesiculated phenotype was calculated from phase contrast images of 
3T3-J2 fibroblasts transfected as in C. Cells were deemed to be vesiculated if they 
contained at least four enlarged vesicles (>2 µm2). At least 50 cells per treatment 
were counted in each separate experiment. The means and SDs from three 
independent experiments are given. * = P<0.05; ** = P<0.01; *** = P<0.001. Scale 
bars = 50 µm. 
 
These data suggest the vesicular phenotype that arises in 3T3-J2 fibroblasts 
in response to transfection with siLyst 2 is maximal at 48-72 hours and is 
likely due to silencing of the Lyst gene. Lyst silencing gave rise to large 
vacuole-like vesicles, clustered around the nucleus that were very similar to 
the refractive vesicles in beige fibroblasts (Figure 3.1C, panel iii). However, 
Lyst silencing did not induce the formation of non-refractive granule-like 
vesicles observed in beige fibroblasts (Figure 3.1C, panel ii).  
Next, the viability of siLyst 2-transfected cells was assessed using Annexin V 
and 7-amino-actinomycin D (7-AAD) staining to determine the proportion of 
healthy and apoptotic cells, as measured by flow cytometry. One of the 
earliest features of apoptosis is the externalisation of the phospholipid 
phosphatidylserine (PS) from the inner leaflet of the plasma membrane to 
the outer leaflet, allowing the recognition and removal of apoptotic cells by 
phagocytes (Fadok et al., 1998). Annexin V is a phospholipid-binding protein 
with high affinity for PS and is a sensitive probe for detecting cells in early 
apoptosis. 7-AAD is a vital dye that is excluded from intact cells but labels 
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the DNA in the later stages of apoptosis and necrosis, when cell membranes 
are fragmented and permeable. Cells stained simultaneously with these 
probes can be identified as healthy (double-negative), early apoptotic 
(Annexin V-positive/7-AAD-negative) or late apoptotic or necrotic (double-
positive). The introduction of siRNA into 3T3-J2 fibroblasts caused a modest 
induction of early apoptosis in siControl cells as 14.8% of cells were Annexin 
V positive compared with 4.8% in the mock-transfected culture. The number 
of double-positive cells was comparable in siControl and mock populations 
(2.1% and 1.3% respectively (Figure 4.3). The fractions of Annexin V-
positive and double-positive cells were greater in the siLyst population, 
indicating 28.1% were early apoptotic and 8.7% late apoptotic or necrotic. 
These results suggest that 3T3-J2 fibroblasts become apoptotic in response 
to Lyst-silencing. However, after long term culture (7-10 days) the proportion 
of dead cells in the siLyst 2 culture was only modestly greater than in the 
siControl, when viewed under a phase contrast microscope (data not 
shown). Phospholipid mislocalisation has been reported in CHS/beige 
fibroblasts (Ward et al., 2003). The inferred increase in surface PS could 
therefore be the result of altered PS trafficking in Lyst-silenced 3T3-J2 
fibroblasts, or a heightened sensitivity of Lyst-silenced cells to the stresses 
of the experimental process. As cell death was not observed after long term 
culture, Lyst-silenced cells were therefore considered viable for further 
investigation. 
4.3 Lyst Silencing by siRNA Causes Lysosomal 
Enlargement and Enhancement of Autophagy 
Given the similarity of the vesicle phenotype of Lyst-silenced 3T3-J2 
fibroblasts to that of beige fibroblasts, the identity of the enlarged vesicles 
was next examined. The subcellular distributions of EEA1, MPR and LAMP1 
(corresponding to early endosomal, late endosomal and lysosomal 
compartments, respectively) and the acidotropic dye LysoTracker were 
analysed using immunofluorescence microscopy. There was no difference in 
the staining pattern of either EEA1 or MPR between siControl- or siLyst 2- 
transfected cells 72 hours post-transfection (Figure 4.4). However, large ring 
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Figure 4.3. Viability assay of siLyst 2-transfected 3T3-J2 fibroblasts 
3T3-J2 cells transfected with siRNA for 48 hours and were labelled with FITC-
Annexin V and 7-AAD and the fluorescence assessed by flow cytometry. Red dots 
indicate intact 3T3-J2 fibroblasts. Cells in early apoptosis are positive for Annexin V 
only and appear in the bottom right quartile, while late-apoptotic cells double-
positive for both Annexin V and 7-AAD appear in the top right quartile. Values are 
expressed as percentages of the intact population that fall within each gate and are 
given as means plus SDs from two independent experiments.  
 
-like structures were observed with anti-LAMP1 antibody in siLyst 2-
transfected cells but not in siControl cells, suggesting that the enlarged 
vesicles induced by Lyst-silencing are lysosomes. This is consistent with the 
beige phenotype in the previous chapter and previous reports (Burkhardt et 
al., 1993, Durchfort et al., 2012). The enlarged vesicles appeared to 
accumulate LysoTracker, consistent with the findings of Mohlig and 
colleagues (2007). 
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In the previous chapter, beige fibroblasts were found to have a higher level 
of constitutive autophagy (Figure 3.5). Therefore, Lyst-silenced 3T3-J2 
fibroblasts were examined for the presence of LC3B puncta formation. 3T3-
J2 fibroblasts were transfected with 50 nM siLyst 2 or siControl for 48 hours 
to allow sufficient time for the vesicle phenotype to be present. Cells were 
then treated with either DMSO or chloroquine for a further 24 hours before 
being immunofluorescently labelled with anti-LC3B antibody, to identify 
LC3B-associated autophagosomes (Figure 4.5A). The mean number of 
LC3B puncta in DMSO-treated cells was almost two-fold greater in the siLyst 
2-transfected population (6.6 puncta) compared to the siControl-transfected 
population (3.5 puncta, Figure 4.5), however, there was no difference in 
puncta size. A similar observation was made in DMSO-treated beige 
fibroblasts, where LC3B puncta were more abundant than in DMSO-treated 
SCID fibroblasts, but comparable in size (Figure 3.5B). The addition of 
chloroquine resulted in the accumulation of large LC3B puncta in both 
siControl- and siLyst 2- transfected populations, but a greater fold increase 
in puncta was observed in siLyst 2 cells (8.5-fold compared to 6.7-fold in 
siControl cells). In both the siControl and siLyst 2 populations, puncta were 
considerably larger in the presence of chloroquine, possibly as a result of the 
accumulated autophagosomes fusing homotypically in the absence of 
lysosome-mediated degradation. However there was no difference in puncta 
size between siLyst 2- and siControl-transfected cells. These data suggest 
that constitutive autophagy is altered in Lyst-silenced 3T3-J2 fibroblasts, 
similar to beige fibroblasts, however, further experiments are needed to 
confirm this.  
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Figure 4.4. The large vesicles in siLyst 2-silenced 3T3-J2 fibroblasts 
are lysosomes  
3T3-J2 fibroblasts were transfected for 72 hours with 50 nM siControl or siLyst 2. 
Identical staining patterns of EEA1 and CI-MPR were observed in siLyst 2 and 
siControl cells, however large ring-like structures were observed with anti-LAMP1 
antibody in siLyst 2-transfected cells but not in siControl cells. Enlarged vesicles 
were LysoTracker positive, suggesting that the enlarged vesicles induced by Lyst-
silencing are lysosomes. DAPI (blue) was used to visualise the nucleus. Images are 
maximum intensity projections of confocal z-stacks, except for the top panel which 
are single confocal sections. Scale bar: main images, 20 µm; inset, 5 µm  
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Figure 4.5. LC3B puncta formation in siLyst 2-silenced 3T3-J2 
fibroblasts 
A) Maximum intensity projections of confocal z-stacks showing LC3B-puncta in 
siLyst 2- and siControl-treated cells 24 hours post treatment with chloroquine (25 
µM) or DMSO. 3T3-J2 were transfected with 50 nM or either siControl or siLyst 2. 
Insets are magnifications of the main image. B) Quantification of the mean number 
of puncta per cell (left graph) and mean puncta size (right graph) was performed 
from a single experiment. At least 50 cells per treatment were analysed. Scale bar: 
main images, 50 µm; insets, 20 µm. 
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4.4 Lyst-Silencing Induces Senescent-Like Changes in 
Fibroblasts 
Another striking phenotypic change in Lyst-silenced cells was observed. 
Cells became unusually large and flattened and spread extensively across 
the culture vessel surface (Figure 4.2D). Cell enlargement was apparent 
from 24 hours post-transfection and persisted through to 96 hours, with no 
apparent increase in cell number after 48 hours. Total cell area was 
calculated from immunofluorescent images of phalloidin-stained cells using 
ImageJ software. Lyst-silenced cells were found to be almost two-fold larger 
than control cells (n = 60 cells, Figure 4.6). Individual cell sizes are indicated 
in the scatter dot plot (Figure 4.6A). The mean sizes of siControl and siLyst 2 
cells were 1450 ± 1238 µm2 and 2872 ± 1773 µm2 respectively, with some 
cells in the siLyst 2 population reaching over 5000 µm2. A large, flattened 
cell morphology is a hallmark of cellular senescence: a state of irreversible 
growth arrest brought about by persistent DNA damage response signalling 
and oncogenic and culture stresses (Rodier and Campisi, 2011). Senescent 
cells frequently double in size compared to non-senescent cells (Hayflick, 
1965). To examine if the increased size was due to the induction of 
senescence, a positive control senescent 3T3-J2 cell population was created 
by exposing cells to γ-radiation. The forward and side scatter parameters of 
a flow cytometer are routinely used to distinguish cell populations based on 
their size and granularity. The low-angle forward scatter of light that occurs 
when a cell passes through a laser beam is roughly proportional to the 
diameter of the cell. The forward scatter parameter was used to quantify the 
percentage of cells in transfected or irradiated 3T3-J2 populations that were 
enlarged relative to their untransfected and non-senescent counterparts, 
respectively. In the siLyst 2 population, 48.1% of cells were enlarged, 
relative to untransfected cells after, 48 hours post-transfection (Figure 4.6B); 
significantly more than in the siControl population (16.6%). As expected, the 
radiation-induced senescent population contained the greatest number of 
enlarged cells (70.4%). These results confirm Lyst silencing stimulates a 
dramatic increase in cell size in nearly 50% of the population, and this 
increase may be associated with senescence.  
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Figure 4.6. Cell size is increased in siLyst 2-transfected 3T3-J2 
fibroblasts 
A) Cell area was calculated from maximum intensity projections of confocal z-
stacks of phalloidin-stained cells, 48 hours post-transfection with 50 nM siLyst 2 or 
siControl. Horizontal bars indicate the mean cell sizes. At least 60 cells per 
population were analysed. B) The forward scatter parameter of a flow cytometer 
was used to determine the number of enlarged cells in a population. 3T3-J2 cells 
exposed to γ-radiation or transfected with 50 nM siLyst 2 or siControl for 48 hours 
were analysed. The percentage of cells with increased forward scatter relative to 
untreated cells was calculated. The means and SDs were calculated form three 
independent experiments *, P=0.0097. 
 
The senescent-like morphology of Lyst-silenced cells is intriguing for several 
reasons. Firstly, as mentioned in the previous chapter, CHS/beige cells 
contain unusually high levels of ceramide. Endogenous ceramide is elevated 
in senescent human endothelial cells and fibroblasts (Mouton and Venable, 
2000, Venable and Yin, 2009) and treatment of cells with exogenous C6-
ceramide induces replicative senescence in fibroblasts, marked by inhibited 
proliferation and increased senescence-associated β-Galactosidase (SA-β-
Gal) activity (Mouton and Venable, 2000). Secondly, two proteins identified 
as LYST-binding partners in two-hybrid assay (Tchernev et al., 2002), CK2β 
and 14-3-3τ, are implicated in cell cycle control (Hanna et al., 1995, Kang et 
al., 2009, Wang et al., 2010). On the basis of these reports, a novel role for 
Lyst in the regulation of cell cycle control seemed both attractive and 
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plausible, and prompted further characterisation of the senescent-like 
phenotype of Lyst-silenced cells.  
In addition to increased size, the senescent state is characterised by 
permanent growth arrest, secretion of cytokines and growth factors and 
expression of SA-β-Gal and p16INK4a (Rodier and Campisi, 2011). 
Although not all of these markers may coexist in a senescent population. To 
assess proliferation, cells transfected with either 50 nM siLyst 2 or siControl 
were seeded at a density of 2.5x104 cells/mL and then counted 48 hours 
later. The number of cells was markedly reduced in siLyst 2-transfected cells 
compared to siControl cells (Figure 4.7A), with no increase in cell death in 
siLyst cells (as determined by trypan blue, data not shown). This data 
indicates that transfection with siLyst 2 slows the rate of proliferation. β-
galactosidase is an enzyme that catalyses the hydrolysis of β-D-galactose 
from molecules such as glycoproteins and glycosphingolipids and functions 
optimally at pH 4.5. However, substantial induction of β-galactosidase 
expression in senescent cells permits the detection of activity at suboptimal 
pH 6.0 (Dimri et al., 1995) and is widely used to discriminate between 
senescent and non-senescent cells. SA-β-Gal activity was detected at pH 
6.0 in fixed transfected and irradiated cells by a cytochemical assay that 
utilises the chromogenic property of 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-gal). Cleavage of X-gal by SA-β-Gal yields an 
insoluble blue product that is readily detectible by phase contrast 
microscopy. Phase contrast images were taken 12-16 hours later when the 
presence of the blue product was maximal. Both siRNA-transfected and 
irradiated cells were stained with X-gal after 48 hours, in the presence of a 
citric acid/sodium phosphate buffer at pH 6.0 and examined for the presence 
of blue product (Figure 4.7B). Low-level SA-β-Gal activity was detected in 
some siControl cells, but the majority of cells were negative (Figure 4.7B). In 
stark contrast however, almost all the large flattened cells in the siLyst 
culture were strongly positive for SA-β-Gal activity, whereas the smaller cells 
of normal morphology, presumed to be untransfected or unresponsive to 
siRNA, had little or no SA-β-Gal activity. Similarly, many large flattened cells 
were observed in the radiation-induced senescent population and were 
strongly positive for SA-β-Gal expression (Figure 4.7B).  
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Figure 4.7. Growth arrest and SA-β-Gal activity in siLyst 2-transfected 
3T3-J2 fibroblasts 
3T3-J2 cells transfected with 50 nM siControl or siLyst were assessed for 
proliferation and SA-β-Gal activity after 48 hours. A) Cell counts revealed 
proliferation was markedly reduced in siLyst 2 cells compared to siControl cells. B) 
SA-β-Gal activity was detected using X-gal in fixed transfected and γ-irradiated 
cells. siControl cells (left) have typical morphology and low or no SA-β-Gal activity. 
In contrast, siLyst 2 cells (middle) are enlarged, flattened and have high SA-β-Gal 
activity (white arrow), similar to radiation-induced senescent cells (right). Some 
siLyst 2 cells were not enlarged and had low SA-β-Gal activity (black arrow). Scale 
bar = 50 µm. C) SA-β-Gal activity was measured in live cells using C12FDG and 
analysed by flow cytometry. The percentage of cells positive for SA-β-Gal activity 
was greater in the siLyst 2 population compared to siControl or mock-transfected 
cells. The means and SDs from two independent experiments are given. D) 
C12FDG fluorescence histograms show the relative level of SA-β-Gal activity. The 
values above the peaks represent the median fluorescence intensity of the 
respective populations. The grey histogram indicates the autofluorescence of a 
culture treated with bafilomycin A1 only.  
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Therefore, an alternative flow cytometric method was adopted to detect SA-
β-Gal activity in substantially larger sample sizes. 5-dodecanoylamino-
fluorescein di-β-D-galactopyranoside (C12FDG) is a cell permeable substrate 
for SA-β-Gal that when hydrolysed, becomes membrane-impermeable and 
emits fluorescence upon excitation at 500-510 nm (Noppe et al., 2009). In 
this assay, the V-ATPase inhibitor bafilomycin A1 was used to raise pH to 
6.0, prior to staining with C12FDG. Both transfection reagent alone and 
control siRNA caused a modest induction of SA-β-Gal activity in 3T3-J2 
fibroblasts (5.0 ± 2.0% and 13.3 ± 5.9% respectively, Figure 4.7C). SA-β-Gal 
activity was further increased in siLyst 2 cells (25.1 ± 7.1), but was maximal 
in the irradiated cells (34.5 ± 5.8%). Treatment with bafilomycin alone did not 
alter cell viability (data not shown). When considered together with Figure 
4.4, these results suggest that Lyst-silencing not only induces an enlarged 
lysosomal phenotype consistent with CHS/beige, but also induces 
senescent-like changes in 3T3-J2 fibroblasts.  
4.5 siLyst 2 Transfection Results in a Failure to Initiate 
Cytokinesis, Aberrant Nuclei and Cell Enlargement  
Lyst-silenced cells were found to be positive for three markers of 
senescence: increased size, arrested growth and expression of SA-β-Gal. 
No direct role for LYST in the regulation of cell cycle control is documented 
and so the underlying mechanism responsible for the senescent like 
changes was unclear. It was noted that the enlarged SA-β-Gal expressing 
cells frequently contained multiple or abnormal nuclei. Binucleated cells 
were apparent 24 hours post-transfection with siLyst 2 (Figure 4.2D). At later 
time points, gross nuclear abnormalities, similar to those seen in irradiated 
cells, were observed (Figure 4.8A). Some of the unusual nuclear 
morphologies observed are represented by confocal sections of DAPI-
stained siLyst 2-silenced cells in Figure 4.8B. Large invaginations gave the 
appearance of multi-lobed nuclei and cells often contained micronuclei 
(Figure 4.8B, arrowhead) or more than one nuclei. 72 hours post-
transfection, the siLyst 2 population contained significantly more cells with 
aberrant nuclei than the siControl population (45.6% and 5.8% respectively) 
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This was almost identical to the number observed in irradiated cells (45.2%; 
Figure 4.8C). 
The finding that Lyst-silenced cells appeared senescent and contained 
abnormal nuclei in the absence of stress-inducing or DNA-damaging stimuli 
was puzzling and the underlying cause of these nuclear abnormalities was 
unclear. Kwak et al., 1999 reported that LvsA, the Dictyostelium BEACH 
protein related to LYST, is required for proper cytokinesis. They observed 
that LvsA mutants enter cytokinesis normally but eventually fail in their 
division attempt, becoming large and multinucleate. To investigate whether a 
similar cytokinesis failure occurred in siLyst 2-transfected cells, time-lapse 
microscopy of live fibroblasts was performed to monitor cell division. From 
as early as seven hours post-transfection, cells with normal oval nuclei were 
observed to round up and remained rounded, for between 40-60 minutes, 
before reattaching and spreading out (Figure 4.9A and B). Abnormal nuclear 
morphologies and nuclear number appeared immediately after the cells 
reattached. Continuous imaging of the cells that contained abnormal nuclei 
following a prolonged rounding event, revealed a gradual increase in cell 
size over many hours that eventually led to the characteristic large and 
flattened morphology of senescence (Figure 4.9C). In contrast, cells 
transfected with siControl rounded and initiated division within 15-30 minutes 
(Figure 4.9D).  
Cell rounding is a common feature of cell division and apoptosis. On the 
basis that siLyst 2-transfected cells are growth arrested and did not 
apoptose after rounding, it was presumed that cell rounding was the result of 
mitotic events that failed to produce two daughter cells. Occasionally 
apoptosis did occur after some rounding events and probably accounts for 
the slight increase in 7-AAD-positive cells in the viability assay (Figure 4.3). 
In contrast to LvsA mutants, which formed two distinct daughter cells prior to 
the eventual relapse into one body (Kwak et al., 1999), siLyst 2-silenced 
cells rounded and relapsed, without the obvious initiation of cytokinesis.  
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Figure 4.8. Nuclear defects in siLyst 2-transfected cells 
A) Phase contrast images of siControl cells with normal oval nuclei (left). In 
contrast, the large flattened cells of the siLyst 2-silenced population (middle) had 
unusual nuclear morphologies and were often binucleated. Similar nuclear 
morphologies were present in the γ-irradiated senescent population (right). B) 
Representative confocal images of DAPI-stained nuclei from five siLyst 2-silenced 
cells. Several large invaginations gave a multi-lobed appearance and cells were 
often bi- or multi-nucleated. Micronuclei were common (arrowheads). C) The 
number of cells with aberrant nuclear morphology and number, 72 hours post- 
transfection was expressed as a percentage of the total number of cells. More than 
450 cells per sample were scored from three independent experiments. The means 
and SDs are given. *: P=0.0147. Scale bars = 20 µm. 
 
When considered together with the results in Section 4.4, these findings 
suggest that nuclear abnormalities formed during mitosis cause failure to 
initiate cytokinesis and senescence-like changes in siLyst 2-transfected 
cells.However, an alternative trigger for cell rounding in siLyst 2-transfected 
cells cannot be dismissed from these observations alone. 
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4.6 Off-Target Binding of siLyst 2 and Further siRNA 
Validation 
One disadvantage of siRNA-mediated gene silencing is the occasional 
silencing of genes other than the intended target. Such off-target effects 
arise through sequence identity of the siRNA strands to non-target mRNA. 
However, such off-target effects are expected to be minimal with pre-
designed sequences that have undergone rigorous validation by the 
manufacturer. Nonetheless, as only one out of the four siRNA sequences 
targeted against Lyst mRNA resulted in the large lysosomal- and senescent-
like- combined phenotypes, it was unknown whether these were a direct 
consequence of Lyst-silencing or due to off-target effects of the siRNA. 
Therefore, a BLAST search (www.ncbi.nlm.nih.gov/BLAST) was performed 
on the siLyst 2 sequence using the mouse RNA sequence database, to 
identify potential sequence matches other than Lyst. All 19 nucleotides of the 
siLyst 2 sequence matched a region of transcription factor 7 like 1 (Tcf7l1) 
mRNA (E value = 0.001) and 18/19 nucleotides matched a region of Tcf7l2 
mRNA (E value = 0.023). qRT-PCR analysis confirmed siLyst 2 targeted 
Tcf7l1 and Tcf7l2 mRNA for degradation (Figure 4.10). Compared to 
siControl-transfected cells, Tcf7l1 and Tcf7l2 mRNAs were reduced by 
92.6% and 90.4% respectively, with 50 nM siLyst 2. Reducing the 
concentration of siRNA transfected into cells can reduce the likelihood of off-
target effects, however even at 1 nM siLyst 2, mRNA expressions of Tcf7l1 
and Tcf7l2 were reduced by at least 70% (data not shown).  
TCF7L1 and TCF7L2 (also known as TCF3 and TCF4) are members of the 
T cell factor/enhanced lymphoid factor family of transcription factors that 
function downstream of β-catenin in the Wnt (wingless and Int) signalling 
pathway and are predominantly expressed in epithelial tissues (Korinek et 
al., 1998). TCF7L1 silencing in breast cancer epithelial cell lines reduced 
proliferation and induced a flattened cell morphology (Slyper et al., 2012), 
therefore, it is possible that the senescent-like phenotype in siLyst 2-
transfected cells is wholly or in part due to reduced Tcf7l1/2 expression, as a 
consequence of off-target binding of the siRNA.  
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Figure 4.9. Failure to initiate cytokinesis precedes formation of 
aberrant nuclei and cell enlargement in siLyst 2-transfected cells 
3T3-J2 fibroblasts seeded into glass-bottomed dishes were transfected with 50 nM 
siLyst 2 (A-C) or siControl (C). Phase contrast images were acquired every 1 
minute. Time after transfection accompanies each frame and is indicated in hours 
and minutes. A) A cell with a typical oval nucleus rounds up but fails to divide and 
eventually reattaches and spreads. Following this, the nucleus has become 
irregular and invaginated (arrowhead). B) A cell containing a single oval nucleus 
rounds up and persists in this state for over an hour without dividing. The cell 
contains three nuclei after eventually reattaching. C) Continuous observation of the 
cell featured in B, revealing a gradual cell enlargement to almost double the original 
cell size, over a 22 hour period. D) An siControl cell divides shortly after rounding 
up and produces two daughter cells. Scale bars = 20 µm. 
 
 
Figure 4.10. Reduced expression of Tcf7l1 and Tcf7l2 mRNA 
transcripts in siLyst 2-transfected cells 
Real-time qRT-PCR measurements of the relative expression levels of Tcf7l1 and 
Tcf7l2 mRNA in 3T3-J2 fibroblasts transfected with 50 nM siLyst 2 or siControl, 48 
hours post-transfection. Values are expressed as a percentage of the Tcf7l1 and 
Tcf7l2 mRNA levels in the siControl-transfected population.  
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Since siLyst 2 was the only sequence out of four to induce lysosomal 
enlargement and aberrant nuclei, a further four individual siRNA sequences 
(siLyst 5, -6, -7 and -8) targeted against Lyst were purchased from an 
alternative manufacturer and assessed for their ability to induce these 
phenotypes. mRNA transcript levels were quantified by qRT-PCR and phase 
contrast microscopy was used to monitor the appearance of large refractive 
vesicles and irregular nuclear number or morphology. All four siLyst 
sequences reduced Lyst mRNA transcripts by at least 60% when measured 
by qRT-PCR 48 hours post-transfection (Figure 4.11A). However, despite 
the appreciable level of silencing, the percentage of cells that displayed an 
enlarged vesicle phenotype was relatively low. Transfection with siLyst 5 and 
siLyst 8 stimulated the greatest reduction in Lyst mRNA (89.1% and 79.2% 
respectively) and the greatest induction of vesicles (Figure 4.11B). However, 
only ~30% of cells were vesiculated in either population after 48 hours, 
compared with 6.5 ± 5.8% in the control. No difference in the number of 
vesiculated cells was observed between siLyst 6 and siControl populations 
and only a 12.6% increase in vesiculated cells in siLyst 7-transfected cells 
relative to the control. The large cytoplasmic vacuole-like vesicles observed 
in siLyst 5, -7 and -8 populations were indistinguishable from those observed 
in siLyst 2-transfected cells (Figure 4.11C), suggesting they are of a similar 
morphology. The level of silencing by siLyst 5 and -8 was comparable to that 
generated by siLyst 2, yet induction of a vesicle phenotype after 48 hours 
was not as pronounced (comparison of Figure 4.2 with Figure 4.11). 
Overall, eight individually transfected siRNA sequences were evaluated for 
their Lyst silencing capacity. All sequences reduced Lyst mRNA levels by 
varying degrees (34% - 83%) but only four out of the eight siRNAs tested 
induced a measureable vesicle phenotype. Only when mRNA expression 
was decreased by at least 70% did the population contain cells that 
exhibited large vesicles. The extent of mRNA reduction roughly correlated 
with the percentage of vesiculated cells and the sequence that gave the 
greatest reduction in Lyst mRNA (siLyst 2) induced the greatest number of 
vesiculated cells.  
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Figure 4.11. Lyst mRNA expression and vesiculation analysis of 
additional siLyst sequences 
3T3-J2 fibroblasts were transfected with 50 nM siControl or siLyst sequences 5–8. 
A) Real-time qRT-PCR measurements of Lyst mRNA 48 and 72 hours post-
transfection. Values are expressed as a percentage of mRNA level in cells 
transfected with siControl. B) The percentage of cells exhibiting the vesiculated 
phenotype after 48 hours was calculated from phase contrast images of cells 
transfected as described in A. Cells were deemed to be vesiculated if they 
contained at least four enlarged vesicles (>2 µm2). At least 200 cells per siRNA 
treatment were counted in each experiment. The means and SDs from two 
independent experiments are given. Bars with no SD are from one experiment only. 
C) Phase contrast images of 3T3-J2 transfected with 50 nM Control or Lyst siRNA, 
48 hours post-transfection. Original magnification: 20x. 
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An aberrant nuclear phenotype was not observed in vesiculated cells 
transfected with siLyst 5, -7 or -8 (data not shown), nor did they acquire a 
senescent morphology. From these observations it seems unlikely that Lyst 
silencing is responsible for the nuclear abnormalities in siLyst 2-transfected 
cells, and these abnormalities may be due to off-target silencing of Tcf7l1 
and Tcf7l2. However, no other siRNAs decreased Lyst mRNA expression to 
the extent of siLyst 2, or induced as many vesiculated cells. Consequently, 
from these studies alone it cannot be concluded whether silencing of Lyst or 
Tcf7l1 disrupts nuclear morphology during mitosis. Unfortunately, due to 
time constraints, further study of the siRNA sequences was not continued.  
4.7 Discussion 
The aim of the present study was to utilise the method of siRNA-mediated 
gene silencing to explore the function of Lyst. Silencing of Lyst has not been 
reported elsewhere and so carried the potential to reveal novel phenotypes 
associated with Lyst-deficiency and to pinpoint molecular pathways in which 
Lyst functions. The key finding of this chapter is that siRNA-mediated Lyst 
silencing in cultured mouse fibroblasts successfully recapitulates the major 
aspect of the CHS/beige phenotype: formation of abnormally large and 
clustered lysosomes. 
In the absence of a Lyst antibody, effective silencing was determined from 
the level of Lyst mRNA present in cells after transfection, and the 
appearance of an enlarged vesicle phenotype. The ability of individual Lyst 
siRNAs to degrade target mRNA varied greatly and may depend on the 
intracellular stability of the molecule and duration of the siRNA-RISC-mRNA 
complex formed. Efficient but short-lived siRNA-RISC-mRNA complex 
formation might explain why some of the siRNA molecules effectively 
decreased mRNA but induced low or no vesiculation when quantified at the 
same time-point. Existing Lyst protein might outlive the duration of mRNA 
degradation and thus maintain normal vesicle homeostasis, even when 
mRNA expression is low. Cell doubling time can also affect the duration of 
silencing: silencing in non-dividing cells is prolonged compared to rapidly 
dividing ones as the siRNA becomes diluted during divisions (Bartlett and 
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Davis, 2006). This is noteworthy because the siRNA which induced the 
greatest number of vesiculated cells was also linked with reduced 
proliferation from mitotic failure as early as seven hours post-transfection. 
mRNA silencing in these non-dividing cells would therefore be prolonged 
compared to normally proliferating cells transfected with other Lyst siRNA 
molecules. Lysosomal enlargement might only occur when Lyst protein is 
reduced below a threshold, or a fraction of its pre-transfection value. The 
abundance or turnover of Lyst protein is not known, however observations in 
this study indicate that Lyst protein remains stable and functional for a period 
exceeding the doubling time of 3T3-J2 cells (~18-24 hours). This suggests 
that siRNA dilution occurring through cell division would result in an 
insufficient level of mRNA silencing and thus a lack of lysosomal 
enlargement in normally proliferating cells. Repeat transfections of the 
siRNAs that gave excellent knockdown, but low or no phenotype, should 
prolong gene silencing and may stimulate vesiculation at later time points. 
Further optimisation of the conditions required for maximal silencing of each 
individual sequence, or pooling of sequences, may enhance the phenotypic 
effect also. 
I report for the first time that siRNA-mediated silencing of Lyst in a murine 
fibroblast cell line induces an enlarged lysosomal phenotype similar to that of 
CHS/beige fibroblasts (Burkhardt et al., 1993, Mohlig et al., 2007, Huynh et 
al., 2004 and observations in Chapter 3). One of the novel findings that 
emerged from the previous chapter was that of enhanced constitutive 
autophagy of beige fibroblasts. Evaluation of autophagy in Lyst-silenced 
3T3-J2 fibroblasts yielded a similar result: the number of LC3B puncta in 
siLyst-transfected cells was greater than in control-transfected cells. 
However, these data are limited to a small number of independent 
experiments and cannot alone conclude the effect of Lyst-deficiency on the 
autophagic process. Nonetheless, in view of the fact that other BEACH 
family members are implicated in the autophagic pathway (Simonsen et al., 
2004, Lopez-Herrera et al., 2012, Rahman et al., 2012), these data provide 
sufficient motive to carefully examine the autophagic pathway in CHS/beige 
which has previously been overlooked.  
- 115 - 
 
The siRNA sequence that induced the greatest number of vesiculated cells 
also inhibited proliferation and induced significant cell enlargement; both of 
which are common features of senescence, prompting further 
characterisation. The arrested growth of cells transfected with siRNA 2 
appears to be the result of mitotic failure as early as seven hours post-
transfection. Live-cell time-lapse imaging indicated that after rounding up, 
cells failed to ingress and the formation of two distinct daughter cells was not 
observed, suggesting that cytokinesis was not initiated. Following the failed 
division events, cells became bi-/multi-nucleated, contained multi-lobed- 
nuclei or micronuclei and later adopted a senescent morphology. Cells were 
strikingly similar in morphology to γ-irradiated senescent cells and positive 
for three hallmarks of senescence: large and flat morphology, arrested 
growth and expression SA-β-Gal activity. However, it was identified that the 
sequence of siLyst 2 could induce off-target effects in the Tcf7l1/2 genes 
and without further experiments, it cannot be ascertained whether the 
observations are caused by depletion of Lyst or Tcf7l1/2, as mRNA levels of 
both were greatly suppressed by siLyst 2. In the absence of specific 
antibodies, it is not known whether a corresponding decrease in Tcf7l1/2 
protein was achieved. TCF7L1 and TCF7L2 are downstream effectors in the 
Wnt/β-catenin signalling pathway that regulates proliferation and 
differentiation. Recent reports show that siRNA-mediated depletion of 
TCF7L1 induces growth arrest concurrent with flattened cell morphology in 
breast cancer epithelial cells (Slyper et al., 2012) and silencing of TCF7L2 
induces apoptosis in colon cancer cells (Xie et al., 2012). Based on these 
reports it is tempting to conclude that Tcf7l1/2 deficiency is responsible for 
mitotic defects in siLyst 2-transfected cells. However, in the studies by 
Slyper and colleagues (2012), TCF7L1-silencing did not induce formation of 
aberrant nuclei and apoptosis was only slightly elevated in siLyst 2-
transfected cells, suggesting an additional or alternative Lyst-mediated 
mechanism is at play.  
It is worth noting that several proteins identified as Lyst-binding partners by 
Tchernev et al., 2002 are implicated in cell cycle regulation and mitosis: 14-
3-3τ, centrobin and CENPJ (Wang et al., 2010, Jeffery et al., 2010, Zou et 
al., 2005, McIntyre et al., 2012). Furthermore, the Dictyostelium BEACH 
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protein LvsA is required for cytokinesis (Kwak et al., 1999). Therefore, the 
possibility that Lyst-deficiency is responsible for nuclear defects cannot be 
ruled out. The nuclear defects in siLyst 2-transfected cells were remarkably 
similar to those observed in γ-irradiated senescent cells. Abnormal nuclear 
morphologies of senescent cells in response to ionising radiation are well 
documented (Hayflick, 1965, Raj and Mahajan, 2011). In mammalian cells, 
duplication of centrosomes is central to the formation of bipolar spindles that 
enable chromosome segregation during mitosis. The unusual assembly of 
multipolar spindles in cells with abnormal centrosomes causes an 
unbalanced segregation of chromosomes and is one proposed cause for 
multinucleation in γ-irradiated tumour cell lines (Sato et al., 2000). Binding 
between LYST and a core centrosome protein, centrobin, was demonstrated 
by Tchernev and colleagues (2002). Centrobin is required for centriole 
duplication and proper cytokinesis during mitosis (Zou et al., 2005). 
Depletion of centrobin disrupts centriole duplication, causing lengthy 
mitoses, cytokinesis failure and formation of bi- and multi-nucleated cells 
(Zou et al., 2005). Centrobin is also required for the attachment of 
centrosomes to the mitotic spindle, as centrobin-depleted cells have 
unfocussed spindle poles that cause spindle assembly checkpoint activation 
and metaphase arrest (Jeffery et al., 2010). These cells also exhibit reduced 
stability in the attachment of chromosomes to kinetochores, which is known 
to generate lagging chromosomes during anaphase (Thompson and 
Compton, 2011). These become separately encapsulated by the nuclear 
envelope, forming micronuclei, a common feature in siLyst 2-transfected 
cells. Similarly, CENPJ plays a key structural role in maintaining normal 
centriole duplication during the cell cycle and depletion of human or mouse 
CENPJ induces centrosome and spindle abnormalities (Cho et al., 2006, 
McIntyre et al., 2012). Furthermore, siRNA-mediated CENPJ silencing leads 
to apoptosis of cells arrested in mitosis, and lagging chromosomes were 
frequently observed in cells with multipolar spindles (Cho et al., 2006).  
siLyst 2-transfected cells failed to form daughter cells during mitosis and this 
may be because the cells failed to initiate cytokinesis. Early stages of 
cytokinesis involve positioning of the division plane and formation of an 
actomyosin ring. Contraction of the ring, via attachment to the plasma 
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membrane, results in ingression and formation of a cleavage furrow that 
partitions the cytoplasm between the two cells. The small GTPase RhoA is 
recruited to the division plane and functions as a master regulator of 
cytoskeletal reorganisation, mediating contraction of the actomyosin ring and 
ingression of the cleavage furrow (Fededa and Gerlich, 2012). The role of 
PtdIns(4,5)P2 in cytokinesis is well documented and thought to mediate 
recruitment of RhoA, the attachment of the contractile actomyosin ring to the 
plasma membrane and the regulation of cytoskeletal remodelling during 
furrow ingression (Emoto et al., 2005). A recent study using super-resolution 
microscopy demonstrated that SM is required for localisation of 
phosphatidylinositol 4-phosphate 5-kinase beta (PIP5Kβ) and PtdIns(4,5)P2 
production at the cleavage furrow (Abe et al., 2012). Ablating SM levels by 
adding exogenous SMase resulted in lost accumulation of both PtdIns(4,5)P2 
and RhoA at the furrow, cytokinesis failure and formation of binucleated 
cells. PtdIns(4,5)P2 is mislocalised in beige fibroblasts (Ward et al., 2003) 
and SM levels are significantly decreased compared to normal fibroblasts 
through enhanced SMase activity (Tanabe et al., 2000). A similarly elevated 
SMase activity in siLyst 2-transfected 3T3-J2 cells might inhibit PtdIns(4,5)P2 
accumulation at the furrow and block cytokinesis initiation. Indeed, no 
ingression furrow was observed in siLyst 2-transfected cells which entered 
mitosis but failed to divide. Furthermore, studies in mammals and yeast 
suggest both calmodulin and PKC generate a positive feedback loop for 
PtdIns(4,5)P2 synthesis at the cleavage furrow. PKC activity is down-
regulated in beige fibroblasts (Tanabe et al., 2000) and calmodulin is a 
binding partner of Lyst (Tchernev et al., 2002). Treatment of HeLa cells with 
a Ca2+/calmodulin inhibitor prevents the formation and ingression of the 
cleavage furrow (Yu et al., 2004), while interfering with PKCβ causes 
microtubule disorganisation and cytokinesis failure (Chen et al., 2004). 
PKCβ expression is decreased in beige cells (Chapter 3.5), thus, mitotic 
failure in Lyst-silenced cells could be due loss of PKC and calmodulin 
activity. 
How or why a protein whose central function lies in lysosomal trafficking 
should interact with key regulators of centrosome and spindle maintenance 
is puzzling. However, if Lyst is required for proper centrobin or Cenpj 
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function, the formation of multi- and micro-nuclei in Lyst-depleted cells is not 
surprising. One mechanism by which LYST might regulate CENPJ function 
is to mediate an interaction between CENPJ and its activating proteins polo-
like kinase (PLK) 2 and PLK4. Phosphorylation of CENPJ by these kinases 
is essential for centrosome duplication during the cell cycle (Chang et al., 
2010, Habedanck et al., 2005). Failure to phosphorylate CENPJ in the 
absence of LYST might induce centrosome and spindle abnormalities and 
could explain the aberrant nuclear morphologies in siLyst 2-silenced cells. 
Time-lapse studies (Figure 4.9) revealed a variety of nuclear abnormalities in 
siLyst 2-transfected cells. It is likely that siLyst 2 cells carry multiple defects, 
for example, in both mitosis and checkpoint control. This is because cells 
containing gross defects that would normally initiate apoptosis or mitotic 
catastrophe, escaped apoptosis and instead became senescent. Lyst 
interacts with the checkpoint protein 14-3-3τ (Tchernev et al., 2002). Wang 
and colleagues reported that 14-3-3τ upregulation in MCF7 breast cancer 
cells mediates cell survival by targeting p21 for proteasomal degradation, 
allowing G1/S entry (Wang et al., 2004). Furthermore, siRNA depletion of 14-
3-3τ induces G1 arrest and inhibits MCF7 proliferation. A similar growth 
arrest was observed in siLyst 2-transfected cells. This raises the intriguing 
possibility that Lyst scaffolds a 14-3-3τ-p21 interaction in 3T3-J2 cells, 
permitting proliferation even in the presence of genotoxic stresses such as 
gross nuclear defects. Loss of this interaction during silencing could promote 
p21 survival and initiate cell-cycle arrest. Determining the levels of 14-3-3τ 
and p21 protein in senescent cells of the siLyst 2-transfected population 
would help to determine whether this is the case.  
Aberrant nuclear shape can often arise from defects in the nuclear lamina, 
microtubules or lipid synthesis. Lamin A and B are components of the 
nuclear lamina and involved in the breakdown and reformation of the nuclear 
envelope around the separated chromosome bundles following segregation, 
to form two separate nuclei (Webster et al., 2009). Mutations in lamin A that 
result in a constitutively lipidated (farnesylated) protein cause a variety of 
abnormal nuclear morphologies in the cells of patients with the premature 
ageing syndrome Hutchinson-Gilford progeria syndrome (Glynn and Glover, 
2005). On the basis that 14-3-3τ is reported to bind both lamin A/C and lamin 
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B1 (Meek et al., 2004), it is conceivable that nuclear lamina defects could be 
the root cause of the multitude of nuclear morphologies observed in Lyst-
silenced cells that are strikingly similar to those of Hutchinson-Gilford 
progeria syndrome.  
The ultimate goal of this study was to measure the effect of siRNA-mediated 
Lyst silencing in cells with secretory lysosomes such as NK cells, and to 
identify other proteins that might function in the same secretory pathway as 
Lyst. Regrettably, due to the lengthy validation of the Lyst-silenced 
phenotype, the investigation did not get this far. However, Lyst silencing did 
mimic the major aspect of CHS/beige, and could be used as an alternative 
system in which to study CHS/beige. The growth arrest of siLyst 2-silenced 
cells may be the result of a combined effect of both a mitotic defect and 
checkpoint dysregulation. Pinpointing whether this is due to loss of Lyst, 
Tcf7l1/2 or both, could yield some very interesting information on the 
function of Lyst and may identify a novel and surprising role for Lyst in 
mitosis and cell cycle control. However, at present, it is difficult to reconcile 
the growth arrest of siLyst 2-silenced cells with the viability of CHS patients 
and the beige mouse.  
For the study of NK cell secretory lysosomes, another approach was sought. 
NK cells are notoriously difficult to transfect, therefore inhibitors of protein 
function are useful for mimicking the effects of RNAi in these cells. In the 
absence of an inhibitor of LYST, attention was turned to the PIKfyve inhibitor 
YM201636 which, in fibroblasts, induces grossly enlarged vesicles, a 
superficially similar phenotype of CHS/beige. 
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Chapter 5 
The Inositol Lipid Kinase PIKfyve is Required for the 
Exocytosis of Natural Killer Cell Lytic Granules 
5.1 Introduction 
NK cells participate in the clearance of virus-infected cells and cancer cells 
as part of the innate immune system. The ability to exocytose preformed lytic 
granules (specialised secretory lysosomes) in response to these stimuli is 
critical to NK cell immune function (Orange and Ballas, 2006). Granule 
secretion is a tightly-regulated process, the mechanisms of which are not 
fully understood. Mutation of genes encoding proteins involved in the 
granule secretory pathway impair NK cell function and underlie many rare 
and severe immunological diseases such as CHS, Griscelli syndrome and 
HPS-2. Indeed, the giant lysosome phenotype associated with CHS/beige 
was the first mutation shown to affect NK cell function (Roder and Duwe, 
1979, Katz et al., 1982). Much work has focussed on the protein exocytic 
machinery components such as SNARE and Munc family members. In 
addition to these, the importance of lipids, particularly the inter-conversion of 
PIs, in regulated exocytosis is becoming increasingly evident. Recently, a 
role for PIKfyve in regulating the exocytosis of secretory vesicles was 
identified (Ikonomov et al., 2007, Osborne et al., 2008, Ikonomov et al., 
2009b). Interestingly, inhibition of PIKfyve activity induces an enlarged 
vesicle phenotype that appears similar to that observed with LYST-
deficiency. The hypothesis was that PIKfyve inhibition would induce a giant 
vesicle phenotype in NK cells and impair granule exocytosis similar to the 
effects of LYST mutations. The apparent similarity between the CHS/beige 
and PIKfyve phenotypes might also reveal more about the mechanism by 
which LYST functions. To test this hypothesis, a pharmacological inhibitor of 
PIKfyve, YM201636, was used. 
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5.2 PIKfyve Inhibition Induces Endosome Enlargement in 
Fibroblasts  
PtdIns(3,5)P2 regulates many intracellular processes including endosome-to-
Golgi retrograde trafficking, vesicle homeostasis and glucose transport 
(Rutherford et al., 2006, Jefferies et al., 2008, Ikonomov et al., 2002b). 
PIKfyve catalyses the phosphorylation of PtdIns(3)P to PtdIns(3,5)P2 and is 
the sole enzyme responsible for PtdIns(3,5)P2 production in the brain, heart, 
lung, kidney, thymus and spleen (Zolov et al., 2012). PIKfyve is implicated in 
maintaining endosome fusion and fission events. Studies show that 
reduction of PtdIns(3,5)P2 levels by siRNA-mediated PIKfyve silencing or the 
expression of inactive PIKfyve mutants causes the formation of enlarged 
cytoplasmic vesicles (Ikonomov et al., 2002a). Short-term (20 minutes to two 
hours) treatment of cells with the small molecule inhibitor of PIKfyve, 
YM201636, induces vesicle enlargement in many cell types (Jefferies et al., 
2008, Osborne et al., 2008). 
The activity of the inhibitor was first tested by analysing its ability to induce 
the giant vesicle phenotype in 3T3-J2 fibroblasts. In agreement with previous 
reports, YM201636 induced the formation of large refractive cytoplasmic 
vesicles in 3T3-J2 cells as analysed by light microscopy, whereas an 
equivalent volume of vehicle alone (DMSO) did not (Figure 5.1A, bottom 
panel). The vesicle phenotype induced by YM201636 was indeed similar to 
that of beige fibroblasts (Figure 5.1A, top panel). To quantify this phenotype, 
cells were scored if they contained four or more enlarged vesicles (>2 µm2). 
After two hours of treatment, 39.2% of cells treated with YM201636 
contained enlarged vesicles, compared to only 1.8% of cells treated with 
DMSO (Figure 5.1B). The effect of PIKfyve inhibition was reversible and 
vesicles returned to normal size upon withdrawal of YM201636, with similar 
kinetics to the duration of inhibition (see Appendix) in agreement with 
previous observations (Jefferies et al., 2008).  
The origin of the enlarged vesicles in PIKfyve-inhibited fibroblasts was then 
analysed and compared to the fibroblasts derived from beige mice. 
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Figure 5.1. YM201636 induces enlarged endosomes in 3T3-J2 cells 
A) Phase contrast images of untreated beige and control SCID fibroblasts (top 
panel) or 3T3-J2 cells treated with DMSO or 800 nM YM201636 for two hours 
(bottom panel). B) The percentage of cells with enlarged vesicles was determined 
from phase contrast images of DMSO- or YM201636- (800 nM) treated 3T3-J2 cells 
after 2 hours. Cells were scored if they contained at least four enlarged vesicles (>2 
µm2). At least 100 cells were scored per treatment, per experiment. The means and 
SDs from three independent experiments are shown. C) 3T3-J2 cells treated with 
YM201636 (800 nM) or DMSO for two hours were immunofluorescently labelled 
with anti-EEA1-, anti-CI-MPR- or anti-LAMP1- antibodies and analysed using a 
confocal microscope. Cells were counterstained with DAPI (blue) to visualise the 
nucleus. Images are maximum intensity projections of confocal z-stacks. Scale bar: 
A, 20 µm; C, main images, 20 µm, insets = 5 µm. 
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Immunofluorescence microscopy revealed that the lysosomal marker 
LAMP1 showed a typical punctate distribution in cells treated with 800 nM 
YM201636, that was indistinguishable from that found in cells treated with 
DMSO alone (Figure 5.1C). Conversely, the early endosomal marker EEA1 
and the late lysosomal marker CI-MPR both revealed a distinct localisation 
to the enlarged vesicles after inhibitor treatment, but not with DMSO (Figure 
5.1C). These results indicate that inhibition of PIKfyve activity disrupts 
endosomes but not lysosomes in 3T3-J2 fibroblasts. This agrees with 
previous findings (Ikonomov et al., 2001, Ikonomov et al., 2003a, Jefferies et 
al., 2008, Osborne et al., 2008). To the best of my knowledge, this is the first 
direct comparison between the giant vesicle phenotypes induced by LYST 
and PIKfyve inhibition. These results indicate that although the phenotypes 
are superficially similar, disruption of PIKfyve and LYST activity affects the 
integrity of distinct endocytic compartments, namely endosomes and 
lysosomes, respectively. 
5.3 PIKfyve Inhibition Impairs NK Cell Lytic Granule 
Exocytosis But Not Cytokine Secretion 
The original hypothesis was that the giant vesicles of PIKfyve inhibited cells 
would represent a phenocopy of the LYST mutation and as a consequence, 
NK cell granule exocytosis would be impaired following PIKfyve inhibition. 
However, the findings above indicate that PIKfyve and LYST affect different 
compartments and hence PIKfyve inhibition might not affect NK cell granule 
exocytosis. Therefore, functional studies of human NK cells treated with the 
PIKfyve inhibitor were performed.  
Full NK cell cytotoxic potential is dependent on the prior-activation of cells 
with cytokines such as IL-2 and IL-15 (Meade et al., 2009). Like primary NK 
cells, the majority of human NK cell lines require exogenous IL-2 for 
prolonged culture.  
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Figure 5.2. YM201636-treated NK-92 cells are viable 
NK-92 cells were stained with propidium iodide to identify dead cells following 
treatment of NK-92 with various concentrations of YM201636 for four hours and 
analysed by flow cytometry. Dot plots show intact NK-92 cells (propidium iodide-
negative, labelled red) together with propidium iodide-positive dead cells (labelled 
black and defined by the gate shown). The values show the proportion of propidium 
iodide-positive cells as a percentage of the total population. SSC, side scatter.  
 
For convenience, a human NK cell line (NK-92) stably expressing human IL-
2 was used in the majority of these experiments; this cell line is formally 
designated as NK-92MI (Tam et al., 1999) but is referred to as NK-92 in the 
present study. First, I investigated the affect of YM201636 on NK-92 cell 
viability using the membrane-impermeable dye propidium iodide to 
discriminate between live (impermeable, propidium iodide-negative) and 
dead (permeable, propidium iodide-positive) cells. No difference was 
observed in the frequency of dead cells in response to YM201636 treatment 
across a range of concentrations (0–10 µM) as measured by flow cytometry 
(Figure 5.2), indicating that YM201636 is not toxic to NK-92 cells at these 
concentrations. 
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I then compared the phenotypes of PIKfyve inhibition in fibroblasts (Figure 
5.1C) to that found in NK-92 cells. Confocal microscopy showed that, like the 
situation in fibroblasts, PIKfyve inhibition did not affect the LAMP1-positive 
compartment (lysosomes) but did result in the generation of enlarged EEA1-
positive structures (Figure 5.3). However, in fibroblasts the giant vesicles 
contained CI-MPR, whereas this was not evident in NK-92 cells and the 
distribution of CI-MPR appeared unaffected by PIKfyve inhibition in NK-92 
cells. Ikonomov and colleagues have shown previously that PIKfyve 
depletion caused an initial enlargement of EEA1-positive early endosomes 
followed later by an enlargement of CI-MPR positive vesicles that they 
describe as late endosomes (Ikonomov et al., 2001, Ikonomov et al., 2003a). 
Although the duration of PIKfyve inhibition was the same in 3T3-J2 
fibroblasts and NK-92 cells (two hours), the kinetics of endosome disruption 
may be slower in NK-92 cells and it is possible that enlargement of CI-MPR-
positive vesicles may occur with prolonged PIKfyve inhibition. An alternative 
explanation is that the difference in endosomal disruption between 3T3-J2 
and NK-92 cells may reflect localisation of PIKfyve to different endosome 
populations in these cells. For example, PIKfyve might associate 
predominantly with early endosomes in NK-92 cells and with both early- and 
late-endosomes in 3T3-J2 fibroblasts. Indeed, over-expressed PIKfyve was 
found to localise to different endosomes in COS and HeLa cells (Shisheva et 
al., 2001). These results suggest that PIKfyve is required for maintaining 
normal endosome homeostasis in NK-92 cells. 
Previous studies have implicated PIKfyve in the insulin-mediated 
translocation of the glucose transporter GLUT4 to the plasma membrane 
(Berwick et al., 2004). In addition, PIKfyve negatively regulates LDCV 
exocytosis in neurosecretory cells (Osborne et al., 2008). To investigate 
whether PIKfyve plays a role in the exocytosis of NK cell lytic granules, I 
analysed the degranulation of PIKfyve-inhibited NK-92 cells in response to 
the tumour cell line K562. This cell line expresses low levels of cell surface 
MHC class I and high levels of ligands to several NK cell activating receptors 
and is the most widely used target cell to analyse human NK cell responses.  
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Figure 5.3. PIKfyve inhibition causes endosome enlargement in NK-92 
cells 
NK-92 cells treated with either DMSO or YM201636 (800 nM) for 2 hours were 
immunofluorescently labelled with anti-EEA1-, anti-MPR- (specific to the cation 
independent MPR) or anti-LAMP1- antibodies. Cells were counterstained with DAPI 
(blue) and analysed using a confocal microscope. Images are maximum intensity 
projections of z-stacks. Scale bar = 20 µm.  
 
Co-culture of NK cells and K562 results in NK cell activation and induction of 
granule exocytosis, leading to killing of K562 by granzyme/perforin-induced 
apoptosis (Alter et al., 2004). The fusion of the NK cell lytic granules with the 
plasma membrane during degranulation results in the externalisation of 
LAMP1 to the cell surface which is readily detectable using flow cytometry 
(Alter et al., 2004). NK-92 cells had a markedly decreased capacity to 
degranulate in response to K562 when pre-treated with 1 µM YM201636, 
compared to DMSO (18% versus 32%, Figure 5.4A) and that degranulation 
was reduced across a range of inhibitor concentrations (0.01-10 µM; Figure 
5.4B). NK cell degranulation can be potently induced in the absence of 
target cells using a combination of PMA (an activator of PKC) and the 
calcium ionophore ionomycin (Alter et al., 2004).  
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Figure 5.4. PIKfyve activity is required for NK cell degranulation but not 
cytokine secretion 
A) NK-92 cells were pre-treated with DMSO or YM201636 (1 µM) for 20 minutes 
and the level of degranulation in response to K562 was measured. The proportion 
of degranulating CD56-positive NK-92 cells is given as a percentage of the total 
population and was determined by the presence of LAMP1 on the cell surface as 
detected by flow cytometry. NK-92 (B, C and E) or primary NK cells (D) activated 
with IL-2 for 7-11 days were pre-treated with various concentrations of YM201636 
for 20 minutes and co-cultured with either K562 target cells for one hour (B, D and 
E) or PMA in combination with ionomycin (PMA/I) for 30 minutes (C). For B, C and 
D, the degranulation response is expressed relative to the degranulation induced in 
the absence of inhibitor (0 µM). E) IFNγ secretion from YM201636- or DMSO- 
treated NK-92 cells in response to K562 was determined by ELISA using NK-
92/K562 co-culture supernatants. The inset shows that NK-92 induce IFNγ 
secretion in response to K562 cells. *: P < 0.05 (n = 3). 
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Pre-treatment of NK-92 cells with 1 µM YM201636 significantly reduced 
degranulation in response to stimulation with PMA and ionomycin as well as 
to K562 target cells (Figure 5.4C and B respectively). Furthermore, the 
inhibition of degranulation was not confined to the NK-92 cell line. Primary 
NK cells were purified from healthy donor blood samples, cultured in IL-2 for 
6-10 days and pre-treated with YM201636 (or DMSO) for 20 minutes prior to 
co-culture with K562. This resulted in a similarly impaired degranulation 
response (Figure 5.4D), although this was not as pronounced as that seen 
with NK-92. These results indicate that NK lytic granule exocytosis is 
impaired in the absence of catalytically-active PIKfyve, establishing a role for 
this enzyme in the granule exocytosis pathway.  
As well as lytic granule-mediated killing, NK cell activation also results in the 
production of immunomodulatory cytokines such as TNFα and IFNγ, that 
recruit and activate inflammatory cells and other immune cells, coordinating 
immunity (Vivier et al., 2011). Cytokines are transported to the cell surface 
and secreted in a non-polarised manner via a population of vesicles that are 
distinct from the lytic granules (Reefman et al., 2010). To asses whether 
PIKfyve inhibition impaired lytic granule exocytosis specifically or secretion 
in general, the secretion of IFNγ from NK-92 cells was measured in 
response to stimulation with K562 (Figure 5.4). Co-culture of NK-92 cells 
with K562 induced IFNγ secretion. However, no difference was observed in 
the amount of IFNγ secreted from NK-92 cells pre-treated with up to 1 µM 
YM201636 or DMSO, in response to K562 (Figure 5.4E). A markedly 
reduced secretion of IFNγ at 10 µM occurred with both YM201636- and 
DMSO- treatments. DMSO was not toxic to NK-92 cells at 10 µM (Figure 
5.2), suggesting that DMSO inhibits secretion at this concentration by an 
unknown mechanism. Importantly, these data suggest that YM201636 
inhibits degranulation but does not interfere with activation-induced 
signalling pathways that elicit downstream effector responses such as 
cytokine secretion. Furthermore, stimulation with K562 induced IFNγ 
secretion by a factor of three-fold and this induction was not affected by pre-
treatment with YM201636 (Figure 5.4E). This indicates that K562-induced 
NK cell activation is unaffected by PIKfyve inhibition. 
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These data reveal that PIKfyve inhibition does not affect NK cell activation or 
cytokine secretion but selectively inhibits the secretion of lytic granules. 
Reduced K562-mediated degranulation in YM201636-treated NK-92 cells 
could result from a failure to form stable conjugates required for 
degranulation. To test this, YM201636-treated NK-92 cells were co-cultured 
with K562 targets, fixed, and the conjugates examined using 
immunofluorescence microscopy. NK-92-K562 conjugates were observed in 
the presence of YM201636 (Figure 5.5A, left panel). Furthermore, the 
number of conjugated cells was similar between YM201636 and DMSO 
treatments (Figure 5.5A, right panel) indicating that the decreased 
degranulation observed is not due to failed conjugate formation. 
During degranulation, several stages precede granule fusion at the plasma 
membrane, such as polarisation of the MTOC toward the immunological 
synapse, docking of granules at the plasma membrane and priming of the 
granules to facilitate fusion (reviewed in Orange, 2008). LAMP1-positive 
granules were frequently observed clustered at the interface with K562 in 
YM201636-treated NK-92 cells (Figure 5.5A, arrowhead). The number of 
cells with granules clustered at the interface was higher in cells treated with 
YM201636 (44% versus 36% with DMSO, Figure 5.5B), although this was 
not statistically tested. This may be because YM201636-treated NK-92 cells 
are unable to elicit target cell killing and remain conjugated to K562, 
whereas some NK-92 cells in the DMSO treatment may have undergone a 
successful round of killing and reattached to new targets, but not yet 
polarised their granules at the time of fixation. Importantly, granule clustering 
at the K562 interface reveals that MTOC polarisation occurs normally in 
PIKfyve inhibited NK-92 cells, suggesting that PIKfyve acts downstream of 
MTOC polarisation.  
To determine whether PIKfyve associates with NK lytic granule membranes 
to mediate plasma membrane docking and/or fusion events, the localisation 
of PIKfyve was analysed in K562-conjugated NK-92 cells by immuno-
fluorescence microscopy (Figure 5.5C).  
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Figure 5.5. PIKfyve inhibition does not affect conjugate formation or 
granule polarisation 
A) Maximum intensity projection of a confocal z-stack showing a DAPI-stained NK-
92 cell (blue) conjugated to a K562 cell stained with CellTrace™ Far Red DDAO-SE 
(violet), in the presence of 1 µM YM201636 (left panel). Anti-LAMP1 antibody 
(green) reveals clustering of the lytic granules at the NK-92-K562 interface 
(arrowhead). Z-stacks were used to determine the number of NK-92 cells 
conjugated to K562 cells (right panel). B) The number of conjugated NK-92 cells 
with LAMP1 granules polarised towards K562 cells was also calculated. C) Cells 
were stained as in A, and counterstained with anti-PIKfyve antibody (red). An 
overlay of the PIKfyve and LAMP1 fluorescence is shown (merge) and colocalised 
regions appear yellow. 
 
PIKfyve displayed both a diffuse and punctate localisation in DMSO-treated 
NK-92 cells, similar to that observed in chromaffin neurosecretory cells 
(Osborne et al., 2008). A comparable PIKfyve staining pattern was observed 
in YM201636-treated NK-92 cells. PIKfyve puncta were predominantly 
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absent of LAMP1 fluorescence in both DMSO- and YM201363-treated NK-
92 cells, with only a small degree of overlap observed between the two 
signals. This suggests that PIKfyve is not associated with granule 
membranes during degranulation. Although minimal colocalisation with 
LAMP1 was observed, PIKfyve puncta were proximal to LAMP1-positive 
granules polarised at interface in conjugated NK-92 cells (Figure 5.5) and 
this positioning may be important during degranulation. Taken together, 
these data suggest that PIKfyve functions at a late stage of NK cell granule 
exocytosis after MTOC polarisation, but prior to granule fusion with the 
plasma membrane. However the exact mechanism(s) governing this process 
remain undetermined at this stage. 
5.4 Discussion 
NK cells and CTLs are central to the defence against virus-infected cells and 
tumour cells. Their cytolytic function requires the stimulated secretion of 
cytolytic effector molecules towards the target cell upon ligation of activating 
receptors. The effector molecules are housed within specialised secretory 
lysosomes (the lytic granules) that function as degradative organelles but 
with the added capacity to engage in regulated exocytosis in response to 
extracellular stimuli (reviewed in de Saint Basile et al., 2010). Granule 
secretion is a tightly-regulated process and the mechanisms involved are not 
fully understood. I have shown here that treatment with YM201636, the 
specific inhibitor of PIKfyve, selectively impairs NK lytic granule exocytosis, 
with no apparent impact on cytokine secretion or target conjugation.  
The use of YM201636 as a specific inhibitor of PIKfyve is well documented 
(Jefferies et al., 2008, Osborne et al., 2008, de Lartigue et al., 2009). 
Recently, however, the specificity of YM201636 has come under question. 
Dual inhibition of insulin-activated class IA phosphoinositide 3-kinase (PI3K) 
and PIKfyve by YM201363 in adipocytes has been reported (Ikonomov et 
al., 2009b). NK cytotoxicity is dependent on a PI3K-mediated signalling 
cascade initiated by ligation of activation receptors. Pharmacological 
inhibition of PI3K activity supresses lytic granule polarisation towards the 
target, resulting in reduced target cell lysis (Jiang et al., 2000), while class IA 
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PI3K subunit knockout mice have normal lytic function but reduced cytokine 
secretion (Kim et al., 2007). However, the experiments performed here with 
YM201636 showed that NK lytic granules polarised normally to the NK-92-
K562 immunological synapse. Furthermore, secretion of IFNγ in YM201636-
inhibited NK-92 cells was unaffected, revealing that the activation-induced 
signalling pathway is unperturbed and showing different effects to those 
documented by PI3K inhibition (Ikonomov et al., 2009b). This suggests that 
the impaired lytic granule exocytosis observed here is most likely due to 
YM201636-mediated inhibition of PIKfyve, rather than inhibition of PI3K.  
Lytic granule secretion is a complex process involving many stages, 
including the polarisation of the MTOC to the immunological synapse, 
docking of granules at the plasma membrane and the priming of granules to 
facilitate fusion. Given the similarities between NK- and CTL-mediated 
cytotoxicity, much of what we assume of NK lytic granule biogenesis and 
secretion is derived from the study of CTLs. Two molecules essential for lytic 
granule exocytosis are Rab27a and Munc13-4 (Ménasché et al., 2000, 
Feldmann et al., 2003). Rab27a mediates the docking of lytic granules at the 
plasma membrane, whereas Munc13-4 is implicated in a priming step that 
renders granules competent for fusion with the plasma membrane. 
Accordingly, deficiencies in Rab27a and Munc13-4 impair NK cell 
cytotoxicity in patients with Griscelli syndrome type 2 and FHL3, respectively 
(Stinchcombe et al., 2001, Marcenaro et al., 2006, Feldmann et al., 2003). In 
the present study, the delivery of lytic granules to the synapse of conjugated 
NK-92 cells was intact in PIKfyve-inhibited cells. Thus, PIKfyve appears to 
function downstream of MTOC polarisation but prior to granule fusion with 
the plasma membrane. Due to the limited resolution of the acquired images, 
it was not possible to determine whether the lytic granules were docked at, 
or just proximal to, the plasma membrane in YM201636-inhibited cells.  
The localisation of PIKfyve to a sub-population of LDCVs in neurosecretory 
cells in response to nicotine stimulation, is important for preventing the over-
secretion of a pool of PtdIns(3)P-primed granules through the depletion of 
PtdIns(3)P on the vesicle membrane (Osborne et al., 2008). In these cells, 
PIKfyve appears to function as a negative regulator of exocytosis, as 
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YM201636-mediated PIKfyve inhibition potentiated the nicotine-stimulated 
secretion of LDCVs (Osborne et al., 2008). Furthermore, the relocation of 
PIKfyve to the secretory vesicles from the cytoplasm upon nicotine 
stimulation appears to be important for its priming function. Contradictory to 
the role of PIKfyve as a negative regulator of exocytosis in neuroendocrine 
cells, PIKfyve was found to positively regulate lytic granule exocytosis in NK 
cells in the present study. Interestingly, PIKfyve was not found to associate 
with LAMP1 on lytic granule membranes in NK-92 cells, indicating that 
PIKfyve is unlikely to participate in a granule membrane priming step that 
promotes exocytosis. Instead, PIKfyve may function in a granule-
independent step to mediate secretion of these organelles.  
Expression of a dominant-negative kinase-deficient PIKfyve mutant inhibits 
the insulin-induced translocation of the GLUT4 to the cell surface in 
adipocytes (Ikonomov et al., 2002b, Ikonomov et al., 2007). This finding 
indicates a positive regulatory role for PIKfyve in the translation of GLUT4 
storage vesicles to the plasma membrane during regulated exocytosis. 
Insulin-induced surface GLUT4 trafficking is coupled with an increase in 
PtdIns(3,5)P2, yet it is unclear how the increased lipid level mediates GLUT4 
translocation. One suggested mechanism is that PtdIns(3,5)P2 on early 
endosomes promotes the budding of carrier vesicles containing GLUT4 that 
have undergone re-internalisation from the plasma membrane and routes 
them to newly synthesised GLUT4 storage vesicles (Shisheva, 2008). This 
likely serves to replenish the depleted pool of readily-releasable GLUT4 
storage vesicles during insulin challenge. In NK cells, the recycling 
endosome was recently found to mediate the refilling of newly synthesised 
lytic granules with perforin (Reefman et al., 2010), suggesting that an 
interaction between endocytic vesicles and lytic granules is important for 
granule maturation. PIKfyve-mediated production of PtdIns(3,5)P2 might be 
required for the trafficking of lytic granule components from early endosomes 
to lytic granules to facilitate granule maturation and/or secretion.  
In addition to its priming function, Munc13-4 was also found to mediate a 
lytic granule maturation step involving recycling endosomes in CTLs. In an 
elegant study by Ménager et al., 2007, Munc13-4 was found to mediate the 
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association of Rab11-positive recycling endosomes with Rab27-positive late 
endosomes to form exocytic vesicles carrying secretory machinery 
components. Upon target recognition, these exocytic vesicles 
simultaneously polarised to the immunological synapse with perforin-
containing lytic granules, where they fused together immediately before 
secretion. This fusion step confers Munc13-4 and Rab27a proteins to the 
membranes of lytic granules rendering them competent to dock and fuse 
with the plasma membrane (Ménager et al., 2007). For a summary of lytic 
granule maturation steps, see Figure 1.4. PIKfyve is unlikely to form part of 
the exocytic machinery, as we would expect a degree of colocalisation 
between PIKfyve and LAMP1 at the NK-92-K562 immunological synapse, 
though this was not the case (Figure 5.5). The role of PIKfyve in maintaining 
endosome integrity and endosome-linked pathways is well documented 
(Jefferies et al., 2008, Ikonomov et al., 2003a, de Lartigue et al., 2009). 
Thus, PIKfyve may instead function in one of the lytic granule maturation 
steps involving endocytic vesicles. Indeed, PIKfyve puncta polarised 
simultaneously with LAMP1-positive granules at the NK-92-K562 interface 
and this positioning may be important during degranulation. Simultaneous 
polarisation with lytic granules has been demonstrated for Rab27a- and 
Munc13-4-containing vesicles that do not colocalise with lytic granule 
proteins until immediately prior to secretion (Capuano et al., 2012, Ménager 
et al., 2007).  
PIKfyve is directed to endocytic membranes by its PtdIns(3)P-binding FYVE 
domain where it generates PtdIns(3,5)P2 and PtdIns(5)P (Jefferies et al., 
2008, Ikonomov et al., 2011). The disrupted endosomal morphology 
observed during suppressed PIKfyve activity is mediated solely through the 
loss of PtdIns(3,5)P2, as micro-injection of PtdIns(3,5)P2, but not PtdIns(5)P, 
into vacuolated cells reversed the phenotype (Ikonomov et al., 2002a). 
Furthermore, lysosomal degradation of the internalised epidermal growth 
factor (EGF) receptor was blocked by PIKfyve inhibition and is thought to 
result from inhibited PtdIns(3,5)P2-mediated fusion between EGF receptor-
containing endosomes and lysosomes (de Lartigue et al., 2009).  
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Figure 5.6. The proposed function of PIKfyve in the NK lytic granule 
maturation pathway 
A schematic diagram (based on Figure 1.4), representing the stages of lytic granule 
exocytosis and including the possible steps in which PIKfyve may function. Through 
the generation of PtdIns(3,5)P2 on late endosomal membranes, PIKfyve could 
mediate the fusion of this compartment with recycling endosomes, to form the 
exocytic vesicle (1), or the formation of mature lytic granules upon target 
conjugation, in the final maturation stage immediately preceding exocytosis (2). 
Alternatively, following degranulation and the re-internalisation of secretory 
machinery components into the early endosome, PIKfyve could mediate their 
sorting into their respective endocytic compartments. This function would ensure 
the correct protein machinery is ultimately delivered to the lytic granule during the 
maturation process, and enable the replenishment of vesicles necessary for further 
rounds of exocytosis (3). Furthermore, PIKfyve may promote normal endosome 
maturation, ensuring a continuous supply of endosome vesicles available for 
granule maturation events. Adapted from de Saint Basile et al., 2010. RE, recycling 
endosome; EE, early endosome. 
 
In NK cells, PIKfyve-mediated production of PtdIns(3,5)P2 on the 
membranes of late endosomes might prime them for fusion with recycling 
endosomes to form exocytic vesicles, or promote the fusion of exocytic 
vesicles with lytic granules upon target recognition (Figure 5.6, steps 1 and 
2). Alternatively, PtdIns(3,5)P2 might promote the trafficking of granule 
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components from early endosomes directly to newly synthesised lytic 
granules, replenishing the pool of granules ready for maturation and/or 
fusion, similar to the mechanism proposed by Shisheva and colleagues 
(2008). This hypothesis is strengthened by observations in the present study 
that PIKfyve inhibition causes early endosome enlargement in NK cells, 
which may reflect inhibited trafficking out of early endosomes. Thus, PIKfyve 
inhibition would impede interaction between endosomes and lytic granules, 
rendering these compartments refractory to fusion and impairing lytic 
granule maturation. Alternatively, PIKfyve may promote endosome 
maturation in NK cells, as has been shown in other cell types (Ikonomov et 
al., 2003a). Late endosomes can form from the gradual maturation of early 
endosomes that accumulate ILVs and become increasingly multivesicular 
(Futter et al., 1996, Huotari and Helenius, 2011). Catalytically-inactive 
mutant PIKfyve results in the formation of enlarged late endosomes with 
relatively few ILVs (Ikonomov et al., 2003a), suggesting that ILV formation 
requires the production of PtdIns(3,5)P2. Although the enlarged organelles in 
YM201636-treated NK-92 cells in the present study were found to be early 
endosomes positive for EEA1 (Figure 5.3), this may reflect a similar failure in 
ILV formation that inhibits normal early-to-late endosome maturation. A 
reduced number of mature late endosomes may affect the pool of exocytic 
vesicles available for fusion during degranulation (Figure 5.6, step 3). 
NK cells are able achieve multiple rounds of killing within a short time period 
(Bhat and Watzl, 2007). The recycling of cytolytic machinery components 
from the plasma membrane after degranulation is thought to be a rate-
limiting step of subsequent rounds of target lysis. The mechanisms 
governing the recycling process in either NK and CTLs is unknown. A recent 
study found that Munc13-4 internalisation from the plasma membrane 
following an initial degranulation event was required for subsequent rounds 
of killing by the same NK cell (Capuano et al., 2012). Recycling was 
dependent on the formation of PtdIns(4,5)P2-rich raft domains and is 
proposed to replenish the pool of endocytic vesicles available for further 
rounds of fusion. It is possible that PIKfyve is involved in the membrane 
retrieval of other secretory components, such as Rab27a for example, back 
to endocytic vesicles, though PIKfyve-mediated membrane retrieval is not 
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documented. Alternatively, PIKfyve might function at the early endosome to 
correctly sort re-internalised secretory components back to their respective 
compartments following degranulation (Figure 5.6, step 3). Reports 
documenting perturbed endosome-to-Golgi trafficking in cells expressing 
kinase-inactive PIKfyve, as well as reduced degradative sorting of EGF 
receptor with addition of YM201636, would seem to support this function, 
though the exact mechanism is disputed (de Lartigue et al., 2009, Rutherford 
et al., 2006). In both cases, PIKfyve inhibition in NK cells would permit an 
initial degranulation event, but limit subsequent rounds of degranulation with 
multiple targets. 
PIKfyve is also a major source of PtdIns(5)P synthesis through the 
phosphorylation of PtdIns (Ikonomov et al., 2011, Zolov et al., 2012). 
Although perturbed endosomal homeostasis is mediated by loss of 
PtdIns(3,5)P2 rather than PtdIns(5)P (Ikonomov et al., 2002a), the inhibition 
of degranulation in YM201636-treated NK cells might be uncoupled from 
endosome enlargement. Instead, it is possible that changes in PtdIns(5)P 
levels during PIKfyve inhibition might contribute to the loss of NK cell 
cytotoxicity observed in the present study. Remodelling of the F-actin stress 
fibre network in response to insulin in adipocytes was shown to be important 
for GLUT4 translocation and appears to be modulated by PtdIns(5)P levels 
(Sbrissa et al., 2004). Overexpression of wild type PIKfyve or microinjection 
of PtdIns(5)P, but not other PIs, enhances F-actin disassembly and 
promotes GLUT4 translocation. Conversely, ectopic expression of a peptide 
containing multiple PHD (plant homeodomains) domains that selectively bind 
and sequester PtdIns(5)P, block insulin-induced F-actin disassembly 
(Sbrissa et al., 2004). The physiological relevance of PtdIns(5)P in NK cells 
is unknown. It may be important for regulating F-actin reorganisation at the 
immunological synapse required for lytic granule secretion in response to 
conjugate formation (Rak et al., 2011). Thus, depletion of PtdIns(5)P through 
PIKfyve inhibition might impair lytic granule exocytosis by blocking actin 
reorganisation at the plasma membrane.  
The function of PtdIns(3,5)P2 or PtdIns(5)P has not been studied in NK cells. 
My results suggest that PIKfyve-mediated production of PtdIns(3,5)P2, and 
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possibly PtdIns(5)P, is important for NK lytic granule secretion and may 
highlight a function of PIKfyve in secretory lysosome exocytosis in other cell 
types. PIKfyve regulates PI levels and may be involved in fine-tuning vesicle 
priming during the lytic granule maturation pathway. It is important to note 
that PIKfyve heterozygous mice (Ikonomov et al., 2011) or patients suffering 
from the autosomal dominant syndrome Francois-Neetens corneal fleck 
dystrophy (caused by mutations in PIKfyve; Li et al., 2005), do not suffer 
from any obvious immune dysfunction. Lytic granule exocytosis in primary 
NK cells is decreased, but not abolished, upon PIKfyve inhibition. This could 
suggest that PIKfyve is not required for NK cell cytotoxicity, or may reflect a 
functional redundancy of PIKfyve, indicating PIKfyve is important but not 
absolutely required for NK cell cytotoxicity (Figure 5.4D). In addition to its 
lipid kinase activity, PIKfyve also phosphorylates a number of proteins 
involved in endocytic trafficking (Ikonomov et al., 2003b). It is possible that 
NK cell degranulation requires PIKfyve protein kinase activity and that 
YM201636 somehow interferes with this function. In the present study, only 
the short-term effect of PIKfyve inhibition was examined. It is possible that 
the effect of reduced PIKfyve activity on degranulation may be overcome 
after prolonged stimulation of NK cells. Nonetheless, the lack of immune 
dysfunction in patients carrying PIKfyve mutations is difficult to explain given 
the observations made in the present study. The apparent reduction in NK 
cytotoxicity may indeed be independent of reduced PIKfyve lipid kinase 
activity, instead reflecting the YM201636-mediated inhibition of other 
proteins required for NK cell lytic granule exocytosis. Further examination of 
the role of PtdIns(3,5)P2 and PtdIns(5)P in NK cells is needed before the 
contribution of these PIs to NK granule exocytosis can be determined. In 
particular, the effects of siRNA-mediated PIKfyve silencing and the 
expression of kinase-inactive PIKfyve mutants are needed to confirm a role 
for PIKfyve in lytic granule exocytosis. Close inspection of the vesicle 
compartment to which PIKfyve is localised, through staining with various 
endocytic markers such as Rab proteins, may help pin-point which step in 
the granule maturation pathway that PIKfyve might function.  
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Chapter 6 
Conclusion and Future Work 
6.1 Key Findings 
The objective of this work was to define the mechanisms that contribute to 
NK cell lytic granule biogenesis and exocytosis. An additional aim was to 
investigate the giant lysosome phenotype seen in CHS/beige using RNA 
interference and the contribution of PtdIns(4,5)P2 and autophagy to the 
cellular defect of beige. 
The major findings of the present study are:  
• siRNA-mediated silencing of Lyst in mouse fibroblasts successfully 
recapitulates the major aspect of the CHS/beige phenotype, namely 
the generation of giant lysosomes. 
• The phosphatidylinositol 3-phosphate 5-kinase PIKfyve is required for 
the exocytosis of NK cell cytotoxic granules. 
6.2 Conclusion and Future Work 
At the time of this study, many questions still remained unanswered 
regarding the mechanistic pathways underlying the biogenesis and 
exocytosis of secretory lysosomes in cells of the immune system. Several 
proteins involved in the exocytosis of granules from cytotoxic lymphocytes 
(NK cells and CTLs) are well defined, such as Rab27a and Munc13-4. Yet 
many proteins remain unidentified, or their function uncharacterised, such is 
the case for LYST. Clear evidence is emerging that lytic granules undergo a 
series of maturation steps involving endocytic vesicles and that these steps 
occur rapidly after cellular stimulation, but prior to secretion (Ménager et al., 
2007, Wood et al., 2009, Capuano et al., 2012). However, our knowledge of 
the molecular machinery involved in these pathways is limited. Furthermore, 
the role of PIs in granule exocytosis downstream of stimulation is reported in 
relatively few studies. The present study provides evidence that PIKfyve is 
involved in the NK cell lytic granule exocytosis pathway, as pharmacological 
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inhibition of PIKfyve impaired degranulation in response to stimulation with 
tumour cells in the NK cell line NK-92 and in primary NK cells isolated from 
the blood. PIKfyve did not colocalise with LAMP1-positive puncta in NK cells; 
however, upon conjugation with a target cell, PIKfyve-positive puncta 
simultaneously trafficked to the immunological synapse with LAMP1-positive 
granules. Similar redistribution of the fusion machinery components Rab27a 
and Munc13-4 (located on endocytic vesicles distinct from lytic granules) 
occurs in response to target conjugation in both NK cells and CTLs 
(Ménager et al., 2007, Wood et al., 2009). Defects in these proteins result in 
lytic granules that polarise normally but are unable to fuse with the plasma 
membrane (Ménasché et al., 2000, Feldmann et al., 2003). Fusion events 
between lytic granules and endocytic vesicles containing Rab27a and 
Munc13-4 are a prerequisite for exocytosis. Previous studies support a role 
for PIKfyve in endocytic trafficking, fusion/fission events and exocytosis of 
storage vesicles (Jefferies et al., 2008, Ikonomov et al., 2003a, de Lartigue 
et al., 2009, Ikonomov et al., 2007, Ikonomov et al., 2009b). Based on these 
published reports and the data presented here, it seems likely that PIKfyve 
functions in a fusion or trafficking step involving endosomes and that this 
activity facilitates the maturation of fusion-competent granules in NK cells. It 
remains to be determined whether the impaired degranulation observed in 
PIKfyve inhibitor-treated NK cells is due to reduced PtdIns(3,5)P2 or 
PtdIns(5)P or both. Examining the changes in levels of these PIs in NK cells 
in response to stimulation may provide further insight, but this is difficult to 
determine in the absence of a functional PtdIns(3,5)P2 probe. Altered levels 
of PtdIns(3,5)P2 are linked with Francois-Neetons corneal fleck dystrophy 
(caused by mutations in PIKfyve; Li et al., 2005) and peripheral neuropathy 
in patients with Charcot-Marie-Tooth disease type 4 (caused by mutations in 
Sac3; Chow et al., 2007). Immunological impairment is not reported in these 
patients and this is difficult to reconcile with the defective NK cell function 
observed in PIKfyve inhibited cells. Patients with Charcot-Marie-Tooth 
disease type 2 (caused by mutations in Dynamin 2; Zuchner et al., 2005), 
suffer from peripheral neuropathy yet do not exhibit immunological defects, 
despite the recent finding that depletion of Dynamin 2 impairs NK cell 
cytotoxicity (Arneson et al., 2008). Dynamin 2 is thought to function in a 
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terminal stage of lytic granule exocytosis and like PIKfyve, traffics 
independently but polarises simultaneously with lytic granules at the 
immunological synapse upon target conjugation (Arneson et al., 2008). 
Furthermore, depletion of Dynamin 2 reduces but does not completely block 
NK lytic granule exocytosis, similar to PIKfyve inhibition.  
In the present study, the effect of suppressed PIKfyve activity on NK cell 
cytotoxicity was tested through a single means; YM201636-mediated 
PIKfyve inhibition, therefore, impaired granule exocytosis as a result of non-
specific YM201636-mediated inhibition of other proteins cannot be ruled out. 
Inhibition of PIKfyve activity through alternative means, i.e., expression of 
kinase-deficient PIKfyve mutants and RNAi, is needed to validate the theory 
that PIKfyve is required for NK cell cytotoxicity. Careful colocalisation 
analysis of PIKfyve with endocytic markers such as Rab5, Rab27a and 
Rab11 during stimulation is required to ascertain whether PIKfyve 
associates with early, late or recycling endosomes, respectively. Such 
analyses will help determine whether PIKfyve co-ordinates an endocytic 
fusion or trafficking event which contributes to granule maturation.  
If potentiation of granule exocytosis occurs alongside an increase in 
intracellular PtdIns(3,5)P2, this would confirm a requirement for PtdIns(3,5)P2 
in granule secretion. Such an increase could be generated experimentally 
through the overexpression of wild type PIKfyve, or inhibition of the Sac3 
phosphatase that depletes PtdIns(3,5)P2. Indeed, siRNA-mediated depletion 
of Sac3 in adipocytes causes a slight but significant elevation in 
PtdIns(3,5)P2 that potentiates insulin-stimulated GLUT4 vesicle exocytosis 
(Ikonomov et al., 2009a). The present study is the first to examine the role of 
PIKfyve in the regulated secretion of NK lytic granules and the data suggest 
a role for this protein and its products, PtdIns(3,5)P2 and PtdIns(5)P, in the 
exocytosis of secretory lysosomes.  
This study reports that siRNA-mediated Lyst silencing in cultured mouse 
fibroblasts successfully recapitulates the major aspect of the CHS/beige 
phenotype of abnormally large and clustered lysosomes. Knockdown at the 
level of Lyst mRNA was confirmed but in the absence of a working Lyst 
antibody, the level of Lyst protein knockdown could not be determined. 
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Nonetheless, this is the first study that uses RNAi to examine the function of 
Lyst and demonstrates that siRNA-mediated Lyst silencing could be used as 
a model system to study Lyst function and CHS/beige. Future studies could 
involve using siRNA to screen the LYST-interacting proteins identified by 
Tchernev and colleagues (2002) for a similar induction of lysosomal 
enlargement, which might establish them as functioning in the same 
pathway of lysosome regulation as LYST.  
A gene network regulating lysosomal biogenesis and autophagy was 
recently discovered to be controlled by the transcription factor EB (TFEB) 
(Settembre et al., 2013). Lysosomal dysfunction (that occurs with lysosomal 
storage diseases, for example) was found to trigger TFEB nuclear 
translocation where it upregulated the expression of genes associated with 
the lysosomal-autophagy pathway (Sardiello et al., 2009). The increase in 
basal autophagy and abundance of the lysosomal membrane protein LAMP1 
observed in beige cells here could be the result of nuclear TFEB signalling in 
response to lysosomal dysfunction and is a potential area for investigation.  
Severe immunologic dysfunction in CHS patients and the beige mouse is 
caused by the defective exocytosis of enlarged secretory lysosomes in many 
immune cell types. Despite extensive analysis of the biogenesis and 
morphology of the enlarged lysosomes, several aspects of the CHS/beige 
phenotype remain relatively unexplored. In particular, the role of LYST in the 
regulation of PtdIns(4,5)P2 metabolism is unknown. The subcellular 
localisation of PtdIns(4,5)P2 was discovered to be significantly altered in 
CHS/beige fibroblasts (Ward et al., 2003), but the contribution of altered 
PtdIns(4,5)P2 levels to the CHS/beige phenotype has not been examined. 
My results suggest that an increase in plasma membrane PtdIns(4,5)P2 is 
coupled with a decreased abundance of two PtdIns(4,5)P2 hydrolysing 
isoenzymes, PLCγ1 and PLCγ2 in beige fibroblasts. 
PLCγ and the products of its enzymatic activity, Ins(1,4,5)P3 and DAG, have 
indispensible roles in the stimulated exocytosis of secretory lysosomes from 
mast cells and NK cells (Hammond et al., 2006, Caraux et al., 2006). Thus, 
reduced PLCγ activity in these cells might contribute to the degranulation 
defect of CHS/beige. The concomitant hydrolysis of PtdIns(4,5)P2 and 
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production of DAG by PLC is required for the exocytosis of mast cell 
granules (Hammond et al., 2006). Both PLCγ1 and PLCγ2 are expressed by 
NK cells (Upshaw et al., 2005) and PLCγ2 is a key component in the 
degranulation pathway of NK cells (Caraux et al., 2006). NK cells from 
PLCγ2-/- mice failed to secrete their lytic granules, despite conjugate 
formation and polarisation of granules to the immunological synapse 
(Caraux et al., 2006). The secretory defect was specific to lytic granules, as 
secretion of IFNγ was unaffected (Caraux et al., 2006). Similarly, CHS/beige 
NK cells and CTLs have normal cytokine secretion, but fail to secrete 
cytotoxic granules despite normal polarisation (Baetz et al., 1995, Targan 
and Oseas, 1983, Shiflett et al., 2002).  
No definitive pathway has been identified in which Lyst functions to regulate 
lysosome morphology or exocytosis of secretory lysosomes. The defective 
lytic granule exocytosis in CHS/beige NK cells has previously been 
attributed to enhanced PKC proteolysis (Ito et al., 1988, Ito et al., 1989, 
Tanabe et al., 1998, Tanabe et al., 2009), but a link between LYST 
deficiency and enhanced PKC proteolysis has not been established. My 
study documents for the first time that the abundance of PLCγ, which lies 
upstream of PKC in the same pathway, is reduced in beige fibroblasts and 
implicates LYST in the PtdIns(4,5)P2 signal transduction pathway. Thus, 
these findings identify an area for further research. If immunoblot analysis 
reveals a similar depletion of PLCγ protein in CHS/beige NK cells, it is likely 
that perturbations in this signalling pathway will contribute to the defective 
exocytosis of lytic granules in LYST-deficient NK cells, and indeed other cell 
types whose secretory function is abolished in CHS/beige. As mentioned 
previously, depletion of plasma membrane PtdIns(4,5)P2 by PLCγ is 
essential for mast cell degranulation (Hammond et al., 2006). A similar 
scenario might exist in NK cells, but was not examined in the present study. 
To test this, immunofluorescence analysis could be used to monitor 
PtdIns(4,5)P2 levels at the plasma membrane at fixed time points following 
stimulation in both normal and CHS/beige NK cells.  
The notion that the PH and BEACH domains function as a single unit (Jogl 
et al., 2002, Gebauer et al., 2004), coupled with the finding that the PH 
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domain of FAN is PtdIns(4,5)P2-binding (Haubert et al., 2007) is a significant 
development in establishing BEACH domain function. HEAT and Armadillo-
like domains have recently been confirmed to be PtdIns(4,5)P2-binding 
modules (Catimel et al., 2008), further supporting a PtdIns(4,5)P2-binding 
capacity for LYST that may be important for its localisation and/or function. 
PtdIns(4,5)P2-rich lipid rafts are found at the NK cell immunological synapse 
and are important for lytic granule exocytosis (Capuano et al., 2012). An 
interesting hypothesis is that specific extracellular stimuli, such as NK cell 
receptor activation, induces binding of LYST to target proteins which in turn 
triggers a conformational change in the PH-BEACH domain that, opens up 
the lipid-binding pocket of the PH domain. This could target LYST to 
PtdIns(4,5)P2-rich sites at the synapse where it might function to recruit and 
scaffold protein complexes involving PLCγ or PKC and co-ordinate signalling 
events that facilitate granule exocytosis. Indeed, several other BEACH 
proteins act as scaffolds for protein interactions (Newlon et al., 1999, 
Filimonenko et al., 2010). 
The PH domains of several protein-tyrosine kinases mediate high affinity 
interactions with PKC (Yao et al., 1997). LYST might interact with PKC 
through its PH domain, scaffolding it to substrates and protecting it from 
proteolysis. In the absence of a LYST scaffold, PKC may become vulnerable 
to degradation, thus resulting in the reduced level of PKC observed in the 
present study and by others (Tanabe et al., 2000, Tanabe et al., 2009). PKC 
and PLC are potent signalling transducers and restricting their subcellular 
localisations through scaffolding, coupled with enhanced degradation when 
not scaffolded, may be an important mechanism for restricting unwarranted 
ectopic signalling. Clearly the need for a working antibody is crucial, as this 
will answer many questions pertaining to the function and localisation of 
LYST. 
PI conversion is tightly regulated; perturbed levels of one species will likely 
affect the overall metabolism of many others and the cellular pathways in 
which they function. This might go some way to explain the enhanced basal 
autophagy observed in beige cells of the present study, as autophagy is 
intrinsically linked to PtdIns(3)P and Ins(1,4,5)P3 levels (Mizushima and 
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Komatsu, 2011, Decuypere et al., 2011). Several lines of evidence exist to 
support a role for LYST in maintaining correct lipid signalling and/or 
metabolism. These include reduced levels of PKC, elevated ceramide and 
PtdIns(4,5)P2 mislocalisation in CHS/beige cells (Tanabe et al., 1998, 
Tanabe et al., 2000, Ward et al., 2003). The present study also documents 
an altered abundance of the PtdIns(4,5)P2-binding protein PLCγ which 
generates the lipid second messengers DAG and Ins(1,4,5)P3. PIs are 
essential for a plethora of cellular processes, including cytoskeletal 
reorganisation, cell signalling and vesicle transport (Roth, 2004). Thus, 
perturbed PI trafficking or altered enrichment or depletion of specific lipids at 
membranes in LYST-deficient cells may account for the impaired lysosome 
homeostasis and defective exocytosis of these cells. Furthermore, the 
function of LYST as master regulator of vesicle and membrane fusion events 
is an attractive hypothesis. LYST function may be differentially regulated 
according to cell type, the organelle to which it associates and the specific 
stimuli, such as NK cell activation and lytic granule secretion. Secretion is 
tightly regulated and even a slight disturbance in lipid signalling or 
metabolism might disrupt this mechanism. This is supported by my finding 
that inhibition of PIKfyve activity reduces NK cell granule exocytosis.  
The regulated exocytosis of secretory lysosomes is critical to the function of 
many immune cell types that contain them. Future studies which examine 
the contribution of specific PIs and their regulatory proteins to exocytosis of 
these specialised organelles will undoubtedly emphasise the importance of 
these lipids in coordinating immune responses.  
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Appendix 
Time-lapse analysis of the swollen vesicles induced by YM201636 
Frames are taken from a film of 3T3-J2 cells treated with 800 nM YM201636 
(+YM201636). The time above each image indicates the time elapsed after the 
addition of YM201636. In a separate experiment, cells which had been treated with 
YM201636 for four hours were washed free of YM201636 and then imaged (–
YM201636). The time above each image indicates the time elapsed after the 
removal of YM201636. The enlarged vesicles return to normal size after withdrawal 
of YM201636. Scale bar = 20 µm. 
